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ABSTRACT 
Human cytomegalovirus (HCMV) is a species-specific β-herpesvirus that establishes a 
lifelong latent infection in ~80% of the world’s population and can cause severe opportunistic 
diseases in immunosuppressed patients including those with AIDS. Of these, AIDS-related 
HCMV retinitis is a significant ophthalmological problem worldwide. Although the clinical 
features of AIDS-related HCMV retinitis are well established, the virologic and immunologic 
events that take place during onset and development of this sight-threatening retinal disease 
remain poorly understood. Toward this end, an established animal model of murine 
cytomegalovirus (MCMV) retinitis in mice with retrovirus-induced immunodeficiency (MAIDS) 
that mimics AIDS-related HCMV retinitis was used in the present investigation to test the central 
hypothesis that pyroptosis, as a programmed cell death pathway of innate immunity, and 
associated inflammasomes contribute to the onset and development of full-thickness retinal 
necrosis during MAIDS-related MCMV retinitis. Our findings show (i) intraocular MCMV 
infection stimulates key pyroptosis-associated transcripts and proteins within the eyes of 
retinitis-susceptible MAIDS mice but not within the eyes of retinitis-resistant mice; (ii) a 
deficiency in key pyroptosis-associated molecules and inflammasomes in MAIDS mice results in 
an atypical histopathologic pattern of retinal disease within MCMV-infected eyes characterized 
by preservation of the neurosensory retina without full-thickness retinal necrosis but with 
proliferation of the retinal pigmented epithelium; (iii) MCMV-infected eyes of corticosteroid-
immunosuppressed mice display stimulation of key pyroptosis-associated molecules and 
inflammasomes similar to that observed for MCMV-infected eyes of mice with MAIDS; (iv) 
MCMV infection of IC-21 macrophages and mouse embryo fibroblasts grown in culture 
stimulates key pyroptosis-associated transcripts in a cell-type specific manner; and (v) increased 
susceptibility to MCMV retinitis during the progression of MAIDS is associated with robust 
upregulation of a surprisingly large number of immune response genes that operate within 
several immune response pathways. Taken together, these results suggest that pyroptosis and 
associated inflammasomes play a significant role during the pathogenesis of full-thickness retinal 
necrosis within MCMV-infected eyes during MAIDS. These findings add new knowledge to our 
understanding of the contributions of programmed cell death pathways of innate immunity 
towards the pathogenesis of AIDS-related HCMV retinitis and may extend to other AIDS-related 
opportunistic virus infections. 
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1 
1 INTRODUCTION  
Human cytomegalovirus (HCMV) is a species-specific β-herpesvirus that establishes 
lifelong infection in approximately 80% of the world’s population [1]. Although usually 
asymptomatic in immunocompetent individuals, infection with HCMV is often asymptomatic 
and can cause severe morbidity in at-risk immunocompromised populations. Specifically, AIDS-
related HCMV retinitis is a sight-threatening manifestation of this virus that remains a significant 
ophthalmological problem since access to combination antiretroviral therapy (cART) is not 
readily available worldwide and several individuals who do have access fail to adhere or respond 
to treatment [2, 3]. Understanding the pathogenesis of this disease is essential to developing new 
and effective treatments for its prevention. Although the clinical features of AIDS-related 
HCMV retinitis are well established, the direct mechanisms by which HCMV infection results in 
severe retinal damage is still unknown. To investigate these direct mechanisms, our lab uses a 
well-established, reproducible, clinically relevant mouse model with retroviral-induced 
immunosuppression (MAIDS) that results in susceptibility to experimental murine 
cytomegalovirus (MCMV) retinitis, which mimics the pathophysiology seen during AIDS-
related HCMV retinitis [1, 4, 5]. Using this model, we have previously found that several 
inflammasomes and pyroptosis markers are significantly stimulated in the eyes of mice during 
experimental MAIDS-related MCMV retinitis [6]. However, the impact and effect this 
inflammatory form of programmed cell death has on the onset and progression of MAIDS-
related MCMV retinitis has yet to be explored.  
1.1 Herpesviruses  
As obligate intracellular organisms, viruses have adapted several basic structures 
necessary for replication inside the cells of living host, and the differences in these essential 
2 
structures differ between the various classes of viruses. All viruses have genetic material that is 
either single-stranded (ss) or double-stranded (ds) DNA or RNA and is packaged in a protein 
capsid, forming the nucleocapsid. The virus may have an envelope surrounding the nucleocapsid, 
which is derived from the host cell, depending on the virus’ evolution for infection. Filling the 
space between the envelope and the capsid is an area known as the tegument. The tegument 
contains viral proteins that are indispensable for early infection and are released into the host cell 
once the virus has gained entry. Entry into the host cell is typically mediated on the surface of 
the virus (either the nucleocapsid or the envelope) by glycoproteins that recognize and bind to 
specific receptors on the host cell. The target host cells, morphological features, mode of 
replication, and pathological consequence of the host organism differ significantly among 
different types of viruses, and so the classification of these viruses are phylogenetically 
organized based on the similarities of the viruses to each other, and how they are thought to have 
evolved [7].   
 Herpesvirales is one of several orders of viruses characterized as enveloped 
dsDNA viruses composed of an icosahedral capsid with a T=16 symmetry, whose target host is 
animals. CMV is further classified into the family Herpesviridae due to its preferred infection of 
amniotes (birds, reptiles, and mammals). Members of this family replicate and partially assemble 
within the nucleus and can establish latency in their host, which often results in reoccurring lytic 
infections that destroy the infected host cell [7, 8]. Herpesviruses are extremely widespread 
among humans, as at least 90% of adults have been infected and therefore maintain a latent form 
of at least one of several herpesviruses. There are nine known human herpesviruses (HHV) to 
date referred to as HHV-1 through HHV-8, with HHV-6B being recognized as distinctly 
3 
different from HHV-6A (Table 1.1). These nine human viruses are further classified into 
subfamilies based on where they form latency in the host cell [7].   
Table 1.1: Human Herpesviruses in the Family Herpesviridae 
 
Adapted from [9]  
Alphaherpesvirinae. The α-herpesviruses (HHV-1 through HHV-3) infect several host 
species and are known to replicate and spread more quickly than the other subfamilies of 
herpesviruses. These viruses initially infect epithelial cells via direct contact and quickly 
disseminate to the neurons to establish latency. The Simplexvirus and Varicellovirus genera of 
the α-herpesviruses infect humans and establish latency in the sensory nerve ganglia. Most 
known of the Simplexvirus genus are herpes simplex type 1 (HSV-1) and HSV-2, which manifest 
in the form of orofacial lesions, genital lesions, keratoconjunctivitis, and encephalitis. The 
Varicellovirus genus contains the varicella-zoster virus (VZV), which is responsible for the 
development of chickenpox in young children and reoccurs as shingles later in life [7]. 
4 
 Betaherpesvirinae. The β-herpesviruses are classified based on their tendency to 
establish latency in lymphoid cells of hematopoietic origin. These viruses also tend to replicate 
more slowly than the other herpesviruses and have strict specificity of the host in which they can 
replicate. The human herpesviruses that comprise this subfamily include HHV-6 and HHV-7, 
which are part of the Roseolavirus genus, form latency in CD4+ T cells, and are responsible for 
roseola [10, 11]. Also included in this subfamily is the genus Cytomegalovirus, which includes 
HHV-5, or HCMV, and form latency in monocytes and bone marrow cells. HCMV is 
responsible for various congenital infections, as well as several infections spanning multiple 
organs in immunocompromised individuals [7].   
 Gammaherpesvirinae. The γ-herpesviruses establish latency within lymphoid 
tissues of mammalian hosts. These viruses vary in their rate of replication—which is generally in 
B or T lymphocytes—and contain the human herpesviruses HHV-4 and HHV-8. HHV-4, known 
as Epstein-Barr virus (EBV), is part of the Lymphocryptovirus genus and is responsible for 
infectious mononucleosis. HHV-8 is part of the Rhadinovirus genus and is commonly referred to 
as Kaposi’s sarcoma-associated herpesvirus (KSHV) [7]. 
1.2 Cytomegalovirus  
1.2.1 CMV Structure 
Because herpesviruses share similar morphological features with other membranes in the 
same order, it makes sense that they share similar virion structures and protein functions. A 
notable difference of CMV is their 200-230 nm diameter, making them slightly larger than all 
other herpesviruses. This size includes their envelope, which is entrenched with virus-encoded 
glycoproteins. HCMV is thought to derive its envelope from the host endoplasmic reticulum 
(ER), the ER-Golgi intermediate compartment, or endosomes [12-14]. The envelopes of HCMV 
5 
are coated with several glycoproteins, which form complexes that are important for HCMV 
replication. One of these complexes consists of a glycoprotein B (gB) trimer, while another 
complex is composed of gH and gL, which form the heterodimer gH:gL. Both complexes are 
required for viral entry into the host cell. Another complex, gM:gH, is vital for virion maturation 
[15].  
Beneath the envelope is a thick tegument, which contains most of the proteins encoded by the 
genome. The tegument is composed of at least 32 known viral proteins as well as several host 
proteins [16] and even host RNA [17]. These tegument proteins are involved in all steps of viral 
replication, including entry into the host cell, in which the virion transactivator (VTA) tegument 
phosphorylated protein (pp)71 quickly translocates to the nucleus and recruits host cell 
machinery to initiate gene transcription [12]. Tegument proteins are also involved with egress 
from the host cell, where other phosphorylated proteins can interact with the immune system of 
the host.  
The tegument encloses a 130 nm, icosahedral nucleocapsid of 162 capsomeres with a T=16 
symmetry. The genome of CMV is contained in a core of linear dsDNA and encodes at least 66 
known tegument proteins (reviewed in [12], and as shown in Figure 1.1 from [18]). Four of these 
virally encoded proteins form the HCMV capsid. These proteins—the major capsid protein 
(MCP), triplex subunits 1 (TRI1), TRI2, and smallest capsid protein (SCP)—are essential for the 
growth of the virus. As the name suggests, MCP comprises the bulk of the capsid and contains a 
specific pore made of the portal protein (PORT), which facilitates the packaging and release of 
the virion genome [12].  
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Figure 1.1. Cytomegalovirus virion structure 
Representation of the cytomegalovirus virion structure, modified from [18].  
 
The HCMV genome consists of linear dsDNA that is divided into two regions, the unique 
long (UL) and the unique short (Us) regions. The ends of these regions are flanked by terminal 
inverted repeat sequences and contain internal redundancy sequences [7] (depicted in Figure 
1.2). The HCMV genome is roughly 236 kb long, and the genes are numbered according to their 
UL or US loci. Additionally, the HCMV genome contains about 200 open reading frames (ORFs) 
and can encode at least 167 proteins [19], including structural and nonstructural proteins, 
tegument proteins, and glycoproteins.  
The genome of the Smith strain of MCMV differs somewhat from HCMV in that it 
contains only one long segment of DNA (UL) and lacks internal repeat sequences [20, 21]. The 
MCMV genome is also approximately 230 kb long and can encode for roughly 170 gene 
products [22]. Despite species-specificity of each, the genomic structures of MCMV and HCMV 
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are comparable to one other [20-23]. The sequences of these two CMV strains overlap one 
another by about 180 kbps of DNA and contain about 78 homologous ORFs [22]. 
 
Figure 1.2. HCMV and MCMV genomic structures. 
Comparison of the HCMV and MCMV genome modified from [24]. TR: terminal repeat, TRL: 
terminal repeat long, TRS: terminal repeat short, IRL: internal repeat long, IRS: internal repeat 
short. 
 
1.2.2  CMV Replication 
HCMV and MCMV replication and assembly occur in the nucleus of the host cell, and 
both viruses undergo a temporal, step-wise viral gene expression and replication cascade [12]. 
The interaction of glycoproteins on the envelope of the virus with a complementary host 
receptor, such as heparin sulfate, mediates attachment and adsorption. Immediately after 
attachment and adsorption, entry into the permissive host cell results from receptor-mediated 
endocytosis (endothelial and epithelial cells) or fusion (fibroblasts) of the viral envelop with the 
host membrane [25]. Viral tegument proteins are then released into the cell, and some are 
believed to be transported to the nucleus of the host cell alongside nucleocapsids via interactions 
with the host microtubule machinery. The nucleocapsid interacts with nuclear pores where it 
injects viral DNA into the nucleus [7], allowing for the commencement of transcription [26-28]. 
The transcription and subsequent translation of viral genes follow a specific sequence, starting 
with immediate early (IE), also known as α genes. Proteins translated from IE transcripts 
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dysregulate cellular functions to allow for viral production. Following transcription of IE genes, 
the transcription of early (E), or β, genes, drive viral DNA synthesis and the expression of late 
(L), or γ, genes. The L genes encode for most of the tegument and glycoproteins. The 
transcription of L genes allows for the assembly of progeny virions, which then egress from the 
cell via exocytosis [12] as outlined in Figure 1.3.  
CMV can infect epithelial cells, endothelial cells, fibroblasts, and myeloid cells. The 
characteristics of CMV infection of several cell types have been widely studied and can differ 
with the species of CMV as well as the infected cell type. Viral IE genes immediately begin 
transcription once the genome enters the nucleus, and this transcription peaks between 8-12 
hours post-infection (hpi) and begins the transcription of E genes, which continues until 
approximately 24 hpi [12, 29]. At this point, the expression of L gene transcription can be seen in 
HCMV infected fibroblasts [30-33], while MCMV IE gene transcription occurs between 1-4 hpi 
in fibroblasts, and as early as 1 hpi in macrophages [32]. The E genes for MCMV are detected at 
about 2 hpi and are seen until about 16 hpi in fibroblasts [33], at the point in which MCMV L 
gene expression begins and can continue for at least 36 hours [30]. The transcription of these L 
genes encodes for most of the viral tegument and glycoproteins, which are involved in capsid 
assembly, virion maturation, and egress from the host cell. 
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Figure 1.3. Lifecycle of HCMV and MCMV within a host cell. 
Depiction of the viral replication of MCMV or HCMV within a host cell. Virion attachment and 
adsorption is followed by entry via fusion into the host cell. The nucelocapsid is shuttled to the 
nucleus followed by IE, and E gene expression. Genome replication is then followed by L gene 
expression, capsid assembly, maturation of virion and ultimately envelopment and egress as the 
virion is released from the cell. Figure from [34]. 
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1.3 HCMV Clinical Disease 
1.3.1 HCMV Infection in Immunocompetent Hosts 
HCMV infects about 80% of adults in developed countries [1] and passes through direct 
contact with bodily fluids, such as saliva, urine, and breast milk. HCMV can be sexually 
transmitted and contracted during organ transplants, blood transfusions, and pregnancy. 
Following acute infection, most immunocompetent individuals do not show any symptoms, 
although occasionally a mild mononucleosis specific for HCMV, has been associated with 
primary infection in immunologically normal persons [35]. Although rare, immunocompetent 
individuals may develop severe diseases, such as myocarditis [36, 37], pneumonia [38-40], 
hepatitis [41-43], encephalitis [44-47], and retinitis [48]. Primary HCMV infection that occurs 
during the first trimester of pregnancy can cross the placenta causing congenital HCMV disease 
[12]. Infected infants may develop neurological inclusion disease [49], which could result in 
manifestations, including microcephaly, the enlargement of ventricles, or cerebral atrophy. Later 
in life, those infected could experience neurological ailments, such as hearing or vision loss or 
even mental retardation [50]. 
1.3.2 HCMV Infection in Immunocompromised Hosts 
HCMV alters the host defenses by either altering the signaling of the recognition receptors, 
weakening the cytokine and interferon activation and suppressing cell death of infected cells, 
thus allowing the virus to survive in the cell and reproduce effectively [12]. In healthy 
individuals, the primary infection is systemic and asymptomatic [1], and the adaptive T cell 
immunity helps to maintain low viral levels [12]. Regardless of the immune response to the 
primary infection, the virus remains latent in the lymphocytes throughout the infected 
individual's life. Competent immune systems typically suppress reactivation of the virus, but in 
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those who are immunocompromised, HCMV becomes an opportunistic infection, and individuals 
exhibit a variety of diseases that are dependent on the cause of their immunosuppression. 
Recipients of organ transplants or bone marrow transplants are at a high risk of developing 
colitis or life-threatening HCMV pneumonitis. Additionally, infection of the transplanted organ 
by HCMV can also contribute to the rejection of the organ by the recipient due to reactivation 
and uncontrolled viral replication in the latent virus [51]. Those who are immunosuppressed by 
HIV-1 infections are particularly susceptible to sight-threatening retinitis caused by HCMV 
directly infecting the retinal tissues [1]. 
1.4 HIV and AIDS 
1.4.1 HIV-1 Replication and Tropism 
HIV-1 has a roughly spherical structure with a 120 nm diameter and is a member of the 
Retroviridae family, meaning that it is an ssRNA virus that changes the genome of the host cell. 
Upon entry into the cytoplasm, HIV-1 uses its own viral reverse transcriptase to produce DNA 
from its RNA genome. The retroviral DNA is then inserted into the host’s genome by a viral 
enzyme, integrase, and is transcribed and translated along with the cell’s own genes. The genome 
encodes for gag, pol, and env regions that are translated as one polypeptide chain cleaved by 
viral-specific proteases. Gag proteins are major components of the capsids, while Pol proteins 
are responsible for viral DNA synthesis and the integration of the viral genome into the host 
genome. The Env proteins are essential for entry of the virions in the host cell, and although 
there are a few copies of these proteins contained within the viral envelope, the enveloped 
nucleocapsid of HIV-1 is composed mostly of lipids obtained from the plasma membrane of the 
host during the budding process. The Env proteins present on the envelope consist of a cap made 
of three molecules of glycoprotein (gp)120, in addition to a stem formed by a trimer of gp41 
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molecules, which anchor this structure to the viral envelope (Figure 1.4). This protein complex is 
what allows the virus to attach to the target host receptors, leading to the fusion of the viral 
envelope with the host cell membrane and allowing for entry into the cell. HIV-1 is further 
classified into the genus Lentivirus, which consist of retroviruses that result in deadly diseases 
following long incubation periods. Lentivirus has a wide range of susceptible hosts that are 
distributed worldwide. There are five serogroups of known Lentivirus, which are classified based 
on the type of host in which they are associated. Primate specific Lentivirus, including HIV-1, 
are distinguished, in part, by their use of CD4 as a receptor for viral entry [52, 53].  
 
Figure 1.4. HIV-1 virion structure. 
Schematic representation of the HIV-1 virion structure. Modified from [54]. 
 
Macrophages, dendritic cells, and CD4+ T cells are the primary targets of HIV-1 due to 
the presence of CD4 on the surface of these cells [52, 53]. In addition to gp120 interacting with 
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the CD4 molecule on the host cell membrane, HIV-1 also interacts with host cell-specific 
chemokine co-receptors, depending on the strain of HIV-1. Macrophage-tropic (M-tropic) HIV-1 
are strains of HIV-1 that do not undergo multiple cell fusions, resulting in multinucleated cells 
known as syncytia. They use the β-chemokine receptor, CCR5, for entry into host cells. T-tropic 
strains of HIV-1 can form syncytia and use the α-chemokine receptor, CXCR4, for entry into 
host cells. There are dual-tropic HIV-1 strains that can use both CXCR4 and CCR5 as co-
receptors for viral entry into host cells. Following binding of the viral Env proteins to the 
specific host receptors and co-receptors, the cell membranes are brought close together, allowing 
for a fusion of the membranes and the injection of HIV-1 RNA and enzymes into the host cell, 
where the virus begins to incorporate its genome into the host’s genome [52, 53]. Following 
transcription, the gp41 and gp120 glycoproteins are again anchored to the host’s plasma 
membrane, where the forming virion is then able to bud from the cell as an immature virion. The 
Gag polyproteins are then cleaved into the matrix, capsid, and nucleocapsid proteins that 
assemble to produce a mature HIV virion, which is able to infect another cell (Figure 1.5) [55]. 
HIV-1 is capable of infecting cells by two distinct mechanisms. The first is cell-free 
spread in which a mature virion enters the blood after recently budding from a host cell and 
encounters another permissible cell in which it enters [56]. The other method of HIV-1 
dissemination is direct transmission from one cell to another, aptly named cell-to-cell spread. 
This direct transmission is either mediated by a virologic synapse [57, 58] or from the help of 
antigen-presenting cells [59]. Cell-to-cell spread is generally more efficient at dissemination of 
the virus within the body than a cell-free spread [60]. Importantly, infection of a host cell by 
HIV-1 results in the destruction of the infected immune cell or obliteration of their immune 
function. 
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Figure 1.5. Steps in HIV-1 replication cycle. 
HIV-1 replication begins by fusion of the HIV-1 virion to the host cell via recognition of the CD4 
host receptor. The capsid containing the viral genome enters the cell, is disintegrated, and the 
viral reverse transcriptase transcribes the viral RNA into DNA. The viral DNA is then 
transported to the nucleus where it is integrated into the host DNA by the viral protein integrase. 
The host then transcribes the viral genome along with its own DNA, making more copies of 
virus as well as new HIV proteins. The new viral RNA and HIV proteins move to the cell surface 
forming a new, immature HIV virus. Once released from the cell the viral protein, protease, 
cleaves newly synthesized polyproteins to create a mature infectious virus. Image from [61]. 
 
Each HIV-1 virion contains two RNA genomes, and recombination between these two 
genomes can occur [62, 63]. This recombination event happens multiple times during each 
replication cycle, which rapidly shuffles the genetic information transmitted to the progeny virus 
[63]. This viral recombination is thought to be a natural repair mechanism against damage to the 
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RNA genome [64]. However, the genetic variability is also compounded with a very rapid 
replication cycle with a high mutation rate, resulting in generations that contain multiple variants 
in a single day. Additionally, a single cell may also be infected by different strains of HIV-1, 
which can result in the progeny being a hybrid of the two strains. The resulting genetic 
variability is likely a contributing factor to the difficulties faced by the host’s immune defenses 
against infection, as well as targets for therapy [65]. 
1.4.2 Pathophysiology of HIV/AIDS 
HIV-1 was first discovered in the early 1980s [53] and, since its discovery, has reached a 
global pandemic in which just under 40 million people worldwide are currently infected, with 
about 1.8 million new infections a year. Those infected with HIV-1 shed the virus in bodily 
fluids and secretions, such as blood, semen, saliva, urine, or breast milk, and transmission occurs 
with direct exchange of the fluids [52, 53]. Infection with HIV-1 can be broken down into three 
main stages: acute infection, clinical latency, and AIDS. 
 Acute Infection. Acute HIV-1 infection occurs during the initial period after 
contracting HIV-1, and many individuals exhibit influenza-like symptoms—including fever, 
headache, tiredness, throat inflammation, and larger tender lymph nodes—2-4 weeks following 
viral exposure. Vomiting, diarrhea, and other gastrointestinal symptoms may also occur. 
Approximately 20-50% of individuals may experience a maculopapular rash occurring on the 
trunk of the body. Due to their non-specificity, these symptoms are not often recognized as signs 
of HIV-1 infection and are even often misdiagnosed as a more common infectious disease [66].  
 Chronic latency. Following the initial symptoms is a stage of asymptomatic 
infection referred to as chronic latency. Without treatment, this stage lasts an average of eight 
years but can prolong for over 20 years. Although there are typically little to no symptoms seen 
16 
in the early years of this disease, fever, weight loss, muscle pains, gastrointestinal issues, and 
persistent generalized lymphadenopathy are often seen in infected individuals [67] as the 
infection progresses to AIDS.  
 Acquired immunodeficiency symptoms. Without treatment, HIV-1 infection can 
progress to AIDS approximately ten years following initial infection. The clinical definition of 
AIDS is a CD4+ T cell count below 200 cells/μL of peripheral blood, which is a dramatic 
reduction from the normal range of between 1,000 and 1,500 cell/μL of peripheral blood [67]. 
HIV-induced cell lysis, as well as the killing of infected cells by cytotoxic CD8+ T cells, 
accounts for much of the CD4+ T cell loss following the acute stage of infection. As HIV-1 
infection progresses through the chronic stages of infection, the regenerative capacity of the 
thymus is slowly destroyed by HIV-1 infection resulting in a gradual loss of the CD4+ T cells. 
At this point, individuals start to present with conditions such as pneumocystis pneumonia, 
cachexia, esophageal candidiasis, and recurrent respiratory tract infections [67]. As the CD4+ T 
cells count continues to drop, infected individuals begin to become more susceptible to a myriad 
of opportunistic infections (as depicted in Figure 1.6). Susceptibility to HCMV diseases, 
including HCMV retinitis, generally occurs when the CD4+ T cell count reaches levels below 50 
cells/μL of peripheral blood.  
17 
 
Figure 1.6. Opportunistic infections with depleting CD4+ T cell counts. 
During the progression of AIDS, the CD4+ T cell count depletes, rendering afflicted individuals 
vulnerable to diseases by a number of opportunistic infections [68]. 
 
1.5 AIDS-related HCMV Retinitis  
AIDS patients are particularly susceptible to sight-threatening retinitis caused by HCMV 
directly infecting the retinal tissues. Factors that contribute to retinal tissue destruction are virus-
induced cytopathology and inflammation mediated by neutrophils and activated macrophages. 
Before the availability of cART, 46% of patients with AIDS experienced vision loss and 
blindness caused by HCMV retinitis [69-71]. Although treatment with cART has lowered the 
number of new cases of HCMV retinitis, AIDS-related HCMV retinitis remains a significant 
ophthalmological problem as access to cART is not readily available worldwide and several of 
the individuals who do have access fail to adhere or respond to treatment [12, 72, 73]. Although 
vaccination is one of the more effective methods for controlling other infectious diseases, 
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attempts at creating an effective vaccine against HCMV have so far been unsuccessful [74, 75]. 
HCMV replication can generally be controlled by lifelong administration of antiviral drugs, such 
as ganciclovir (GCV), yet these drugs may cause harmful side-effects, do not eradicate the virus, 
and only slows the progression of ocular damage associated with HCMV infection [76-78]. 
HCMV-related disease, therefore, remains a severe ophthalmological problem worldwide. 
1.5.1 Anatomy of the Eye 
The human eye is a complex organ that reacts to light and facilitates vision with the use 
of a complex visual system. The eye sits in a protective socket, known as the orbit, and is 
attached to the six extraocular muscles that are responsible for moving the eye. These muscles 
are attached to the white part of the eye, known as the sclera, which is a strong layer of tissue 
that helps maintain the integrity of the organ [79, 80]. Although the anatomy of the eye has an 
intricate design and is comprised of multiple layers, the basic anatomy can be separated into two 
distinct segments. The anterior segment is the outer portion of the eye and is composed of the 
cornea, the anterior side of the uveal tract (consisting of the iris and ciliary body), and the 
crystalline lens, which are the components necessary to focus incoming light. Behind the cornea 
is the anterior chamber that is filled with a fluid known as the aqueous humor. This fluid 
produced by the eye, bathes the crystalline lens, and helps maintain proper ocular pressure in the 
eye [79]. Between the lens and the back of the eye lies the vitreous cavity, which comprises a 
majority of the posterior segment of the eye. This cavity is filled with a jelly-like substance 
consisting of hyaluronic acid, collagen, water, proteins, and regulatory cytokines [81]. Also, a 
part of the posterior segment is the posterior side of the uveal tract (the choroid), the retinal 
pigment epithelium, and the neurosensory retina. Information that is processed by the retina 
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travels to the brain through the optic nerve and allows us to process the information received by 
the eye [79] (Figure 1.7). 
 
Figure 1.7. Schematic of the human eye. 
Depiction of a sagittal section of the adult human eye [82].  
 
1.5.2 The Neurosensory Retina and RPE 
Light first enters the front of the eye through the cornea, where the lens focuses it 
towards the back of the eye and onto the retina. The retina itself is composed of several layers 
that consist of specific cells: the inner limiting membrane, the nerve fiber layer, the ganglion cell 
layer, the inner plexiform layer, the inner nuclear layer, the outer plexiform layer, the outer 
nuclear layer, the external limiting membrane, the photoreceptor layer, and the retinal pigment 
epithelium (RPE) (Figure 1.8). The inner limiting membrane is the layer closest to the vitreous 
cavity, while the RPE is more posterior and lies just next to the choroid. The cells that compose 
these layers have a specialized function that aid in the processing of information received by the 
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retina. The ganglion cell layer is composed of the nuclei of ganglion cells that run their axons 
throughout the nerve fiber layer. The ganglion cells receive signals from amacrine cells and 
bipolar cells whose nuclei are within the inner nuclear layer but whose synapses extend into the 
inner plexiform layer. Horizontal cell nuclei also compose the inner nuclear layer, and their 
dendrites extend into the outer plexiform layer where they can interact with photoreceptors. The 
nuclei of these photoreceptors comprise the outer nuclear layer, and the inner and outer segments 
of photoreceptors span the external limiting membrane and towards the RPE [80, 83, 84].  
The photoreceptors contain proteins that can absorb photons and convert them into 
signals to neurons within the retina. There are three main types of photoreceptors in human eyes: 
rods, cones, and intrinsically photosensitive retinal ganglion cells. While the rods and cones are 
notorious for their role in sight, the function of intrinsically photosensitive retinal ganglion cells 
is thought to hone more of a regulatory role important for vision, by supporting circadian 
rhythms and pupillary reflexes [85]. The human retina contains about 120 million rod cells 
dispersed throughout the retina, that are extremely sensitive to light and are the sole cell type 
responsible for vision processing at low light levels. The six million cone cells of the human 
retina are concentrated in the fovea and require a more significant amount of light to produce a 
signal than the rods. Three different kinds of cone cells respond to light of different wavelengths: 
short, medium, or long, referred to as S-cone, M-cone, and L-cones, respectively. The response 
of these three distinct signals is perceived as color. In order to process the vast amount of 
information fed to the retina, the outer segments of the photoreceptors are shed continuously and 
replaced with help from the RPE layer of cells (reviewed in [86]). 
The RPE cells are polarized epithelial cells that reside between the retina and choroid and 
provide several functions essential for the survival of the neurosensory retina. Some of these 
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functions include transporting nutrients to the retina, regulating homeostasis, scavenging free 
radicals and reactive oxygen species, and phagocytosis of the rod outer segments following 
normal circadian shedding [87]. The RPE cells are connected by tight junctions forming a 
physical barrier between the retina and choroid, referred to as the blood-retinal-barrier [86, 88]. 
This barrier prevents the passage of drugs and other large substances from penetrating the eye, 
therefore contributing to the immune privilege of the eye [89]. 
 
Figure 1.8. Light micrograph of the human retina. 
Light focused from the cornea and the crystalline lens and hits the retina starting at the inner 
limiting membrane (ILM) and transverses the retina until it reaches the rods and cones, directly 
past the outer limiting membrane (OLM), also referred to as the external limiting membrane 
(ELM). Adapted from [90] 
1.5.3 Ocular Immune Privilege  
Ocular immune privilege essentially means that the eye does not generate a typical 
inflammatory immune response to an unknown antigen [91-93]. Therefore, the passage of 
nutrients delivered to the retina must be tightly regulated and is delivered by two major blood 
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supply routes supplied from either the choroid to the photoreceptors via the choriocapillaris or in 
conjunction with the optic nerve [83]. The physical barrier alone is not all that is necessary for 
the establishment and maintenance of ocular immune privilege. Another essential feature is the 
establishment of a microenvironment that drives the immune cells of the eye into anti-
inflammatory phenotypes, therefore providing some protection from the damaging effects of 
inflammation. One such example is the production of immunoregulatory molecules, such as the 
anti-inflammatory molecules, transforming growth factor-β2, somatostatin, and alpha-
melanocyte-stimulating hormone by the aqueous humor and neurosensory retina, which work to 
inhibit T cell activation [94]. Due to the tight regulation in maintaining this microenvironment, it 
is no surprise that the neurosensory retina contains its own, specialized glial cells, to help 
maintain the integrity of the retina. 
Microglial cells are resident, macrophage-like cells, that are distributed throughout the 
inner and outer plexiform, the ganglion cell, and the nerve fiber layers of the retina [95]. The 
functions of microglial include antigen presentation and phagocytosis during the onset of retinal 
injury or infection [96]. Müller cells are macroglial cells that span the entire thickness of the 
retina and aid in many functions, including regulating glucose metabolism, maintaining ion 
balance through ion channels and transmembrane transporters, and mitigating oxidative stress. 
Müller cells are also capable of releasing pro-inflammatory cytokines following retinal insult or 
injury. Müller cells then act in tandem with microglial to phagocytize foreign substances or 
damaged cells and can alter the retinal blood flow, allowing for the infiltration of leukocytes into 
the retina [97].  
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1.5.4 Pathogenesis of AIDS-Related MCMV Retinitis 
During AIDS-related MCMV retinitis, the ocular immune privilege of the eye fails, leaving 
the eye vulnerable to high levels of HCMV replication and subsequent inflammatory response, 
which included the infiltration of activated macrophages and neutrophils [98, 99]. HCMV enters 
the eye through the hematogenous spread of infected monocytes that enter the retinal vasculature 
and is then capable of penetrating and replicating in all layers of the retina and the contiguous 
RPE. [73]. The presence of active viral replication can be confirmed by the appearance of 
conspicuous cytomegalic cells, which are characterized as giant cells with eosinophilic type A 
intranuclear or “owl eye” inclusions. HCMV replication destroys all layers of the retina, 
resulting in a distinctive full-thickness retinal necrosis. Ultimately, a thin white membrane 
replaces the areas of retinal destruction, which can be clinically observed, and may be 
accompanied by hemorrhaging. Fundus photographs depicting the differences in a healthy retina 
and a retina with advanced AIDS-related HCMV retinitis are seen in Figure 1.9. Left untreated, 
these areas with irreversible lesion of retinal destruction are capable of merging and may 
consume the whole retina within six months [100]. 
 
Figure 1.9. Fundus of the human retina during AIDS-related HCMV retinitis 
Fundus photograph of a normal human retina (A), from [90], and a retina during AIDS-related 
HCMV retinitis (B). Present are white areas of retinal necrosis and red areas of associated 
hemorrhaging, from Drs. Dix and Cousins, Bascom Palmer Eye Institute, Miami, FL. 
24 
1.6 Animal Models of MCMV Retinitis 
A murine model of experimental CMV retinitis is valuable to study the mechanisms 
responsible for the retinal destruction involved in the pathogenesis of AIDS-related HCMV 
retinitis. As CMV is a species-specific virus, HCMV is unable to establish a productive infection 
in animal models [101], but MCMV offers a viable substitute to explore the pathophysiology of 
CMV retinitis [12]. As with humans, MCMV infection of mice is generally not as productive in 
immunologically normal mice, and these mice are often resistant to developing MCMV retinitis 
[4, 102-104]. However, if the mice are immunosuppressed and injected with a high enough titer 
of MCMV into the subretinal space (Figure 1.10), MCMV retinitis typically manifests with 
frequencies higher than 75% [1, 105, 106], although exact frequencies depend on the strain of 
mouse used [4, 105-109]. Two methods of immunosuppression are successful in establishing 
susceptibility to MCMV retinitis: corticosteroid-induced immunosuppression [105, 106, 109] 
and the administration of a mixture of mouse-specific retroviruses (LP-BM5) [110, 111], which 
results in the established of immunosuppression that confers susceptibility to MCMV retinitis in 
C57BL/6 mice 8-12 weeks following the onset of immunosuppression [5, 112, 113].    
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Figure 1.10. Schematic mouse eye depicting site of subretinal injection. 
Representation of the subretinal injection site for MCMV by 1 30-gauge needle. A 2-uL volume 
in injected into the subretinal space, followed by an air bubble to prevent back flow. Figure from 
[114]. 
1.6.1 Corticosteroid-Induced Immunosuppression 
Corticosteroid-induced immunosuppression results in a rapid, acute decline in the 
immune system, which develops over several days resulting in dysfunction of several types of 
immune cell populations [115, 116]. Specifically, corticosteroid-induced immunosuppression 
results in a rapid loss of macrophages within days of immunosuppression [115], and the number 
and function of CD4+ and CD8+ T cells are also dramatically reduced. This model, therefore, 
results in a dampened immune response by suppressing inflammatory cytokines expressions, 
such as IFN-γ, TNF-α, IL-2, and IL-1β [116]. 
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1.6.2 Murine Acquired Immunodeficiency Syndrome (MAIDS) 
Retroviral-induced immunosuppression (MAIDS) is established by intraperitoneal 
injection of murine leukemia viruses (MuLV) and designated as lymphoproliferative bone 
marrow 5 (LP-BM5) [111]. The induction of MAIDS is dependent on the infected strain of mice. 
For instance, BALB/c mice are more resistant to MAIDS development than C57BL/6 and take 
over a year to progress to late-stage MAIDS [5, 117]. The MAIDS model of immunosuppression 
differs in many ways from that of corticosteroid-induced immunosuppression. One of the more 
prominent differences is the timing it takes to establish immune suppression. MAIDS have a 
slow and progressive development, which goes through distinct phases of immune cell 
dysfunction over several weeks. Also different is the presence and functionality of the immune 
cell populations throughout the course of infection. For instance, macrophage populations show a 
dramatic difference between the two models of immunosuppression. In MAIDS mice, 
macrophage populations decrease and change their phenotypic function towards the later stages 
of the disease, which is in direct contrast to the rapid loss of macrophage numbers within days 
following corticosteroid-induced immunosuppression [115]. Additionally, MAIDS results in an 
unusual proliferation of B and T cells [118], which are rendered dysfunctional by the retrovirus 
[5, 110, 119]. Furthermore, natural killer cells [120] and neutrophils [118] are also dysfunctional 
during the progression of MAIDS development.  
1.7 MAIDS-related MCMV Retinitis  
The use of subretinal MCMV infection in susceptible MAIDS mice is a combination 
unique to our laboratory [1, 4]. The MAIDS model is a suitable model for this study because 
species-specific retroviruses cause both MAIDS and AIDS, and mice with MAIDS share many 
immunopathologic features with AIDS patients. These similarities include a characteristic 
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progressive development of chronic generalized lymphadenopathy, a polyclonal B cell 
activation, and a shift in the levels of Th1 and Th2 CD4+ T-cells with an eventual diminishment 
in CD4+ T cell and CD8+ T cell counts and functions [112, 119, 121-123]. Healthy mice and 
mice with MAIDS-4 duration (MAIDS-4) or less are resistant to the development of MCMV 
retinitis. However, due to the decline in T cell functionality [123, 124], mice subjected to 
MAIDS for a duration of eight weeks (MAIDS-8) become susceptible to the development of 
MCMV retinitis with full susceptibility (80-100%) by MAIDS of ten-week duration (MAIDS-
10) [4], as depicted in Figure 1.11. MAIDS-10 mice will then develop retinitis 10 days post 
subretinal MCMV injection and exhibit histopathological features similar to that seen in AIDS-
related HCMV retinitis, which include full-thickness retinal necrosis, the presence of 
cytomegalic cells, and transition zones between areas of the normal and diseased retina [4, 125] 
as depicted in Figure 1.12. Since both MAIDS-4 and MAIDS-10 mice harbor equivalent 
amounts of infectious MCMV but MCMV-infected eyes of MAIDS-4 mice fail to develop 
retinal necrosis [1], the viral infection alone is not sufficient for the onset and progression of 
retinitis. 
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Figure 1.11. Progression of MAIDS. 
The MAIDS model shares many features similar to the development of AIDS. During the first 
few weeks following MAIDS induction, mice experience chronic generalized lymphadenopathy, 
a polyclonal B-cell activation, and hypergammaglobulinemia. The progression of MAIDS then 
results in a shift in the levels of Th1 and Th2 CD4+ T-cells. Healthy mice and mice with a 
MAIDS duration of 4 weeks (MAIDS-4) are resistant to retinitis development. However, as 
MAIDS progresses and results in the diminishment in CD4+ T-cell and CD8+ T-cell counts and 
functions, mice become susceptible to MCMV retinitis. From [114].  
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Figure 1.12. Histopathology of experimental MAIDS-related MCMV retinitis. 
Hematoxalin and eosin (H&E)-stained cross-sections of eyes during retinitis development 8 days 
following subretinal MCMV infection. (A) full-thickness retinal necrosis, (B) section showing 
the presence of cytomegalic cells, and (C) transition zones between intact retina (with areas of 
retinal folding) and full-thickness retinitis. Photomicrographs from [4], original magnification 
200×. 
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1.7.1 MAIDS-related MCMV Retinitis  
Over the last several years, our lab has extensively studied several mechanisms that may 
be involved in the pathogenesis of MAIDS-related MCMV retinitis. Briefly, we have found that 
the expression of anti-inflammatory cytokines, interleukin (IL)-4 and IL-10, are upregulated 
during the onset and progression of experimental MCMV retinitis and may mediate the 
inflammatory response following MCMV infection. However, it has been demonstrated that the 
systemic deletion of either of these cytokines is insufficient to improve the developed retinitis 
[126]. Interestingly, the pro-inflammatory cytokine, IL-17, which is constitutively expressed 
intraocularly, is downregulated by MCMV during MAIDS-related MCMV retinitis. It is thought 
that this downregulation of IL-17 is mediated through the stimulation of the suppressor of 
cytokine signaling (SOCS)1 and SOCS3, which are both stimulated during the pathogenesis of 
MAIDS-related MCMV retinitis [127]. Although tumor necrosis factor alpha (TNF-α) is 
considerably upregulated following ocular MCMV infection of MAIDS-10 mice, this cytokine 
may be playing a dual role mediating either apoptosis or the anti-apoptotic pathway as the 
receptors for TNF-α, TNFR1 and TNFR2 are also stimulated following MCMV infection and 
diverge towards either pathway [6]. 
A major area of focus of our lab, the pathogenesis of experimental MAIDS-related 
MCMV retinitis, is the involvement of multiple cell death pathways. In addition to the 
stimulation of TNF-α, TNFR1, and TNFR2 being stimulated during experimental MCMV 
retinitis, activated caspase-3 and activated caspase-8 are also upregulated. Interestingly, 
however, neither apoptosome-related molecules, cytochrome c, apoptotic protease activating 
factor 1 (Apaf-1), nor caspase-9 are stimulated in MCMV-infected eyes, and histopathology has 
suggested that apoptosis-related cell death only constitutes about 8% of the dead cells during 
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retinitis. RIPK1 and MLKL molecules related to the inflammatory cell death pathway, 
necroptosis, are stimulated during MAIDS-related MCMV retinitis, suggesting the involvement 
of this mode of cell death may be associated with the retinal destruction seen in this model. 
Additionally, pyroptosis-associated molecules—caspase-1, caspase-11, IL-1β, and IL-18—and 
several inflammasome components are also stimulated during MAIDS-related MCMV retinitis. 
This suggests that multiple cell death pathways may operate simultaneously following ocular 
infection of MCMV in MAIDS-10 mice [6]. 
1.8 MAIDS-related MCMV Retinitis and the Stimulation of Cell Death Pathways  
1.8.1 Apoptosis 
Due to the discovery that MCMV-infected eyes of MAIDS-4 and MAIDS-10 mice harbor 
equivalent amounts of infectious MCMV despite MAIDS-4 mice being resistant to the 
development of retinal necrosis, it was concluded that virus alone is not sufficient for the onset 
and progression of retinal destruction in MCMV-infected eyes of MAIDS-10 mice [103]. It was 
therefore hypothesized that other mechanisms must be responsible for the retinal necrosis seen 
following MCMV infection. Bigger et al. [128] first detected apoptotic cells by TUNEL assay in 
retinal tissues of MCMV-infected eyes from immunocompetent BALB/c mice and 
methylprednisolone acetate-immunosuppressed BALB/c mice. As a result of this work, 
apoptosis, a programmed form of cell death, was considered the predominant mechanism of 
retinal pathology of AIDS-related HCMV retinitis, and its involvement in MCMV-infected eyes 
of MAIDS mice was investigated.  
Apoptosis is often initiated by TNF-ɑ. TNF-ɑ is a proinflammatory cytokine that induces 
diverse cellular responses by binding to the receptors TNFR1 and TNFR2. Binding of TNF-ɑ to 
its receptor results in the cleavage and activation of caspase-3 and caspase-8, leading to 
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apoptosis and cell death [129, 130]. TNF-ɑ was shown to be ocularly expressed during AIDS-
related HCMV retinitis [131], suggesting the infiltrating macrophages were a source of TNF-ɑ 
[98]. Using the MAIDS model for MCMV retinitis, it was shown that key TNF-ɑ-induced 
apoptotic molecules, TNF-ɑ, TNFR1, TNFR2, caspase-8, and caspase-3 are not upregulated in 
MCMV-infected eyes of MAIDS-4 mice resistant to retinitis when compared to the media-
injected contralateral control eye but that these molecules are highly stimulated in MCMV-
infected eyes of MAIDS-10 mice that are susceptible to retinitis. This stimulation showed a peak 
of mRNA for all molecules occurring at day 6 post-infection before the development of severe 
retinal destruction seen at day 10 post-infection. The production of TNF-ɑ was detected in 
several cell types, including infiltrating macrophages and neutrophils, as well as resident Müller 
cells and microglia. Using knock-out (KO) mice, it was shown that mice deficient in TNF-ɑ, 
TNFR1, and TNFR2 showed a reduction in the frequency of retinitis in MCMV-infected 
MAIDS-10 mice when compared to MCMV-infected eyes of wild-type (WT) MAIDS-10 mice, 
suggesting that TNF-ɑ and its receptors are important for the development of retinitis in this 
model. However, neither of these KO mice exhibited a change in the ocular levels of infectious 
MCMV, indicating that these molecules are not responsible for controlling the viral levels of 
MCMV, and also strengthening the idea that it is not solely the level of infectious virus that is 
responsible for the retinitis. This work suggests that TNF-ɑ-induced apoptosis could be 
contributing to the retinal destruction seen during MAIDS-related MCMV retinitis [6]. 
Apoptosis is not limited to being induced by one signaling pathway and can be stimulated 
by several signaling proteins with specific death receptors (Figure 1.13) [132]. To help determine 
if apoptosis induced by stimuli other than TNF-ɑ plays a role in the pathogenesis of MAIDS-
related MCMV retinitis, other apoptotic pathways were investigated. TNF-related apoptosis-
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inducing ligand (TRAIL) induces apoptosis via a caspase-8-dependent pathway after binding to 
death receptors (DR) 4 or DR5 (TRAIL-R) [133, 134]. Additionally, FasL can induce apoptosis 
via a caspase-independent pathway after binding to the Fas receptor [133, 135-137]. Similar to 
what was seen for TNF-ɑ, mRNA for TRAIL, TRAIL-R (DR5), Fas, and FasL were all 
upregulated in MCMV-infected eyes of MAIDS-10 mice, but not MAIDS-4, when compared to 
media-injected control eyes, with a peak stimulation at day 6 post-infection. This indicated that 
apoptosis initiated through other pathways might also be stimulated during the pathogenesis of 
MAIDS-related MCMV retinitis. Surprisingly, however, mRNA for caspase-9, cytochrome c, 
and Apaf-1 were not upregulated in MCMV-infected eyes of MAIDS-4 or MAIDS-10 mice. 
These molecules are known to participate in apoptosis induced by the apoptosome [138, 139], 
and the absence of their stimulation suggests no significant role for the mitochondrion-associated 
mechanism of apoptosis during MAIDS-related MCMV retinitis. It is possible that the MCMV 
gene m38.5, which encodes vIBO, might be inhibiting apoptosis at the mitochondrial level [140]. 
To further elucidate the involvement of apoptosis in the retinal destruction, a study was done to 
detect the number and localization of TUNEL-positive cells in the MCMV-infected retina. 
Following MCMV infection of MAIDS-10 mice, sparse TUNEL-positive cells were detected at 
day 3 post-infection, and a substantial increase was seen at day 6 post-infection, with a 
distribution showing localization within the RPE layer as well as the neurosensory retina. At day 
10 post-infection, the TUNEL-positive cells displayed a diffuse distribution within the retina. 
However, quantification revealed that only ~8% of retinal cells were found to be TUNEL 
positive after MCMV infection, suggesting that although apoptosis may contribute to retinal 
tissue destruction, its pathogenic contribution was relatively minimal [6]. 
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Although mRNA for the ligands and receptors of the Fas and TRAIL-related apoptosis 
pathway, as well as mRNA for caspase-3 and caspase-8, were increased in MCMV-infected 
eyes, other molecules associated with apoptosis, including cytochrome c and Apaf-1, were not 
upregulated in MCMV-infected eyes when compared to the media-injected, contralateral control 
eyes. This may explain why apoptosis appears to only contribute minimally to the retinal damage 
seen during MAIDS-related MCMV retinitis. It has been shown that TNF-ɑ- induced apoptosis 
is expressed at elevated levels within the eyes of patients with AIDS-related HCMV retinitis [98, 
131], and TNF-ɑ and its respective receptors were found to be upregulated in MCMV-infected 
eyes of MAIDS-10 mice. Since apoptosis may only contribute minimally to the retinal damage, it 
is also possible that the increase in TNF-ɑ seen in MCMV-infected eyes could be related to that 
of another cell death pathway induced by TNF-ɑ, such as necroptosis.  
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Figure 1.13. Apoptosis cell death signaling pathway. 
The apoptosis pathway is a form of cell death that can be induced through either the extrinsic 
pathway, the intrinsic pathway, or the granzyme pathway. Induction through either of these 
pathways result in the activation of either caspase-8 or caspase-9 which both results in the 
activation of caspase-3, which leads to apoptotic death of the cell. Apoptosis results in 
mitochondrial membrane permeabilization, chromatin condensation, and DNA fragmentation. 
This results in smaller cells and apoptotic bodies that are phagocytized. Figure from [141]. 
1.8.2 Necroptosis  
Necroptosis is a form of TNF-ɑ induced programmed cell death that results in membrane 
and organelle swelling followed by cell lysis [17-19]. Necroptosis is induced when apoptosis is 
inhibited by blocking caspase-8 activity, such as by uncleaved caspase-8/cellular FLICE 
inhibitory protein (cFLIP) heterodimer formation [20]. Unlike apoptosis, necroptosis cell lysis 
results in the release of damage-associated-molecular patterns (DAMPs) that trigger a highly 
inflammatory response [21]. The necroptotic pathway is caspase-independent and initiated when 
ligand binding induces the recruitment of adaptor proteins Fas-associated protein with death 
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domain (FADD), tumor necrosis factor receptor type 1-associated death domain (TRADD) or 
TIR-domain-containing adapter-inducing interferon-β (TRIF) associated with various accessory 
proteins, in addition to receptor-interacting serine/threonine-protein kinase 1 (RIPK1), forming a 
death complex. The upregulation of the de-ubiquitinating enzyme CYLD or the cellular inhibitor 
of apoptosis protein 1 (cIAP1) causes RIPK1 to dissociate from the initial death complex and 
form a second death complex associated with caspase-8. When caspase-8 is inactivated, either 
directly by a pathogen or during anti-apoptosis signaling, RIPK1 recruits another receptor-
interacting serine/threonine-protein kinase, RIPK3, through its RIP homotypic interaction motif 
(RHIM) domain. Both proteins are phosphorylated and form the necrosome [22, 23]. 
Subsequently, the formation of the necrosome recruits mixed-lineage kinase-like domain 
(MLKL) protein, and it too is phosphorylated. Activated MLKL forms an oligomer complex that 
associates with the cell membrane and forms a pore, resulting in cell lysis and the release of pro-
inflammatory molecules (shown in Figure 1.14) [24].  
To determine if necroptosis plays a role in the pathogenesis of MCMV retinitis, MCMV-
infected eyes of MAIDS-4 and MAIDS-10 mice were compared to media-injected contralateral 
control eyes for the upregulation of crucial necroptosis molecules, RIPK1 and RIPK3. RIPK1 
was found upregulated in MCMV-infected eyes of MAIDS-10 mice with a peak at day 6 post-
infection but not in MCMV-infected eyes of mice with MAIDS-4. RIPK3, however, was not 
significantly upregulated in MCMV-infected eyes with either MAIDS-4 or MAIDS-10 duration 
[7]. The stimulation of RIPK1, but not RIPK3, following MCMV infection suggests that 
necroptosis may be playing a role in MAIDS-related MCMV retinitis, in a manner independent 
of RIPK3. 
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Figure 1.14. Necroptosis cell death signaling pathway. 
TNFR1 can mediate either cell survival, apoptosis, or necroptosis pathways. Binding of TNFR1 
with TNFα leads to the formation of complex I which consists of TRADD, TRAF2, RIP1, and 
cIAP1. Left: Polyubiquitination of RIP1 by cIAP1, leads to the recruitment of IKK complex and 
TAK1, activating the NF-κB and MAPK survival pathways. Middle: If cIAP1 does not 
polyubiquitinate RIP1, then RIP1, associates with FADD and caspase-8 to form cytosolic 
complex IIa which induces apoptosis. Right: If caspase-8 activity is inhibited, RIP1 interacts 
with RIP3 and MLKL to form complex Iib. RIP3 and MLKL are phosphorylated and translocate 
to the plasma membrane, mediating membrane permeabilization and resulting in cell death via 
necroptosis. Figure from [142]. 
1.8.3 Pyroptosis 
In addition to the TNF-α-induced cell death pathways, there are other programmed cell 
death pathways that do not rely on TNF-α, such as pyroptosis. Pyroptosis is a highly 
inflammatory form of programmed cell death [143] that can be induced by both pathogen-
associated molecular patterns (PAMPs) and DAMPs. During pyroptosis, there is a net increase of 
osmotic pressure, cell swelling, and lysis, followed by a mass release of cellular contents, 
including active IL-1β and IL-18 [144].  Alternatively, the noncanonical pathway involves the 
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activation of caspase-11 (murine), which can also cleave gasdermin D (GSDMD) and is thought 
to function independently of inflammasomes [145]. In addition to the upregulation of several 
apoptosis-and necroptosis-related molecules, it was shown that MCMV-infected eyes of 
MAIDS-10 mice highly upregulates mRNA expression of caspase-1, IL-1β, and IL-18, 
collectively peaking 6 days following subretinal MCMV infection, but no upregulation was seen 
in MCMV-infected eyes of MAIDS-4 mice [6]. Similar trends were seen for the upregulation of 
mRNA for several inflammasomes in the MCMV-infected eyes of MAIDS-10 mice but not those 
of MAIDS-4. Additionally, it was seen that the protein levels of cleaved caspase-11 were also 
significantly elevated at 6 days following MCMV infection [100]. Taken together, these results 
suggest that both the canonical and noncanonical pathways of pyroptosis may be playing a role 
in the pathogenesis of MAIDS-related MCMV retinitis.  
1.9 Pyroptosis Pathway and Inflammasomes 
1.9.1 Canonical Pyroptosis Pathway 
The canonical pathway of pyroptosis occurs with the initiation and assembly of an 
inflammasome complex. The inflammasome is a multiprotein oligomer responsible for the 
activation of inflammatory responses by promoting the maturation and secretion of pro-
inflammatory cytokines IL-1β and IL-18. Once active, the inflammasome binds to pro-caspase-1 
either homotypically via its own caspase-activation and recruitment domain (CARD), or via the 
CARD of the adaptor protein, associated speck-like protein containing CARD (ASC), which it 
binds to during inflammasome formation. The clustering of many p45 pro-caspase-1 molecules 
together induces their autocatalytic cleavage allowing caspase-1 to then assemble into its active 
form consisting of two heterodimers each with a p20 and p10 subunit. Once active, caspase-1 
then cleaves and activates pro-IL-1β and pro-IL-18 to induce interferon (IFN)-γ secretion 
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and natural killer cell activation [146]. Caspase-1 also cleaves the cytoplasmic protein, GSDMD, 
which localizes to the membrane where it is responsible for forming pores. These pores result in 
a net increase in osmotic pressure, water influx, swelling, and osmotic lysis, allowing for the 
release of IL-1β and IL-18 (Figure 1.15) [144].   
 
 
Figure 1.15. Pyroptosis cell death signaling pathway. 
The canonical pyroptosis pathway results after intracellular danger signals initiate the assembly 
of an inflammasome, which then recruits and activates procaspase-1. Active caspase-1 is then 
able to cleave pro-inflammatory cytokines IL-1β and IL-18 as well as the cytosolic protein 
GSDMD which forms holes in the plasma membrane resulting in the release of cellular contents. 
GSDMD can also be cleaved by caspase-11 through the noncanonical pyroptosis pathway. Figure 
from [147]. 
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Caspase-1. Caspase-1 is an evolutionarily conserved protease that, like other caspases, is 
produced as a biologically inactive zymogen that requires cleavage by other caspase-members, 
or themselves, to become active (reviewed in [148]). The structure of caspase-1 contains two 
heterodimers of cleaved subunits, p20 and p10, and is also composed of a catalytic domain [149] 
as well as a CARD domain. The CARD domain can interact with CARD domains on other 
proteins, such as the ASC-adapter protein associated with activated inflammasomes or directly 
with the CARD domain of the inflammasome [150, 151]. This interaction results in the self-
cleavage of caspase-1 resulting in its activation. Cleaved caspase-1 is then able to cleave and 
activate the pro-inflammatory cytokines IL-1β and IL-18 [152]. 
IL-1β. IL-1β is a pro-inflammatory, fever producing cytokine, which is a member of the 
IL-1 family. The IL-1 family includes several cytokines that are either pro-inflammatory 
agonists— IL-1α, IL-1β, IL-18, IL-33, IL-36α, IL-36β, IL-36γ—or IL-1R antagonist (IL-1Ra)— 
IL-36Ra, IL-37, and IL-38—that exert anti-inflammatory activities. Many of these cytokines 
play a critical role in response to pathogens [153]. Pro-IL-1β is produced by activated 
macrophages as a biologically inactive protein that must be cleaved to become activated. 
Because IL-1β invokes a potent inflammatory response, its secretion is tightly regulated. The 
transcription of the inactive precursor is induced by activation of toll-like receptor (TLR) 
activation, TNF, or IL-1 receptor activation by cleaved IL-1β. In order for this mature form to be 
secreted and engage in the stimulation of these receptors, a second signal is needed in the form of 
inflammasome activation. The formation of the inflammasome then results in the activation of 
caspase-1, which results in the proteolytic processing of IL-1β. Cleavage of IL-1β by activated 
caspase-1 allows for IL-1β to fulfill its functions as part of the inflammatory response, as well as 
cellular activities, such as cell proliferation and differentiation. Caspase-1 is not the only 
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protease that can cleave pro-IL-1β, as neutrophil serine proteases proteinase 3 and elastase, and 
the mast cell-derived serine protease, chymase, also have this ability [154, 155]. 
IL-18. IL-18 is a pro-inflammatory cytokine notorious for the induction of IFN-γ 
production from Th1 cells, non-polarized T cells, natural killer cells, natural killer T cells, B 
cells, dendritic cells, and macrophages in the presence of IL-12. IL-18 also display other 
functions, including the induction of IL-2 production, the facilitation of the expression of IL-2 
receptor on Th1 cells, and the activation of natural killer cells. In conjunction with IL-3, IL-18 is 
able to facilitate the production of IL-4 and IL-33 from mast cells and basophils (reviewed in 
[156]). Murine IL-18 proteins consist of 192 amino acids, and the homology of this sequence to 
IL-1β results in its classification as a member of the IL-1 family [157, 158]. Like IL-1β, IL-18 is 
produced as a biologically inactive precursor, pro-IL-18, which requires proteolytic processing to 
become active via caspase-1 [159].  
Gasdermin D. GSDMD is the best-understood member belonging to the gasdermin 
family, and its role in pyroptosis has been well characterized [160]. The GSDMD protein 
consists of two domains, the N-terminal and C-terminal, with a cleavage site at D276 between 
the two domains. This cleavage site is mainly targeted by caspase-1 following inflammasome 
activation, while caspase-11 is also able to cleave GSDMD independent of canonical 
inflammasome activation [161]. Recently, however, it has been shown that caspase-8 is also 
capable of cleaving GSDMD, but the drive to cleave GSDMD by this caspase-is weaker than 
caspase-1, and thus it is thought that cleavage by caspase-8 is more of a backup measure in 
situations where the other caspases are unable to cleave GSDMD [162]. Additionally, both the 
neutrophil specific elastase [163] and cathepsin G [164] were shown to be sufficient in cleaving 
GSDMD at a site upstream of that cleaved by the caspases. Once cleaved, the two domains of 
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GSDMD serve different functions. The C-domain (p20) functions as an intrinsic inhibitor of the 
molecule while the N-terminal domain translocates to the plasma membrane where it 
oligomerizes and inserts itself into the membrane, forming a pore. It is the development of this 
pore that results in the loss of osmotic homeostasis, cell swelling, and mass release of 
inflammatory cytokines, including IL-1β and IL-18 [165-168]. Interestingly, it has been shown 
that cleavage of GSDMD by caspase-3 at D88 in the N-terminal domain can decrease the 
induction of pyroptosis by inhibiting oligomerization and pore formation [169, 170] that could be 
used as regulatory mechanisms against unwarranted cell death. 
1.9.2 Inflammasomes 
Characteristic of the canonical pathway of pyroptosis is the activation of inflammasomes. 
Inflammasomes are high-molecular-weight, multi-protein complexes that are found in the 
cytosol of immune cells and regulate the activation of inflammatory responses [171]. There are 
multiple types of inflammasomes, and each of their distinct assemblies is determined by a unique 
pattern-recognition receptor (PPR) in response to specific PAMPs or danger signals present in 
the host’s cytosol. Once activated by the inflammatory ligand, the central domain of the 
inflammasome undergoes oligomerization, resulting in the recruitment of adaptor proteins, such 
as ASC, to the effector and variable N-terminal domain, which is composed of a pyrin domain 
(PYD) and a CARD domain. The CARD domain, on either the inflammasome or ASC binds and 
activates pro-caspase-1 to initiate an inflammatory response [172]. There are several types of 
inflammasome proteins known to date, including the nucleotide-binding oligomerization domain 
(NOD), leucine-rich repeat (LRR)-containing protein (NLR) family members, NLRP3, NLRP1b, 
and NLRC4, as well as the protein absent in melanoma 2 (AIM2) (Figure 1.16) [161]. 
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 NLRP3. NLRP3 is the more well-characterized inflammasome of the NLR subset 
of inflammasomes. Like all members of the NLR family, NLRP3 has a three-domain structure: 
An N-terminal homotypic interaction domain that contains CARD and PYD, a central NOD-like 
domain crucial for activation, and a series LRRs on the C-terminal which are presumed to be 
responsible for the recognition of NLR ligands. NLRP3 is known to respond to a variety of 
stimuli: particulate matter, such as uric acid crystals [173], silica and asbestos [174], extracellular 
ATP [175], toxins [176], and several viral [177], bacterial [178, 179], fungal [180] and protozoal 
[181] pathogens. Due to the diversity of these stimuli, a cellular event common to all these 
stimuli has been suggested to be the inducer for NLRP3. Possible triggers include potassium 
efflux [182], mitochondrial dysfunction [183], or reactive oxygen species [184], but no unified 
mechanism has yet to be determined.  
 NLRP1b. Although not as well characterized as NLRP3, NLRP1 was the first 
NLR shown to form an inflammasome complex [171]. Unique to NLRP1 is the presence of a 
function-to-find domain (FIIND) motif, which is flanked by the CARD domain at its C-terminal 
end, and aids in the recruitment of ASC. Although human NLRP1 contains a PYD, this is 
missing in murine paralogues, such as NLRP1b. While information is available on the 
involvement of NLRP1b with the lethal toxin of B. anthracis [185], much is still unknown 
regarding NLRP1b and other possible stimuli. 
 NLRC4. Unlike the other NLR family members, NLRC4 contains only a CARD 
domain that can interact with the CARD domain of caspase-1 resulting in direct activation of 
caspase-1 by NLRC4. Whereas the association with the adapter protein ASC enhances this 
activation of caspase-1, unlike the other inflammasomes, this interaction is not necessary for 
caspase-1 activation by NLRC4 [186]. NLRC4 can interact with different neuronal apoptosis 
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inhibitory protein (NAIP) members, and the combination of the different NAIPs may determine 
ligand specificity [187]. The NLRC4 inflammasome is often associated with bacterial infections 
[188-192], but the involvement of NLRC4 in non-alcoholic steatohepatitis supports the notion 
that stimuli other than bacteria can induce the activation of the NLRC4 inflammasome [193]. 
 AIM2. AIM2 is independent of the NLR protein family, contains an N-terminal 
PYD domain and a C- hematopoietic interferon-inducible nuclear antigens with 200 amino acid 
repeats (HIN-200) domain [194], and senses and binds foreign cytoplasmic double-stranded 
DNA [195]. The PYD domain interacts with other PYD domains, such as that on the ASC 
protein, via highly specific, homotypical PYD-PYD interactions [196, 197]. As seen with 
NLRP3, the AIM2 inflammasome requires an initial pro-inflammatory signal to promote the 
expression of its substrates. For NLRP3, this priming is mostly mediated by NF-κB 
transcriptional activation, but for AIM2, this signal is type I interferon induction, a response 
typical of viral infections [198], including MCMV [195].  
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Figure 1.16. Inflammasomes sensors and potential activators. 
Inflammasomes are multiprotein complexes that are activated in response to intracellular danger 
signals. Once activated, the inflammasome recruits and binds pro-caspase-1 through either a 
caspase-activation and recruitment domain (CARD) or a pyrin domain (PYD), and may also 
contain an adaptor proteins like the apoptosis speck-like protein with a CARD domain (ASC). 
The NLR subset of inflammasomes contain a central nucleotide-binding domain (NBD) as well a 
C-terminal leucine-rich repeat (LRR) domain. Unique to NLRP1b (far left) is the presence of a 
function-to-find domain (FIIND) presumably for the inflammasome activation. The AIM2 
inflammasome (right) contains a C-terminal hematopoietic interferon (IFN)-inducible nuclear 
protein with 200-amino acid repeat (HIN-200) domain. Modified from [199] 
1.9.3 Noncanonical Inflammasome Pyroptosis Pathway 
In addition to the canonical pyroptosis pathway that is dependent on the activation of 
either NLRP3, NLRP1b, NLRC4, or AIM2 inflammasomes to recruit and activate caspase-1, 
there is also the noncanonical pathway mediated by caspase-11. In 2011, it was discovered that 
caspase-11 could trigger the maturation of IL-1β and subsequent pyroptosis in 
lipopolysaccharide (LPS)-primed mouse macrophages in an NLRP3-ASC-caspase-1 
inflammasome-dependent pathway [200]. Additionally, the human homologs of caspase-11, 
caspase-4/5, were shown to have the ability to bind to intracellular LPS [188] directly, and the 
46 
caspase-4/5/11-LPS complex has since been referred to as the noncanonical inflammasome. 
Although activated caspase-11 can induce pyroptosis by cleaving GSDMD [165, 166], it is 
unable to promote the maturation of pro-IL-1β and pro-IL-18 by direct interaction and must do 
so through the stimulation of the NLRP3-ASC-caspase-1 noncanonical pathway [201]. Although 
much focus has been centered on the presence of lipopolysaccharide (LPS) to stimulate caspase-
11, saturated fatty acids [202] and lipid peroxidation [203] have been shown to trigger caspase-
11 mediated pyroptosis in vitro, suggesting that LPS is not the only ligand needed for caspase-11 
induction of pyroptosis. Studies have suggested that caspase-11 does have a role in the murine 
host defenses against Aspergillus fumigatus [204] and may have a role in the murine host 
defenses against influenza A viruses [177, 205, 206], the rabies virus [207], and MCMV [6].  
1.9.4 Pyroptosis and Inflammasomes in Ocular Disease 
The stimulation of pyroptosis-associated molecules is not limited to MAIDS-related 
MCMV retinitis and has been associated with the pathogenesis of several other ocular diseases 
and ailments. Of note are the recent discoveries centered on the extent to which inflammasomes 
and/or pyroptosis plays a role in several ocular disorders. Age-related macular degeneration 
(AMD) is a sight-threatening, progressive disorder of the retina that specifically targets and 
damages the macula, the part of the retina responsible for sharp, central vision. Recently, 
elevated levels of the NLRP3 inflammasome, IL-1β, and IL-18 expression were found in AMD 
macular lesions [208]. The destructive effects of AMD can also be seen by resultant RPE 
thinning or depigmentation, which can lead to RPE atrophy and death of photoreceptors. The 
NLRP3 inflammasome was found to be upregulated in the RPE during the pathogenesis of 
advanced AMD following RPE atrophy [209]. Inhibition of the NLRP3 inflammasome 
components prevented RPE degeneration in a model of AMD [210], providing evidence for 
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NLRP3-driven pyroptosis in the pathophysiology of AMD. Analysis of photoreceptor cell death 
in a model of retinal degeneration showed an upregulation of NLRP3, caspase-1, IL-1β, and IL-
18 in cone photoreceptors but not rod photoreceptors [211], suggesting that the overall induction 
of pyroptosis in the retina may be unique to specific cell populations or influenced by the 
mechanism leading to cell death.  
Additionally, an association between pyroptosis and oxidative stress has been established, 
which is one factor that leads to the formation of cataracts. Human lens epithelium cells that 
were treated with H2O2 showed in a significant increase of caspase-1 and IL-1β mRNA and 
protein expression when compared to the control cells. This involvement was ablated by the 
addition of a caspase-1 inhibitor, implicating the role of these molecules in cataract formation 
[212]. Another ocular disease manifestation of oxidative stress is the formation of proliferating 
fibrovascular tissue on the cornea of the eye, known as pterygium. NLRP3, caspase-1, IL-1β, and 
IL-18 were all expressed in human pterygium samples, as well as an experimental cell model of 
pterygium, suggesting the involvement of this pathway in the process of pterygium formation 
and progression [213]. Additionally, an experimental model of ocular hypertension, brought on 
by mechanical stress and hypoxia, demonstrated the activation of the NLRP1, NLRP3, and 
AIM2 inflammasome complexes, as well as caspase-1 activation and subsequent IL-1β release 
and formation of GSDMD pores. These results thus provide evidence for inflammasome-driven 
pyroptosis in retinas damaged by ocular hypertension [214].  
Pyroptosis induction has also been demonstrated in experimental models of diabetic-
related diseases. One study looking at diabetic retinopathy determined that exogenous addition of 
a high level of glucose resulted in increased expression of NLRP3, NLRP1, caspase-1, and IL-
1β. Furthermore, the downregulation of host miR-590-3p boosted pyroptosis by targeting 
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NLRP1 and activating the NOX4 signaling pathway [215]. Another study investigated the 
association of pyroptosis in diabetic corneal endothelial keratopathy. Their studies demonstrated 
that the long noncoding RNA KCNQ1OT1, associated with diabetic complications, was 
triggered in diabetic human and rat corneal endothelium, while the expression of miR-214 was 
downregulated. Further investigation revealed that KCNQ1OT1 may bind miR-214 to regulate 
the expression of caspase-1. Additionally, pyroptosis was promoted with the suppression of miR-
214 and suppressed with the silencing of KCNQ1OT1. Therefore, their results suggest that 
KCNQ1OT1-mediated pyroptosis is induced by high glucose via targeting of miR-214 [216]. 
Taken together, these results emphasize the involvement of pyroptosis in ocular complications of 
diabetes and provide potential targets responsible for this induction. 
The overwhelming association of pyroptosis-associated molecules with ocular disease 
underscores the importance of understanding the mechanisms behind pyroptosis induction in the 
ocular microenvironment. The advancement of this knowledge is critical for the development of 
treatment strategies that may help prevent the onset of ocular disease rather than in response to 
symptoms of this damage. Investigating the role of pyroptosis in the retinal destruction seen 
during MAIDS-related MCMV retinitis will not only expand the knowledge of the pathogenesis 
of this disease but will also provide valuable insight into the advancement of ocular research. 
1.10 Goals of this Dissertation 
We have previously shown that the NLRP3, NLRP1b, NLRC4, and AIM2 inflammasome 
mRNA is stimulated in MCMV-infected eyes MAIDS-10 mice but not in MCMV-infected eyes 
of MAIDS-4 mice [93] as shown in Figure 1.17. Additionally, canonical pyroptosis-associated 
mRNA (caspase-1, IL-1β, and IL-18) are also stimulated in MCMV-infected eyes of MAIDS-10 
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but not in MAIDS-4 mice [6] (Figure 1.18), while the activated, cleaved, noncanonical caspase-
11 proteins were also expressed in MCMV-infected eyes of MAIDS-10 mice [93] (Figure 1.19).  
To advance our understanding of the ocular expression of inflammasome-driven 
pyroptosis in MAIDS-related MCMV retinitis, this study focused on the role that MCMV has on 
the induction of pyroptosis and explored the extent to which pyroptosis effects retinal damage 
during MCMV-retinitis. One important focus is on the degree that MCMV infection results in 
the stimulation of GSDMD. As GSDMD is considered the executioner of pyroptosis, it is 
imperative to determine the involvement of GSDMD in the pathogenesis of MAIDS-related 
MCMV retinitis prior to attempting to attribute the associated retinal destruction with the 
induction of pyroptosis. If pyroptosis is directly responsible for the destruction seen during 
MAIDS-related MCMV retinitis, then pyroptosis-associated molecules are not likely to be 
stimulated in MCMV-infected eyes of mice that are not susceptible to the development of 
MCMV retinitis. Furthermore, the expression of these pyroptosis-associated molecules would 
likely have to be stimulated in other models of immunosuppression that confer susceptibility to 
the development of MCMV retinitis. Ultimately, if the inflammasome and pyroptosis-associated 
molecules are necessary for the onset and progression of retinal destruction seen during MAIDS-
related MCMV retinitis, then the loss or suppression of these genes should ultimately spare the 
retina from destruction following ocular infection of MCMV.  
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Figure 1.17. Intraocular inflammasome mRNA are highly stimulated in the MCMV-
infected eyes of retinitis-susceptible MAIDS-10 mice, but not retinitis-resistant MAIDS-4 
mice.  
C57BL/6 mice with MAIDS-4 or MAIDS-10 were subretinally injected with 10^4 PFU of 
MCMV (left eye) or media (right eyes) and assessed for AIM2, NLRP1b, NLRP3, and NLRC4 
inflammasome mRNA at 3, 6, and 10 days post-infection and depicted as a fold-change of 
MCMV infected eyes compared with media-injected control eyes. Adapted from [100] 
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Figure 1.18. Intraocular pyroptosis-associated mRNA is highly stimulated in the MCMV-
infected eyes of retinitis-susceptible MAIDS-10 mice, but not retinitis-resistant MAIDS-4 
mice. 
MCMV-infected eyes collected from groups of MAIDS-4 mice and MAIDS-10 mice at 3, 6, and 
10 days after subretinal MCMV injection compared with mock-infected eyes. Levels (fold-
change) of caspase-1 mRNA (A), IL-1β mRNA (B), and IL-18 mRNA (C) were determined by 
quantitative RT-PCR assay. Bars indicate standard errors (*, P < 0.05; **, P < 0.001). From [6] 
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Figure 1.19. Figure 1.19: Intraocular cleaved caspase-11 protein is clearly abundant at day 
6 post-infection in MCMV infected eyes of MAIDS-10 mice. 
C57BL/6 mice with MAIDS-10 were subretinally injected with 10^4 PFU of MCMV (left eye) 
or media (right eyes) and assessed by western blot for cleaved caspase-11 protein at 3, 6, and 10 
days post-infection. Adapted from [100] 
 
Also, as whole eyes are being evaluated for the appearance of molecules connected with 
retinal destruction, it is possible that the stimulation of pyroptosis-associated molecules within 
the eye results from a multitude of stimuli following MCMV infection and may not be actually 
stimulated in the cells directly infected with MCMV. Therefore, it is crucial to determine 
whether or not CMV is capable of directly stimulating pyroptosis-associated molecules in 
infected cells and elucidating whether or not this stimulation requires viral replication. 
As we have previously demonstrated that multiple facets of the immune response to 
infection are stimulated following subretinal injection of MCMV retinitis in MAIDS-10 mice 
[205], a multitude of factors may be interplaying with one another to contribute to the retinal 
destruction seen during MCMV retinitis. This, therefore, begs the question: What other factors 
are stimulated following MCMV infection of MAIDS-10 mice that may be contributing to the 
pathogenesis of MAIDS-related MCMV retinitis?   
The central hypothesis that pyroptosis-associated molecules and associated 
inflammasomes contribute to the onset and progression of retinal damage during MAIDS-related 
MCMV retinitis was investigated by the use of three specific aims. 
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Specific Aim 1 will test the hypothesis that pyroptosis and associated 
inflammasomes are stimulated by MCMV during immunosuppression, contributing to the 
onset and development of MCMV retinitis. Pyroptosis-associated molecules, caspase-1, IL-1β, 
and IL-18, and inflammasomes NLRP3, NLRP1b, NLRC4, and AIM2 mRNA was significantly 
upregulated during experimental MAIDS-related MCMV retinitis but not in MAIDS-4 mice 
resistant to the development of MCMV retinitis [6] (Figure 1.18). As GSDMD is considered the 
executioner of pyroptosis, due to its ability to form pores resulting in the change in osmotic 
pressure and mass release of pro-inflammatory cytokines, we further support the notion that 
pyroptosis may be present during the onset of retinal destruction by determining whether 
GSDMD is stimulated following MCMV retinitis in MAIDS-10 mice. If pyroptosis is directly 
responsible for the destruction seen during MAIDS-related MCMV retinitis, then pyroptosis-
associated molecules are not likely to be stimulated in MCMV-infected eyes of mice that are not 
susceptible to the development of MCMV retinitis. To deem the necessity of these pyroptosis-
related molecules and associated inflammasomes for the development of CMV retinitis, we 
measured the frequency of retinitis in mice lacking one of the following genes: caspase-1, 
GSDMD, IL-18, IL-1R1, NLRP3, NLRP1b, and AIM2. If pyroptosis-related molecules and 
associated inflammasomes do play a role in the development of MCMV retinitis in mice with 
MAIDS, the expression of these pyroptosis-associated molecules would likely have to be 
stimulated in other models of immunosuppression that confer susceptibility to the development 
of MCMV retinitis, such as corticosteroid-induced immune suppression. Through the completion 
of these experiments, we will determine whether pyroptosis-related molecules and associated 
inflammasomes play a role in the development of MCMV retinitis is mice with 
immunosuppression.  
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Specific Aim 2 will test the hypothesis that MCMV replication directly stimulates 
pyroptosis in infected cells. Pyroptosis-related molecules were significantly upregulated in 
whole eyes infected with MCMV during experimental MAIDS-related MCMV retinitis [6] 
(Figure 1.18). As pyroptosis can be signaled by both PAMPs and DAMPs, it is uncertain if the 
stimulation of these pyroptosis-associated molecules during the pathogenesis of MAIDS-related 
MCMV retinitis is in direct response to MCMV replication in the cells or brought on indirectly 
by the host response to viral infection. To determine whether pyroptosis is directly stimulated by 
infection of cells by CMV, the stimulation of pyroptosis-associated molecules in response to 
MCMV replication was measured in IC-21 mouse macrophages and mouse embryonic 
fibroblasts (MEFs). HCMV-induced stimulation of pyroptosis-related molecules was measured 
in HCMV-infected ARPE-19 cells and MRC-5 fibroblasts. To determine the viral mechanisms 
responsible for any observed stimulation in infected cells, monolayers were infected with UV-
inactived CMV. UV treatment damages the CMV genome preventing viral replication but allows 
for attachment and adsorption of the viral to host cells and the subsequent release of tegument 
proteins.  
Specific Aim 3 will test the hypothesis that other immune response genes or 
pathways are stimulated during the pathogenesis of MAIDS-related MCMV retinitis.  
Previous studies by us has demonstrated the involvement of several cell death pathways 
and cytokine signaling during MAIDS-related MCMV-retinitis. To determine what other factors 
might be involved during the onset and development of retinitis we looked at the stimulation of 
multiple additional immune response pathways between MAIDS-4 and MAIDS-10 mice.  If 
pertinent, these findings could help shape the future focus of our investigation on the 
mechanisms underlying the pathogenesis of MAIDS-related MCMV retinitis. 
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2 MATERIALS AND METHODS 
2.1 Cell Lines and Stocks 
C57BL/6 MEF cells obtained from ATCC (Manassas, VA, No. SCRC-1002) were grown 
in Dulbecco’s modified eagle medium (DMEM) supplemented with 15% fetal bovine serum 
(FBS), 4 mM L-glutamine, 1% penicillin/streptomycin, 0.1 mg/mL gentamicin, and 1.5 g/L 
sodium bicarbonate and maintained according to ATCC recommendations. These cells were used 
for titration of MCMV stocks and in some experiments. 
IC-21 mouse macrophages (ATCC, Manassas, VA, No. TIB-186) were maintained 
according to ATCC recommendations and sustained in RPMI-1640 medium supplemented with 
10% FBS, 1% penicillin/streptomycin, and 0.1 mg/mL gentamicin. This cell line was 
transformed with a simian virus 40 (SV40) [217] and is commonly used in cell culture studies 
with MCMV infection [32, 218-221].  
MRC-5 (human fetal lung fibroblast obtained from ATCC, Manassas, VA, No. CCL-171) 
cells were cultured according to ATCC recommendations and in DMEM supplemented with 
10% FBS, 4 mM L-glutamine, 1% penicillin/streptomycin, 0.1 mg/mL gentamicin, and 1.5 g/L 
sodium bicarbonate. 
Human retinal pigmented epithelial cells, ARPE-19 (ATCC, Manassas, VA, No. CRL-
2302), were grown in DMEM: F12 containing 10% FBS, 1% penicillin/streptomycin, and 0.1 
mg/mL gentamicin and cultured as recommended by ATCC. 
SC-1 fibroblasts (ATCC, Manassas, VA, No. CRL-1404) and SC-1/MuLV LP-BM5 cells 
[106] provided by the AIDS Research and Reference Reagent Program, Division of AIDS, 
NIAID, NIH (Germantown, MD) and were maintained in DMEM containing 10% FBS, 24 mM 
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L-glutamine, 1% penicillin/streptomycin, and 0.1 mg/mL gentamicin. These cell lines were used 
for propagation of the mouse retrovirus mixture used to induce MAIDS. 
2.2 Viral Stocks 
Propagation of CMV. MCMV (Smith) stocks were propagated via passage through 
salivary glands of adult female BALB/c mice (Harlan Laboratories, USA) as previously 
described [4, 222, 223]. The use of these BALB/c mice was conducted with the approval of the 
Georgia State University Institutional Animal Care and Use Committee (IACUC) and in 
compliance with the Association for Research in Vision and Ophthalmology (ARVO) statement 
for Use of Animals in Ophthalmic and Vision Research. The Towne strain of HCMV was 
propagated through (MRC-5) cells acquired from the American Type Culture Collection (ATCC, 
Manassas, VA, No. CCL-171). Stocks of viruses were centrifuged to remove cellular debris and 
frozen in liquid nitrogen. Viral titers for the MCMV and HCMV stocks were quantified by 
standard plaque assay in C57BL/6 MEFs and MRC-5, respectively.   
Propagation of mouse retrovirus mixture for MAIDS induction. Stocks of murine 
retrovirus (LP-BM5 murine leukemia virus [MuLV]) were prepared in SC-1 fibroblasts and SC-
1/MuLV LP-BM5 cells [106] provided by the AIDS Research and Reference Reagent Program, 
Division of AIDS, NIAID, NIH (Germantown, MD). To prepare each stock, the two cell lines 
were seeded in a 1:1 ratio and maintained for six days. The cells were then scraped into a 
complete SC-1 medium and stored at -80°C. Aliquots of stocks were thawed and clarified by 
centrifugation prior to each use. 
UV-inactivation of MCMV. For experiments utilizing UV-inactivation of the virus, a 
portion of MCMV from the same stock of each experiment was exposed to DNA-damaging UV 
light (UVi-MCMV) [224]. UV-inactivation was achieved by placing approximately 1 mL of the 
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virus stock in an uncovered dish on ice approximately 5-cm from the UV light for three hours 
[99]. Aliquots of UVi-MCMV were titered to ensure complete inactivation. 
2.3 Animals 
Adult female BALB/c mice, used for MCMV propagation, were purchased from Harlan 
Laboratories (Indianapolis, IN, USA). Wild-type female C57BL/6 mice used for experiments 
were purchased from Jackson Laboratory (Bar Harbor, ME, USA). All mice were housed in the 
Georgia State University vivarium with 12-hr light/dark cycles with unrestricted access to 
standard diet and water. All animal procedures were conducted in compliance with Georgia State 
University IACUC protocols and with the ARVO statement for Use of Animals in Ophthalmic 
and Vision Research. 
Induction of MAIDS. MAIDS was induced in WT C57BL/6 mice and in various groups 
of knockout mice (B6.129S6-Nlrp3 tm1Bhk/J, B6.129S6-Nlrp1b tm1Bhk/J, and B6.129P2-
Aim2Gt(CSG445) Byg/J, B6N.129S2-Casp 1tm1Flv/J, B6.129S7-Il1r1tm1Imx/J, B6.129P2-Il18tm1Aki/J, 
and C57BL/6J-Gsdmdem1Vnce/J) by intraperitoneal injection of 1.0 ml of inoculum containing 
approximately 5 × 103 infectious LP-BM5 murine leukemia retrovirus. The retrovirus mixture 
was allowed to progress to MAIDS-4 or to MAIDS-10.  
Corticosteroid-induced Immunosuppression. For the corticosteroid-induced 
immunosuppression experiments, corticosteroid-induced immunosuppression was established in 
adult female C57BL/6 mice, as previously described [109, 225, 226] via intramuscular injection 
of methylprednisolone acetate (2mg/mouse, ~40 mg/kg) every three days starting two days prior 
to MCMV infection. All mice were age matched to groups of female adult mice, 
immunosuppressed for MAIDS. 
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Subretinal MCMV Injections. Prior to subretinal injections of MCMV, all groups of 
mice eyes were first dilated with atropine and tropicamide eye drops. Mice were then 
anesthetized by intramuscular injection of 0.1 mL xylazine (1.72 mg/mL) and 0.1 mL 
acepromazine (0.28 mg/mL), followed by intraperitoneal injection of 0.1–0.2 mL ketamine (8.58 
mg/mL). Once mice were confirmed to be under deep anesthesia, both eyes were injected with 2 
μL of DMEM containing approximately 104 plaque-forming units (PFU) of MCMV. Three, six, 
or ten days following infection, mice were anesthetized with isoflurane, euthanized, and whole 
eyes were harvested. The eyes were either frozen in liquid nitrogen for protein analysis and 
quantification of ocular MCMV or stored in a 10% buffered formalin solution for histology. 
2.4 Quantification of Infectious MCMV  
Infectious MCMV was quantified in each eye by individually homogenizing the MCMV-
infected eyes in a 2 mL Tenbroeck tissue grinder (Wheaton, Millville, NJ) with 1 mL phosphate-
buffered saline (PBS). The virus was clarified from the tissue by centrifugation. The resultant 
aliquots underwent a freeze-thaw cycle and were then serially diluted and inoculated onto 
monolayers of ~90% confluency MEFs in duplicate. After a 1-hour incubation at 37°C, infected 
wells were then overlaid with 2% methylcellulose in DMEM and incubated for another six days. 
Individual plaques were counted with an inverted light microscope, and MCMV titers for whole 
eyes were reported as PFU/mL/eye. 
2.5 Histology 
The frequency of retinitis in all mice (n = >3) was measured after euthanizing and 
harvesting eyes ten days post-MCMV infection. Harvested eyes were stored at 4°C for at least 
five days in a 10% buffered formalin solution. After fixation, eyes were then embedded in 
paraffin, cut into 5-μm-thick transverse sections, and stained with hematoxylin and eosin by the 
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Pathology Department of the Emory Eye Center. Every sixth section of each eye was evaluated 
under light microscopy for the presence or absence of retinitis 
2.6 Western Blot Analysis 
MCMV-infected eyes frozen in liquid nitrogen were thawed and homogenized in PBS 
containing a protease inhibitor cocktail (Sigma, St. Louis, MO). Samples were subjected to 
sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (SDS-PAGE) and transferred 
to a 0.2-μm-pore polyvinylidene fluoride membrane blocked in 5% bovine serum albumin. 
Target proteins were completed using rabbit anti-mouse IL-1β antibody (1:250) (Abcam, 
Toronto, ON), rabbit anti-mouse IL-18 antibody (1:250) (Abcam), rabbit anti-mouse GSDMD 
(1:500) (Abcam), rabbit anti-mouse caspase-1 (1:500) (Abcam), rabbit anti-mouse caspase-11 
(1:500) (Abcam), rabbit anti-mouse RIPK1 (1:500), rabbit anti-mouse RIPK3 (1:500), rabbit 
anti-mouse MLKL (1:500), rabbit anti-mouse TNFα (1:1000), rabbit anti-mouse beclin-1 
(1:1000), rabbit anti-mouse LC3B (1:1000), rabbit anti-mouse GAPDH antibody (1:1,000) 
(Abcam), or rabbit anti-mouse β-actin antibody (1:1,000) (Abcam) as primary antibodies. Goat 
anti-rabbit IgG antibody (heavy plus light chains [H+L]) conjugated with horseradish peroxidase 
(Thermo Scientific, Pittsburgh, PA) was chosen as a secondary antibody (1:5,000). Probed 
nitrocellulose membranes (Bio-Rad, Hercules, CA) were treated with Clarity Western ECL 
Substrate (Biorad) and exposed to HyBlot film (Denville, Holliston, MA) for band detection. 
2.7 Immunofluorescence Staining 
Immunofluorescence (IF) staining was performed in MEFs grown in 24-well dishes infected 
with 0.5 mL per well of either MCMV (multiplicity of infection (MOI) = 3 PFU/cell), UVi-
MCMV from the same stock, or control medium. At 6 and 24 hpi, wells were fixed in ice-cold 
methanol, blocked in 5% bovine serum albumin, and probed for rabbit-anti-mouse caspase-1, IL-
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1β, IL-18, gasdermin D primary antibodies (Santa Cruz Biotechnology, Inc., Dallas, TX). Goat-
anti-rabbit IgG Fab’ fragment antibody conjugated with FITC (green) (Jackson 
ImmunoResearch, West Grove, PA) was used as the secondary antibody. Cell nuclei were 
counterstained with 4', 6-diamidino-2-phenylindole (DAPI) in Vectashield® mounting solution 
(Vector Laboratories, Burlingame, CA). Cells were then observed using a Keyence microscope. 
2.8 RNA Extraction and Real-Time RT PCR 
RNA extraction from tissue samples. Whole MCMV-infected eyes and mock infected 
eyes were collected at the indicated time points following subretinal injection and stored at 4°C 
in RNAlater solution (Ambion, Austin, TX). Following collection at all time points, eyes were 
then individually homogenized in 1mL of TRIzol® reagent (Invitrogen Life Technologies, 
Carlsbad, CA) using a 2-ml Ten Broeck tissue grinder (Wheaton, Millville, NJ). Total RNA was 
extracted in chloroform and purified using the PureLink® RNA Mini Kit according to the 
manufacturer’s instructions (Ambion/ThermoFisher). RNA concentrations were determined 
using a Nanodrop™ 2000 spectrophotometer (Thermo Scientific, Pittsburgh, PA) and 
normalized for each sample.  
RNA extraction from cell monolayers. Monolayers of cells were harvested at indicated 
time points in TRIzol® reagent (Ambion/ThermoFisher Scientific, Waltham, MA, USA) at 
indicated time points. Total RNA was extracted with chloroform and purified over PureLink® 
RNA Mini Kit spin cartridge filters according to the manufacturer’s instructions 
(Ambion/ThermoFisher). RNA concentrations were determined using a Nanodrop 2000 
spectrophotometer (Thermo Scientific, Pittsburgh, PA) and normalized for each sample. 
Real-Time Reverse Transcriptase Polymerase Chain Reaction (RT-PCR). The RNA 
for all sample types was then reverse-transcribed into cDNA using SuperScript™ III First-Strand 
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Synthesis Kit reagents according to the manufacturer’s instructions (Invitrogen/ThermoFisher). 
Detection and quantification of target gene expression were performed via real-time RT-PCR 
using Applied Biosystems 7500 Fast Real-Time PCR System hardware and software in 
conjunction with Power SYBR Green Master Mix (Applied Biosystems, Foster City, CA). 
Mouse-specific primers for caspase-1, caspase-11, IL-1β, IL-18, GSDMD, NLRP3, NLRP1b, 
NLRC4, AIM2, and GAPDH were obtained from QIAgen (Valencia, CA). Samples were run 
under the following thermocycling parameters: 10 min at 95°C followed by 40 cycles consisting 
of 15 seconds at 94°C, 31 seconds at 55°C, and 35 seconds at 70°C. Cycles to the threshold (CT) 
for each target gene were determined, and the ΔCT value for each sample was normalized by 
subtracting the CT value of their own endogenous housekeeping gene (GAPDH) from the CT 
value of the target gene. The ΔCT values of each target gene mRNA of MCMV-infected eyes 
were compared with mock infected control eyes by the 2-ΔΔCt method to determine the change 
in gene expression, yielding a relative fold-change in mRNA expression for each group. Data 
points represent mean fold-changes ± standard deviations (SD) of at least duplicate experimental 
repeats. 
2.9 NanoString Analysis  
Whole MCMV-infected eyes and mock infected eyes were collected at indicated time 
points and stored at 4°C in RNAlater solution (Ambion, Austin, TX). Eyes were then 
homogenized in 1 mL of TRIzol® reagent (Invitrogen Life Technologies, Carlsbad, CA) using a 
2-ml Ten Broeck tissue grinder (Wheaton, Millville, NJ). Total RNA was extracted in 
chloroform and purified using the PureLink® RNA Mini Kit according to the manufacturer’s 
instructions (Ambion/ThermoFisher). The extracted RNA from each group and respective time 
points were pooled together, and the RNA concentrations were determined using a Nanodrop 
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2000 spectrophotometer (Thermo Scientific, Pittsburgh, PA). Approximately 100 ng of the 
purified total RNA was hybridized to a reporter and capture probe prior to being added to the 
NanoString panels for analysis of raw RNA counts. The nCounter murine immunology panel 
designed by NanoString Technology (Nanostring, Seattle, WA, USA) was used to analyze the 
expression of 561 genes, including several internal references and housekeeping genes. A 
custom-made panel including 30 genes of interest and 3 housekeeping genes was also loaded to 
explore the expression of RNA associated with several genes not specific to the murine 
nCounter Immunology Panel. All data were analyzed using the NanoString nSolver 4.0 
software (Nanostring, Seattle, WA, USA). 
2.10 Statistical Analyses 
All statistical analyses were performed with a significance level (α) set to 0.05. P-values 
of < 0.05 were considered statistically significant and were denoted by asterisks in figures where 
appropriate: * p<0.05, ** p<0.01, and *** p<0.001. Statistical tests were performed as 
appropriate for each study as specified below. 
Statistical analysis for in vivo studies. All quantitative data obtained from real-time RT-
PCR were performed with a significance level (α) set to 0.05 so that p-values of <0.05 were 
considered statistically significant and expressed as means ± SD. At least two independent 
experiments were performed for each study. Statistical analysis was performed by comparing 
MCMV-infected eyes with mock infected control eyes by paired, two-tailed Student’s t-test.  
Statistical analysis for in vitro studies. Statistical analysis was performed using 
GraphPad Prism® v8.2.1 software with a significance level (α) set to 0.05, so that p-values of 
<0.05 were considered statistically significant. Experimental groups were compared with 
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respective control groups at the same time points using a two-way analysis of variance 
(ANOVA) with Bonferroni posthoc analysis. 
Statistical analysis for ocular titers. All quantitative data obtained for ocular titers were 
performed with a significance level (α) set to 0.05 so that p-values of <0.05 were considered 
statistically significant and expressed as means ± SD. At least two independent experiments were 
performed for each study. Statistical analysis was performed by comparing MCMV-infected eyes 
of WT MAIDS-10 mice to each knockout MAIDS-10 mouse by unpaired, two-tailed Student’s t-
test. 
Statistical analysis for NanoString studies. Two independent experiments were 
performed for each study and ran independently through the NanoString software. Any p-values 
obtained were done on fold-changes of raw RNA counts as determined by the NanoString 
nSolver software and performed with a significance level (α) set to 0.05 so that p-values of 
<0.05 were considered statistically significant. Statistical analysis was performed by comparing 
MCMV-infected eyes with mock infected control eyes by unpaired, two-tailed Student t-test, and 
values were expressed as means ± SD. 
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3 SPECIFIC AIM 1 
Specific Aim 1: Test the Hypothesis That Pyroptosis and Associated Inflammasomes are 
Stimulated by MCMV during Immunosuppression, Contributing to the Onset and 
Development of MCMV Retinitis 
3.1 GSDMD and Caspase-11 Expression during MAIDS-related MCMV Retinitis 
Expression and translation of GSDMD during MAIDS-related MCMV retinitis. We 
reported previously that MCMV-infected eyes of MAIDS-10 mice show high stimulation of 
mRNA expression of pyroptosis-associated molecules, caspase-1, IL-1β, and IL-18, collectively 
peaking 6 days following subretinal MCMV inoculation. To further confirm a role for pyroptosis 
in the pathogenesis of MAIDS-related MCMV retinitis, we assessed whether protein and/or 
mRNA of the pore-forming molecule, GSDMD, increased following ocular MCMV infection in 
MAIDS-10 mice. We found that MCMV-infected eyes of MAIDS-10 mice showed upregulation 
of both GSDMD mRNA transcripts (Fig. 3.1A) and protein (Fig. 3.1B). However, unlike 
caspase-1, IL-1β, and IL-18 mRNA transcripts that showed a peak upregulation at 6 days post-
infection, GSDMD mRNA appeared to be consistently upregulated days 3, 6, and 10 following 
MCMV inoculation. Protein levels for full-length GSDMD were robustly increased in MCMV-
infected eyes when compared to the media control eyes at all days post-infection while a 
substantial stimulation of cleaved GSDMD protein was seen at 10 days post-infection. 
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Figure 3.1. Intraocular GSDMD mRNA and protein expression were highly expressed in 
the MCMV infected eyes of retinitis-susceptible MAIDS-10 mice. 
Whole eyes were collected at 3, 6, and 10 days following subretinal injection of MCMV (left 
eyes) or media control (right eyes) from groups (n=3-5) of MAIDS-10 mice. Homogenized eyes 
were assessed for GSDMD mRNA (A) or protein expression, with GAPDH used as a loading 
control. *p<0.05, MCMV groups compared with media group at the same time point.  
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Expression and translation of caspase-11 during MAIDS-related MCMV retinitis. 
We previously saw that protein levels of cleaved caspase-11 was also significantly stimulated at 
6 days following MCMV injection of MAIDS-10 mice [6]. Since we have not previously 
characterized the expression of caspase-11 mRNA, we assessed whether this was also stimulated 
during the onset and progression of MAIDS-related MCMV retinitis. Like GSDMD, mRNA 
levels of caspase-11 (Fig. 3.2A) were also stimulated in MCMV-infected eyes of MAIDS-10 
consistently at days 3, 6, and 10, following ocular MCMV infection. Assessing levels of the 
zymogen version of caspase-11 revealed that procaspase-11 protein was also stimulated at days 3 
and 6 post-MCMV infection (Fig.3.2B). The locus of caspase-11 has been shown to encode two 
polypeptides of 43 and 38 kDa [227] in which the p20 cleavage product of procaspase-11 
appears to be derived from the 43 kDa species [228]. Interestingly, at day 3 post-infection, the 43 
kDa band of procaspase-11 was highly expressed, while the 38 kDa band was more highly 
expressed at day 6 post-infection. Taken together, these results suggest that MCMV stimulates 
both GSDMD and caspase-11 mRNA and protein following ocular infection of MCMV in 
MAIDS-10 mice. 
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Figure 3.2. Intraocular caspase-11 mRNA and protein expression were highly stimulated in 
the MCMV infected eyes of retinitis-susceptible MAIDS-10 mice. 
Whole eyes were collected at 3, 6, and 10 days following subretinal injection of MCMV (left 
eyes) or media control (right eyes) from groups (n=3-5) of MAIDS-10 mice. Homogenized eyes 
were assessed for caspase-11 mRNA (A) or protein expression, with GAPDH used as a loading 
control. *p<0.05, MCMV groups compared with media group at the same time point.  
68 
3.2 GSDMD and Caspase-11 Expression Following MCMV Infection in MAIDS-4 Mice 
Expression and translation of GSDMD following MCMV infection of retinitis 
resistant MAIDS-4 mice. We reported previously that MCMV-infected eyes of MAIDS-10 but 
not MAIDS-4 mice showed mRNA expression of pyroptosis-associated molecules, caspase-1, 
IL-1β, and IL-18. To determine if GSDMD expression follows this pattern, we assessed whether 
the mRNA and/or protein of GSDMD was expressed following ocular infection of MCMV in 
retinitis resistant MAIDS-4 mice. Interestingly, expression of GSDMD during MCMV infection 
of MAIDS-4 eyes showed a substantial increase in fold-change of mRNA when compared to the 
mock infected control eyes at each time point during viral infection (Fig.3.3A). The pattern of 
mRNA production of GSDMD at MAIDS-4 was different from that at MAIDS-10 (Fig. 3.3B). 
MAIDS-4 mice showed a peak in mRNA production at day 6 post-infection that reached the 
relative level seen in MAIDS-10 infected eyes. Both at days 3 and 10 post-infection, however, 
there was less GSDMD transcript production than the corresponding days of MAIDS-10 
MCMV-infected eyes. The pattern of protein expression for full-length GSDMD protein was 
similar at MAIDS-4 as it was at MAIDS-10, in which the protein was stimulated in MCMV-
infected eyes at all days post-infection with higher expression at day 6 post-infection (Fig. 3.3C). 
Interestingly, cleaved GSDMD protein was expressed only at day 6 post-infection in MCMV-
infected eyes of mice with MAIDS-4 while MAIDS-10 mice showed expression only at day 10 
post-infection, which correlates with the presence of retinitis. 
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Figure 3.3. Intraocular GSDMD mRNA and protein were stimulated in MCMV infected 
eyes of both retinitis susceptible MAIDS-10 mice and retinitis-resistant MAIDS-4 mice. 
Whole eyes were collected at 3, 6, and 10 days post-infection (dpi) and from MCMV infected 
eyes and media control eyes from groups (n=3-5) of MAIDS-4 and MAIDS-10 mice. 
Homogenized eyes were assessed for GSDMD mRNA from the MAIDS-4 mice (A) and the 
MAIDS-10 mice (B). Western blot analysis (C) was performed to assess ocular GSDMD protein 
expression in MAIDS-4 mice with GAPDH used as a loading control. *p<0.05 and **p<0.01, 
MCMV groups compared with media control at the same time points. 
Expression and translation of caspase-11 following MCMV infection of retinitis 
resistant MAIDS-4 mice. We previously saw that protein levels of cleaved caspase-11 were also 
significantly stimulated at 6 days following MCMV injection of MAIDS-10 mice [6]. Since we 
had not previously characterized the expression of caspase-11 mRNA during MAIDS-4, we 
assessed whether caspase-11 mRNA was also stimulated in MAIDS-4 mice resistant to MCMV 
retinitis. Like GSDMD, mRNA levels of caspase-11 was stimulated in MCMV-infected eyes of 
both MAIDS-4 (Fig. 3.4A) and MAIDS-10 (Fig. 3.4B) mice. mRNA expression in MAIDS-4 
mice, however, exhibited an initially high upregulation at day 3 post-infection which resulted in 
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an almost linear decrease in production continuing through 6- and 10-days post-infection. 
Similar to the protein levels seen at MAIDS-10, procaspase-11 protein levels showed a 
stimulation at day 6 post-infection in MCMV-infected eyes of MAIDS-4 mice, which decreased 
by day 10 post-infection, whereas media-injected eyes did not stimulate caspase-11 protein 
production at any days post-infection (Fig. 3.4C). However, unlike MCMV-infected eyes of 
MAIDS-10 mice, procaspase-11 protein was not expressed 3 days post-infection in MCMV-
infected eyes of MAIDS-4 mice. Taken together, these results suggest that MCMV stimulates 
both GSDMD and caspase-11 following ocular infection in both retinitis susceptible MAIDS-10 
mice and retinitis resistant MAIDS-4 mice.  
 
Figure 3.4. Intraocular caspase-11 mRNA and protein were stimulated in MCMV infected 
eyes of both retinitis susceptible MAIDS-10 mice and retinitis-resistant MAIDS-4 mice. 
Whole eyes were collected at 3, 6, and 10 days post-infection (dpi) and from MCMV infected 
eyes and media control eyes from groups (n=3-5) of MAIDS-4 and MAIDS-10 mice. 
Homogenized eyes were assessed for caspase-11 mRNA from the MAIDS-4 mice (A) and the 
MAIDS-10 mice (B). Western blot analysis (C) was performed to assess ocular procaspase-11 
protein expression in MAIDS-4 mice with GAPDH used as a loading control. *p<0.05 and 
**p<0.01, MCMV groups compared with media control at the same time points. 
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3.3 Effect of the Loss of the Pyroptosis Pathway or Associated Inflammasomes on the 
Development of MAIDS-related MCMV Retinitis 
3.3.1 The Loss of the Pyroptosis Pathway and MAIDS-related MCMV Retinitis 
We have previously reported that mRNA for caspase-1, IL-1β, and IL-18 are stimulated 
during the onset and development of MAIDS-related MCMV retinitis [6]. To continue our 
investigations on the involvement of pyroptosis-associated proteins in the retinal destruction seen 
during this disease, we employed several mice knocked-out of either caspase-1, GSDMD, IL-
1R1, or IL-18 to determine the necessity of these proteins in the development of retinitis. 
MCMV-infected eyes of caspase-1 KO mice with MAIDS, GSDMD KO mice with 
MAIDS, IL-1R1 KO mice with MAIDS, and IL-18 KO mice MAIDS show patterns of 
protein synthesis that are relatively similar to those of MCMV-infected eyes of wildtype 
mice with MAIDS. We next embarked on a comprehensive investigation of MCMV retinitis 
pathogenesis using mice with MAIDS that were deficient in one of four pyroptosis-associated 
genes to define with greater precision the contribution of pyroptosis toward the onset and 
progression of MAIDS-related MCMV retinitis. This investigation included a gene deficiency in 
the production of either caspase-1, GSDMD, IL-1R1, or IL-18. All caspase-1 KO mice, GSDMD 
KO mice, IL-1R1 KO mice, and IL-18 KO mice infected with the immunosuppressive murine 
retrovirus mixture (LP-BM5 MuLV) developed MAIDS as assessed by their development of a 
number of MAIDS-related physical and immunologic characteristics (data not shown) described 
by us previously [100]. 
 Prior to assessing possible virologic, pathogenic, and histopathologic differences 
during the development of MCMV retinitis among MAIDS mice with a pyroptosis-associated 
gene deficiency when compared with the development of MCMV retinitis in wildtype MAIDS 
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mice, we investigated the patterns of pyroptosis-associated proteins of the canonical and 
noncanonical pyroptosis pathways for possible alterations in their pattern of synthesis with 
particular attention given to cleavage events. Western blot analysis of MCMV-infected eyes 
collected from caspase-1KO mice with MAIDS, GSDMD KO mice with MAIDS, IL-1R1 KO 
mice with MAIDS, and IL-18 KO mice with MAIDS at 10 days after subretinal MCMV 
inoculation showed relatively similar patterns of protein production for corresponding proteins 
associated with the canonical and noncanonical pyroptosis pathways when compared with the 
patterns of protein production collected from MCMV-infected eyes of wildtype MAIDS mice 
(Fig. 3.5). Some notable exceptions were observed, however. A deficiency in either capsase-1 
production during MAIDS or IL-1R1 production during MAIDS resulted in an absence of 
cleaved caspase-11 of the noncanonical pyroptosis pathway despite evidence for pro-caspase-11 
production (Fig 3.5A and 3.5C). Similarly, a deficiency in IL-1R1 production during MAIDS 
also resulted in a marked decrease in cleaved GSDMD protein of the canonical pyroptosis 
pathway (Fig 3.5B). 
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Figure 3.5. Expression of pyroptosis-associated proteins in MCMV infected eyes of 
wildtype MAIDS mice and caspase-1KO, GSDMD KO, IL-1R1KO, and IL-18KO micewith 
MAIDS. 
WT MAIDS mice and groups of caspase-1 KO (A), GSDMD KO (B), IL-1R1 KO (C), and IL-
18 KO (D) mice with MAIDS (n= 4- 6 mice/group) were subretinally infected with 10^4 PFU 
MCMV. Whole eyes were collected and at 10 dpi and assessed for ocular expression of the 
known pyroptosis-associated markers by western blot with beta-actin serving as a loading 
control.  
 
74 
 
MCMV-infected eyes of wildtype mice with MAIDS and MCMV-infected eyes of 
mice with MAIDS deficient in the production of a pyroptosis-associated protein harbor 
equivalent amounts of infectious MCMV. We showed previously that MCMV-infected eyes of 
retinitis-susceptible wildtype mice with MAIDS harbor significantly high amounts of infectious 
virus at 10 days after subretinal MCMV inoculation when compared with retinitis-resistant 
MCMV-infected eyes of healthy mice similarly inoculated with virus [6, 103]. To determine if 
loss of the canonical pyroptosis pathway (defined as a deficiency in the production of a key 
pyroptosis-associated protein) resulted in reduced intraocular virus replication during the 
development of MAIDS-related MCMV retinitis, whole MCMV-infected eyes were collected 
from groups of wildtype MAIDS mice, caspase-1KO mice with MAIDS, GSDMD KO mice with 
MAIDS, IL-1R1KO mice with MAIDS, and IL-18KO mice with MAIDS at 10 days after 
subretinal MCMV inoculation (n = 4 – 6 per group) and were individually homogenized and 
subjected to standard plaque assay to quantify infectious MCMV. Results are shown in Fig 3.6. 
In agreement with previous findings [6, 103, 226], MCMV-infected eyes of retinitis-susceptible 
wildtype mice with MAIDS were found to contain high amounts of infectious MCMV (4.3 
x104). In comparison, MCMV-infected eyes of mice with MAIDS with a deficiency in either 
caspase-1, GSDMD, IL-1R1, or IL-18 also showed high amounts of infectious virus and at levels 
equivalent to that found within MCMV-infected eyes of wildtype mice with MAIDS with 
amounts ranging from 4.8 x104 to 4.4 x104. While there was a trend for the MCMV-infected eyes 
collected from pyroptosis-deficient MAIDS mice to exhibit greater amounts of infectious 
MCMV when compared with wildtype MAIDS mice, this difference was not statistically 
significant. Thus, loss of the canonical pyroptosis pathway during MAIDS did not affect the 
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intraocular replication of MCMV when compared with wildtype animals with MAIDS at 10 days 
following subretinal MCMV inoculation. 
 
 
Figure 3.6. WT MAIDS mice and groups of MAIDS mice deficient in the production of a 
pyroptosis-associated protein harbored equivalent amounts of infectious MCMV. 
MCMV-infected eyes were collected 10 dpi following intraocular MCMV injection from 
wildtype MAIDS mice and MAIDS mice deficient in either caspase-1, IL-1R1, IL-18, and 
GSDMD. Amount of infectious MCMV were detected in whole eyes by standard plaque assay 
(n=4-6). 
 
The frequency of full-thickness retinal necrosis is significantly reduced within 
MCMV-infected eyes of MAIDS mice deficient in the production of a pyroptosis-associated 
protein when compared with the frequency of full-thickness retinal necrosis MCMV-
infected eyes of wildtype MAIDS mice. Our finding that MCMV-infected mice with MAIDS 
with a deficiency in the pyroptosis pathway harbor high amounts of infectious MCMV led us to 
suspect that these animals would also develop full-thickness retinal necrosis at a frequency of 80 
to 100% as observed by us previously for wildtype mice with MAIDS [6, 103, 226]. To confirm 
this suspicion, the eyes of groups of mice with MAIDS lacking either caspase-1, GSDMD, IL-
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1R1, or IL-18 were inoculated subretinally with MCMV, collected 10 days later, subjected to 
histopathologic analysis, and scored for the frequency of full-thickness retinal necrosis. The 
MCMV-infected eyes of groups of wildtype mice with MAIDS included in each experiment 
served as controls. As reported previously, the frequency of full-thickness retinal necrosis for 
mice with MAIDS was 100% in each experiment. Surprisingly, however, none (0%) of the 
MCMV-infected eyes of mice with MAIDS with a deficiency in either caspase-1, GSDMD, IL-
1R1, or IL-18 developed full-thickness retinal necrosis. Despite high amounts of intraocular 
infectious MCMV at levels observed within MCMV-infected eyes of wildtype mice that 
consistently developed full-thickness retinal necrosis, MCMV-infected eyes of MAIDS mice 
deficient in a gene essential for pyroptosis consistently failed to develop full-thickness retinal 
necrosis.   
MCMV-infected eyes of MAIDS mice deficient in the production of a pyroptosis-
associated protein consistently show prominent RPE proliferation but with relative 
preservation of the neurosensory retina. In an attempt to resolve the apparent discrepancy of 
high and equivalent amounts of intraocular infectious virus but without expected full-thickness 
retinal necrosis development within MCMV-infected eyes of pyroptosis-deficient MAIDS mice 
when compared MCMV-infected eyes of wildtype MAIDS mice, a detailed histopathologic 
analysis was performed to define with greater precision the patterns of retinal disease among the 
different animal groups at 10 days after subretinal MCMV inoculation. Results are shown in Fig 
3.7. As expected, histopathologic examination of sections of MCMV-infected eyes collected 
from wildtype mice with MAIDS showed areas of full-thickness retinal necrosis containing 
virus-induced inclusions and cytomegalic cells in agreement with several previous publications 
by us [103]. In sharp contrast, however, histopathologic analysis of MCMV-infected eyes of 
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groups of caspase-1 KO mice with MAIDS, GSDMD KO mice with MAIDS, IL-1R1 KO mice 
with MAIDS, and IL-18 KO mice with MAIDS when paired experimentally with MCMV-
infected eyes of groups of wildtype mice with MAIDS as controls in separate experiments 
revealed two major findings. One was an atypical histopathologic feature characterized by 
widespread RPE proliferation accompanied by detection of virus-induced inclusions. The second 
was a relative preservation of the neurosensory retina with loss of photoreceptors in some cases 
but without detection of virus-induced inclusions or cytomegalic cells and without the 
development of full-thickness retinal necrosis. Moreover, it is noteworthy that this pattern of 
histopathologic changes was relatively consistent among all groups of animals with MAIDS 
deficient in the canonical pyroptosis pathway whether loss of caspase-1, GSDMD, IL-1R1, or 
IL-18 gene activity. Instead, MCMV-infected eyes from caspase-1 KO mice with MAIDS, 
GSDMD KO mice with MAIDS, IL-1R1 KO mice with MAIDS, and IL-18 KO mice with 
MAIDS exhibited an unexpected abnormal histopathologic outcome quite different from the of 
full-thickness retinal necrosis.     
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Figure 3.7. MCMV-infected eyes from groups of MAIDS mice deficient in the production 
of a pyroptosis-associated protein showed prominent RPE proliferation but preservation of 
the neurosensory retina. 
MCMV-infected eyes were collected 10 dpi following intraocular MCMV injection from 
wildtype MAIDS mice and MAIDS mice deficient in either caspase-1, IL-1R1, IL-18, and 
GSDMD. H & E staining was done to histopathologically evaluate the presence of retinitis and 
changes in the retinal architecture. 
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Loss of pyroptosis-associated genes for caspase-1, GSDMD, IL-1R1, and IL-18 does 
not entirely abolish the expression of necroptosis-associated proteins in MCMV-infected 
eyes of MAIDS-10 mice. Necroptosis is another form of programmed cell death pathway that 
results in a disruption in the membrane integrity, leading to the release of cellular components 
and resulting in inflammation. During necroptosis, RIPK1 and RIPK3, promoted by TNF-α, are 
recruited and activated [229-231]. This activation leads to the recruitment and phosphorylation 
of MLKL, which forms an oligomer complex and migrates to the plasma membrane [230]. Once 
at the membrane, MLKL forms a pore resulting in the rupture of the cell and subsequent release 
of DAMPs, triggering a highly pro-inflammatory response [232]. Like inflammasomes and 
pyroptosis-associated proteins, these necroptosis-related proteins have also been seen stimulated 
in MAIDS-related MCMV retinitis. To determine if the preservation in the neurosensory retinas 
in these KO mice had anything to do with the downregulation of necroptosis proteins in the 
absence of pyroptosis-associated genes, western blot analysis was utilized to detect the presence 
of necroptosis-associated proteins in caspase-1, GSDMD, IL-1R1, and IL-18 KO MAIDS mice. 
Western blot analysis was done on the MCMV-infected eyes of WT MAIDS mice and 
MAIDS mice deficient in either caspase-1 (Fig. 3.8A), GSDMD (Fig. 3.8B), IL-1R1 (Fig. 3.8C) 
or IL-18 (Fig. 3.8D) for molecules essential to the necroptosis pathway. For all KO MAIDS 
mice, RIPK1 and RIPK3 expression in MCMV-infected eyes was relatively similar to that seen 
in MCMV-infected eyes of WT MAIDS mice. MLKL protein expression and the 
phosphorylation of MLKL was also expressed in the MCMV-infected eyes of MAIDS mice, 
either WT or KO. Protein analysis for TNF-α revealed that the unprocessed protein [233] and 
cleaved form of TNF-α were both expressed in KO MAIDS mice and that this level of 
expression was the same as the WT MAIDS mice for all KO MAIDS mice except for mice 
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deficient in GSDMD. This suggests that GSDMD expression may have an influence on the 
expression of TNF-α in MCMV-infected eyes of MAIDS-10 mice. 
The Effect of the Loss of Pyroptosis-associated Proteins on the Expression of 
Autophagy Proteins in MCMV-infected Eyes of MAIDS-10 Mice. Western blots were also 
done to determine the level of expression of autophagy-related proteins, beclin-1, and LC3B. 
Unlike pyroptosis and necroptosis, autophagy is a non-inflammatory form of cell death induced 
under times of cellular stress [234]. Previously, we have shown that autophagy is not expressed 
in MAIDS-10 mice with MCMV retinitis. We were then interested in determining if the lack of 
retinitis in these KO mice was due to the stimulation of autophagy proteins as a means of 
protecting the retina. Western blots showed that there was no substantial difference seen in both 
beclin-1 and LC3B between WT MAIDS mice and Casp 1 KO MAIDS mice (Fig. 3.8A), 
GSDMD KO MAIDS mice (Figure 3.8B), IL-1R1 KO MAIDS mice (Fig. 3.8C), and IL-18 KO 
MAIDS mice (Fig. 3.8D). This suggests that the loss of these pyroptosis-associated proteins does 
not result in the upregulation of autophagy markers to preserve the retina from damage following 
MCMV infection. 
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Figure 3.8. Expression of necroptosis- and autophagy-related proteins following ocular 
MCMV infection in mice deficient in key pyroptosis-associated molecules. 
Western blot analysis was performed to visualize ocular expression of necroptosis-associated 
proteins and autophagy-associated proteins in MCMV infected eyes of WT MAIDS mice and 
either  caspase-1 KO mice (A), GSDMD (B) IL-1R1 KO mice (C), or IL-18 KO mice (D) with 
the presence or absence of MCMV and/or MAIDS, with GAPDH used as a loading control.  
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3.3.2 The Loss of Inflammasomes and MAIDS-related MCMV Retinitis  
Inflammasomes are high-molecular-weight, multi-protein complexes, that are found in 
the cytosol of immune cells and regulate the activation of inflammatory responses [171]. There 
are multiple types of inflammasomes, and each of their distinct assemblies is determined by a 
unique PPR in response to specific PAMPs or danger signals present in the host’s cytosol. Once 
activated by the inflammatory ligand, the central domain of the inflammasome undergoes 
oligomerization, resulting in the recruitment of adaptor proteins, such as ASC, to the effector and 
variable N-terminal domain, which is composed of a PYD and a CARD. The CARD domain, on 
either the inflammasome or ASC, binds and activates pro-caspase-1 to invoke an inflammatory 
response [172]. There are several types of inflammasome proteins known to date, including the 
NLR family members, NLRP1 and NLRP3, as well as AIM2 [161]. The NLRP3 inflammasome 
[235-250], the NLRP1 inflammasome [251-253] and the AIM2 [214] are well-characterized 
inflammasomes that have been shown to play a role in several ocular diseases. As we have 
previously shown that mRNA production of these inflammasomes are highly stimulated in 
MCMV-infected eyes of MAIDS-10 mice [100], we wanted to define with greater precision the 
contribution of the NLRP3 inflammasome towards the onset and progression of MCMV retinitis 
during MAIDS-10. 
MCMV-infected eyes of NLRP3KO mice with MAIDS, NLRP1b KO mice with 
MAIDS, and AIM2 KO mice with MAIDS show patterns of protein synthesis that are 
relatively similar to those of MCMV-infected eyes of wildtype mice with MAIDS. We 
continued our comprehensive investigation of MCMV retinitis pathogenesis using mice with 
MAIDS who were deficient in the production of one of three inflammasomes, either NLRP3, 
NLRP1b, or AIM2. All groups of KO mice infected with the immunosuppressive murine 
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retrovirus mixture (LP-BM5 MuLV) developed MAIDS as assessed by their development of a 
number of MAIDS-related physical and immunologic characteristics (data not shown) described 
by us previously [100]. 
 Again, we investigated the patterns of pyroptosis-associated proteins of the 
canonical and noncanonical pyroptosis pathways for possible alterations in their pattern of 
synthesis. Western blot analysis of MCMV-infected eyes collected from NLRP3KO mice with 
MAIDS, NLRP1b KO mice with MAIDS, and AIM2 KO mice with MAIDS at 10 days after 
subretinal MCMV inoculation showed relatively similar patterns of protein production for 
corresponding proteins associated with the canonical and noncanonical pyroptosis pathways 
when compared with the patterns of protein production collected from MCMV-infected eyes of 
WT MAIDS mice (Fig. 3.9). Some notable exceptions were observed, however. A deficiency in 
either NLRP1b production during MAIDS or AIM2 production during MAIDS resulted in an 
increased in the cleaved caspase-1 protein (Fig 3.9B and 3.9C) but no real changes in the cleaved 
caspase-11 protein production. Similarly, a deficiency in NLRP1b production during MAIDS 
also resulted in a slight increase in cleaved GSDMD protein. 
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Figure 3.9. Expression of pyroptosis-associated proteins MCMV infected eyes of wildtype 
MAIDS mice, NLRP3KO, NLRP1b KO, and AIM2KO mice with MAIDS. 
WT MAIDS mice and groups of NLRP3KO, NLRP1b KO, and AIM2KO mice with MAIDS (n= 
3 - 7 mice/group) were subretinally infected with 104 PFU MCMV. Whole eyes were collected 
and at 10 dpi and assessed for ocular expression of the known pyroptosis-associated markers by 
western blot with beta-actin serving as a loading control.  
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MCMV-infected eyes of wildtype mice with MAIDS and MCMV-infected eyes of 
mice with MAIDS deficient in the production of an inflammasome protein harbor 
equivalent amounts of infectious MCMV. To determine if loss of any inflammasome resulted 
in reduced intraocular virus replication during the development of MAIDS-related MCMV 
retinitis, whole MCMV-infected eyes were collected from groups of WT MAIDS mice, NLPR3 
KO mice with MAIDS, NLRP1b KO mice with MAIDS, and AIM2 KO mice with MAIDS at 10 
days after subretinal MCMV inoculation (n = 4 – 9 per group) are were individually 
homogenized and subjected to standard plaque assay to quantify infectious MCMV. Results are 
shown in Fig 3.10. In agreement with previous findings [6, 103, 226], MCMV-infected eyes of 
retinitis-susceptible wildtype mice with MAIDS were found to contain high amounts of 
infectious MCMV (2.96 x104). However, the level of infectious virus was significantly lower in 
the different group of KO MAIDS mice, with amounts ranging from 1.61 x104 to 1.75 x104. 
Thus, loss of either of these inflammasomes during MAIDS did affect the intraocular replication 
of MCMV when compared with WT mice with MAIDS at 10 days following subretinal MCMV 
inoculation. 
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Figure 3.10. WT MAIDS mice and groups of MAIDS mice deficient in the production of an 
inflammasome-associated protein harbored a decreased amount of infectious MCMV. 
MCMV-infected eyes were collected 10 dpi following intraocular MCMV injection from 
wildtype MAIDS mice and MAIDS mice deficient in either, NLRP3, NLRP1b, or AIM2. 
Amount of infectious MCMV were detected in whole eyes by standard plaque assay (n=3 - 9). 
 
The frequency of full-thickness retinal necrosis is significantly reduced within 
MCMV-infected eyes of MAIDS mice deficient in the production of an inflammasome 
protein when compared with the frequency of full-thickness retinal necrosis MCMV-
infected eyes of wildtype MAIDS mice. Our finding that MCMV-infected mice with MAIDS 
with a deficiency in one of several inflammasomes harbor high amounts of infectious MCMV, 
despite the significantly lower levels seen in the WT mice with MAIDS, led us to question 
whether these animals would also develop full-thickness retinal necrosis at a frequency of 80 to 
100% like previously seen in WT mice with MAIDS mice or fail to develop this full-thickness 
retinal necrosis as seen with the MAIDS mice deficient in a key pyroptosis protein. To confirm 
this, the eyes of groups of mice with MAIDS lacking either NLRP3, NLRP1b, or AIM2 were 
inoculated subretinally with MCMV, collected 10 days later, subjected to histopathologic 
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analysis, and scored for the frequency of full-thickness retinal necrosis. The MCMV-infected 
eyes of groups of WT mice with MAIDS included in each experiment served as controls. As 
reported previously, the frequency of full-thickness retinal necrosis for mice with MAIDS was 
between 89-100% in each experiment. Surprisingly, however, none (0%) of the MCMV-infected 
eyes of mice with MAIDS with a deficiency in either NLRP3 or AIM2 developed full-thickness 
retinal necrosis, and only 25% of mice (2/8) developed a full-thickness retinal necrosis. Despite 
high amounts of intraocular infectious MCMV, MCMV-infected eyes of MAIDS mice deficient 
in an inflammasome gene consistently showed a reduction in its ability to develop full-thickness 
retinal necrosis.   
MCMV-infected eyes of MAIDS mice deficient in the production of an 
inflammasome-related protein consistently show prominent RPE proliferation but with 
relative preservation of the neurosensory retina. A detailed histopathologic analysis was 
performed to define with greater precision the patterns of retinal disease among the different 
animal groups at 10 days after subretinal MCMV inoculation. Results are shown in Fig 3.11. As 
expected, histopathologic examination of sections of MCMV-infected eyes collected from 
wildtype mice with MAIDS showed areas of full-thickness retinal necrosis containing virus-
induced inclusions and cytomegalic cells. In sharp contrast, however, histopathologic analysis of 
MCMV-infected eyes of groups of KO MAIDS mice revealed the same two major findings as 
seen in the pyroptosis KO MAIDS mice, when paired experimentally with MCMV-infected eyes 
of groups of WT MAIDS mice. This includes the atypical histopathologic feature characterized 
by widespread RPE proliferation accompanied by detection of virus-induced inclusions as well 
as a relative preservation of the neurosensory retina with loss of photoreceptors in some cases 
but without detection of virus-induced inclusions or cytomegalic cells and without the 
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development of full-thickness retinal necrosis (the exception being the two NLRP1b KO mice 
with MAIDS that did show the development of a full-thickness retinal necrosis).  
 
Figure 3.11. MCMV-infected eyes from groups of MAIDS mice deficient in the production 
of an inflammasome-associated protein showed prominent RPE proliferation but 
preservation of the neurosensory retina. 
MCMV-infected eyes were collected 10 dpi following intraocular MCMV injection from 
wildtype MAIDS mice and MAIDS mice deficient in either NLRP3, NLRP1b, or AIM2. H & E 
staining was done to histopathologically evaluate the presence of retinitis and changes in the 
retinal architecture. 
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Loss of genes for inflammasomes NLRP3, NLRP1b, and AIM2 does not entirely 
abolish the expression of necroptosis-associated proteins in MCMV-infected eyes of 
MAIDS-10 mice. Western blot analysis was done on the MCMV-infected eyes of WT MAIDS 
mice and MAIDS mice deficient in either NLRP3 (Fig. 3.12A), NLRP1b (Fig. 3.128B), or AIM2 
(Fig. 3.12C) for molecules essential to the necroptosis pathway. For all KO MAIDS mice, 
RIPK1 and RIPK3 expression in MCMV-infected eyes was relatively similar to MCMV-infected 
eyes of WT MAIDS mice. MLKL protein expression and the phosphorylation of MLKL were 
also similarly expressed in the MCMV-infected eyes of the groups of KO MAIDS mice when 
compared to the WT MAIDS mice. Protein analysis for TNF-α revealed that the unprocessed 
protein and cleaved form of TNF-α were both expressed in KO MAIDS mice and that this level 
of expression was the same as the WT MAIDS mice for all groups of KO MAIDS mice.  
Loss of genes for inflammasomes NLRP3, NLRP1b, and AIM2 does not entirely abolish 
the expression of autophagy-associated proteins in MCMV-infected eyes of MAIDS-10 
mice.  Next, we sought to determine if the preservation of the retina during MCMV infection in 
the eyes of the inflammasome KO MAIDS mice had anything to do with the upregulation of 
autophagy proteins, LC3B, and beclin-1. Western blots showed that there was no substantial 
difference seen in both beclin-1 and LC3B among WT MAIDS mice and NLRP3 KO MAIDS 
mice (Fig. 3.12A), NLRP1b KO MAIDS mice (Fig. 3.12B), and AIM2 KO MAIDS mice (Fig. 
3.12C). This suggests that the loss of these pyroptosis-associated proteins does not result in the 
upregulation of autophagy markers to preserve the retina from damage following MCMV 
infection. 
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Figure 3.12. Expression of necroptosis- and autophagy-related proteins following ocular 
MCMV infection in mice deficient in several inflammasomes. 
Western blot analysis was performed to visualize ocular expression of necroptosis-associated 
proteins and autophagy-associated proteins in MCMV infected eyes of WT MAIDS mice and 
either  NLRP3 KO mice (A), NLRP1b KO mice (B), or AIM2 KO mice (C) with the presence or 
absence of MCMV and/or MAIDS, with GAPDH used as a loading control.  
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3.4 Ocular MCMV Infection during Corticosteroid-Induced Immunosuppression 
The development of MAIDS in C57BL/6 mice shows many immunopathological features 
like this seen with the maturation of AIDS in HIV-1 infected patients. Additionally, MCMV 
infection in mice with late stage MAIDS produces retinitis that exhibits histopathologic features 
that mimic those seen in patients with AIDS-related HCMV retinitis [254]. However, the 
MAIDS model is not the only model available to study MCMV retinitis. Other researchers have 
shown that MCMV-infected eyes of C57BL/6 mice immunosuppressed by corticosteroid 
treatment also results in the development of MCMV retinitis. However, there are several 
differences between this model of retinitis and the MAIDS model of MCMV retinitis. One 
significant difference is the development of retinitis in C57BL/6 mice with corticosteroid-
induced immunosuppression is at a frequency of only ~50% [109] as opposed to the 80 to 100% 
frequency seen in MAIDS-related MCMV retinitis. This may be related to the vast difference in 
the type of immunosuppression between these two models. MAIDS has a slow and progressive 
development, which goes through distinct phases of immune cell dysfunction over the course of 
several weeks. Corticosteroid-induced immunosuppression, however, results in a rapid, acute 
decline in the immune system, which develops over the course of a few days and shows a 
difference in immune cell populations, particularly macrophages and cytokine response to 
infection [115, 116]. Recently, our lab has shown that the expression of SOCS1 and SOCS3, 
which are highly expressed in MAIDS-related MCMV retinitis, are only mildly stimulated in 
MCMV-infected eyes of corticosteroid-induced immunosuppression [226]. This reduction in 
SOCS1 and SOCS3 expression is correlated to a less severe retinitis development along with a 
reduction in ocular viral titer when compared to previously established MAIDS studies [4, 6, 
103, 126].  
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Because of these vast differences in the two immunosuppression models, we were 
interested in seeing if there were any other differences in molecules known to be stimulated 
during MAIDS-related MCMV retinitis. As we have repeatedly established that pyroptosis-
associated molecules are upregulated in MCMV-infected eyes of MAIDS-10 mice, we sought to 
determine if these molecules are also stimulated in MCMV-infected eyes of mice with 
corticosteroid-induced immunosuppression. Theoretically, if these molecules play a role in the 
pathogenesis of MCMV retinitis, then they should be stimulated in multiple models of this 
disease.  
3.4.1 Pyroptosis Expression during Corticosteroid-induced Immunosuppression   
Expression and translation of caspase-1 mRNA in MCMV-infected eyes of mice 
with corticosteroid-induced immunosuppression. mRNA analysis showed that caspase-1 was 
significantly stimulated in MCMV-infected eyes of mice with corticosteroid-induced 
immunosuppression (Fig. 3.13A). Although the level of mRNA stimulation was similar at day 3 
post-infection as that seen in MAIDS-10 mice (Fig. 3.13B), there was a slight dip in mRNA 
expression at day 6 post-infection prior to peak expression seen at day 10 post-infection. Western 
blot analysis showed that pro-caspase-1 was greatly expressed in MCMV-infected eyes of mice 
with corticosteroid-induced immunosuppression at all days post-infection with a gradual increase 
in overall protein levels as the infection progressed. Pro-caspase-1 was also greatly expressed in 
MCMV-infected eyes of MAIDS-10 mice at all days post-infection, with a slight increase at 6 
days post-infection. The appearance of pro-caspase-1 seemed slightly higher in MCMV-infected 
eyes of MAIDS-10 mice at 3 and 6 days post-infection when compared to the corticosteroid-
induced immunosuppressed mice, while the levels of protein expression were reasonably similar 
at 10 days post-infection between both models of immunosuppression. Although not as greatly 
93 
stimulated, the mature caspase-1 protein followed the same trend of stimulation as pro-caspase-1 
in MCMV-infected eyes of both MAIDS-10 and corticosteroid-induced immunosuppressed mice 
(Fig. 3.14).  
Expression and translation of caspase-11 mRNA in MCMV-infected eyes of mice 
with corticosteroid-induced immunosuppression. MCMV-infected eyes of mice with 
corticosteroid-induced immunosuppression showed substantial stimulation of caspase-11 mRNA 
at all days post-infection (Fig. 3.13C). The level of expression at 3 days post-infection was only 
half that seen, at the respective time, in MCMV-infected eye of MAIDS-10 mice (Fig. 3.13D). 
However, mRNA production for caspase-11 continued to increase in MCMV-infected eyes of 
mice with corticosteroid-induced immunosuppression from day 6 to day 10 post-infection, where 
it reached levels not significantly different that that seen in MCMV-infected eyes of MAIDS-10 
mice. Protein levels for pro-caspase-11 and cleaved caspase-11 showed similar levels of 
expression in MCMV-infected eyes between both models of immunosuppression. The main 
difference seen in caspase-11 protein expression was that MCMV-infected eyes of mice with 
corticosteroid-induced immunosuppression showed appearance of both pro-caspase-11 and 
cleaved caspase-11 at day 10 post-infection, whereas the expression of caspase-11 in MCMV-
infected eyes of MAIDS-10 was only seen at days 3 and 6 post-infection (Fig. 3.14).  
Expression and translation of GSDMD mRNA in MCMV-infected eyes of mice with 
corticosteroid-induced immunosuppression.  Expression of GSDMD mRNA transcripts were 
significantly stimulated in MCMV-infected eyes of mice with corticosteroid-induced 
immunosuppression at all days post-infection (Fig 3.13E). Although there was a slight decrease 
in expression at day 6 post-infection, there was not significant difference in the stimulation of 
GSDMD mRNA at any day post-infection in mice with corticosteroid-induced 
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immunosuppression and MAIDS-10 mice (Fig. 3.13F). Protein for the full-length precursor 
GSDMD was abundant in MCMV-infected eyes of corticosteroid-induced immunosuppressed 
mice when compared to the mock-treated eyes. The level of expression was greater at days 6 and 
10 post-infection. There was a difference in the trend in the expression of GSDMD seen in 
MCMV-infected eyes of MAIDS-10 mice in which there was greater at days 3 and 6 post-
infection. Cleaved GSDMD protein was also higher in MCMV-infected eyes of mice with 
corticosteroid-induced immunosuppression at 3 and 6 days post-infection with a slight drop in 
expression at 10 days post-infection. Similar trends were seen for the cleaved form of GSDMD, 
in MCMV-infected eyes of MAIDS-10 mice (Fig. 3.14). 
Expression and translation of IL-1β mRNA in MCMV-infected eyes of mice with 
corticosteroid-induced immunosuppression IL-1β mRNA expression following MCMV 
infection of mice with corticosteroid-induced immunosuppression was greatly stimulated at 3 
days post-infection. The level of mRNA expression dramatically decreased by 6 days post-
infection, and by 10 days post-infection, there was no significant stimulation over the media 
control eyes (Fig 3.13G). This trend in mRNA expression was similar to that seen in the MCMV-
infected eyes of MAIDS-10 mice (Fig. 3.13H), and there was no significance difference in 
mRNA stimulation between the two groups of mice. Western blot analysis showed that there was 
a slight appearance of IL-1β protein in MCMV-infected eyes of corticosteroid-induced 
immunosuppressed mice when compared to the mock injected eyes. This difference was slightly 
greater at 6 days post-infection. However, there was a greater level of expression in MCMV-
infected eyes of MAIDS-10 mice when compared to mock-treated eyes at 3 and 6 days post-
infection. There appeared to be no significant differences between the protein levels of MCMV-
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infected eyes of mice with either corticosteroid-induced immunosuppression or MAIDS-10 (Fig. 
3.14).  
Expression and translation of IL-18 mRNA in MCMV-infected eyes of mice with 
corticosteroid-induced immunosuppression. Although similar levels of IL-18 mRNA 
stimulation were seen at 3 and 10 days post-infection between mice with corticosteroid-induced 
immunosuppression (Fig. 3.13I) and MAIDS-10 mice (Fig. 3.13J), the IL-18 mRNA production 
was slightly greater in MCMV-infected eyes of MAIDS-10 mice at 6 days post-infection. 
MCMV-infected eyes of corticosteroid-induced immunosuppression mice saw a greater 
expression of IL-18 protein at all days post-infection when compared to the mock-treated eyes. 
Not surprisingly, a similar trend was seen in MAIDS-10 mice with possibly a slight increase in 
protein at 6 days post-infection when compared to mice with corticosteroid-induced 
immunosuppression (Fig. 3.14), findings that correlated with the trend seen in mRNA 
production.  
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Figure 3.13. Pyroptosis-associated mRNA is stimulated in mice with either corticosteroid-
induced immunosuppression (CS-IS) or MAIDS-10. 
Homogenized whole eyes of mice with CS-IS and MAIDS-10  were assessed at 3, 6, and 10 dpi 
for caspase-1 (A and B), caspase-11 (C and D), GSDMD (E and F), IL-1beta (G and H), and IL-
18 (I and J) mRNA, with MCMV samples compared back to media controls per day (n=3-5 
mice/group). *p<0.05, **p<0.01, and ***p<0.001, MCMV groups compared with media 
controls at the same time points. 
97 
 
Figure 3.14. Pyroptosis-associated proteins was stimulated in mice with either 
corticosteroid-induced immunosuppression (CS-IS) or MAIDS-10. 
Western blot analysis was performed to assess ocular expression of pyroptosis-associated 
proteins in groups of mice with corticosteroid-induced immunosuppression (left) or MAIDS-10 
mice (right) of both MCMV infected and media control eyes at days 3, 6, and 10 post-infection. 
GAPDH used as a loading control and a ladder was loaded in the well separating the two groups 
of mice. 
3.4.2 Inflammasome Expression during Corticosteroid-induced Immunosuppression  
 
NLRP1b, but not other inflammasomes, showed a marked reduction in mRNA 
production of MCMV-infected eyes of mice with corticosteroid-induced 
immunosuppression when compared to MAIDS-10 mice. Since we have previously shown 
that the NLRP3, NLRP1b, NLRC4, and AIM2 inflammasomes are stimulated in MCMV-
infected eyes of MAIDS-10 mice, we sought to determine if the mRNA of these inflammasomes 
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were also stimulated in mice immunosuppressed with corticosteroids. mRNA stimulation of 
NLRP3 in MCMV-infected eyes was highest at 3 days post-infection, dropped off by 6 days 
post-infection and stayed relatively similar at 10 days post-infection (Fig. 3.15A). No major 
differences were seen with the level of NLRP3 stimulation in MCMV-infected eyes of MAIDS-
10 mice except at 10 days post-infection, when mice with corticosteroid-induced 
immunosuppression showed a significantly greater level of expression of NLRP3 (Fig. 3.15B). 
mRNA production for NLRP1b showed a slight significant increase in MCMV-infected eyes 
over media control eyes that stayed a consistent level at all days post-infection (Fig. 3.15C). This 
differed from the mRNA production seen in MCMV-infected eyes of MAIDS-10 mice that 
showed a greater level of stimulation at days 3 and 6 post-infection (Fig. 3.15D). When 
investigating the NLRC4 inflammasome, it was interesting to see that the levels of stimulations 
were similar in mice with corticosteroid-induced immunosuppression (Fig. 3.15E) and mice with 
MAIDS-10 (Fig. 3.15F). However, mice with MAIDS-10 did show a greater stimulation in 
mRNA expression of NLRC4 at day 3 post-infection when compared to the MCMV-infected 
eyes of mice with corticosteroid-induced immunosuppression. Although there was a slight 
difference in the trends of mRNA expression for AIM2 between mice with corticosteroid-
induced immunosuppression (Fig. 3.15G) and MAIDS-10 mice (Fig. 3.15H) during the course of 
infection, no significant difference was seen between the two groups of mice at any days post-
infection. 
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Figure 3.15. Inflammasome mRNA was stimulated in mice with either corticosteroid-
induced immunosuppression (CS-IS) or MAIDS-10. 
Homogenized whole eyes of mice with corticosteroid-induced immunosuppression and MAIDS-
10 were assessed at 3, 6, and 10 dpi for NLRP3 (A and B), NLRP1b (C and D), NLRC4 (E and 
F), and AIM2 (G and H) mRNA, with MCMV samples compared back to media controls per day 
(n=3-5 mice/group). *p<0.05, **p<0.01, and ***p<0.001, MCMV groups compared with media 
controls at the same time points. 
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3.5 Ocular Expression Following Needle Stick or in Unmanipulated Eyes 
Although the expression of our target inflammatory markers is consistently significantly 
higher in MCMV-infected eyes when compared to the media control eyes, there does seem to be 
slight stimulation of several of these proteins in eyes injected with media only. To determine the 
extent that the the needle stick into the subretinal space, or the administration of fluids (void of 
virus), has on the induction of the inflammatory response, we compared the mRNA expression of 
the pyroptosis-associated mRNA, caspase-1, caspase-11, GSDMD, IL-1β, and IL-18 (Fig. 
3.16A-E), as well as NLRP3, NLRP1b, NLRC4, AIM2 inflammasomes (Fig. 3.17A-D), among 
groups of mice that received the MCMV infection, the standard media control injection, eyes that 
were simple poked by the needle without any injection, and eyes that were unmanipulated at all. 
Six days following the subretinal injections, all eyes were harvested and assessed for target 
mRNA expression. mRNA analysis of the eyes showed no major stimulation of any target 
pyroptosis-related and associated inflammasome mRNA in mice without manipulation to their 
eyes, or with those that received only the needle stick without an injection of fluid. Although a 
few molecules (caspase-1, GSDMD, IL-18, and NLRP1b) may have seen a slight trend in 
increased expression in media-injected eyes, these levels were not statistically different from 
either the unmanipulated eyes or those that were merely poked with the needle. On the contrary, 
the eyes that received a subretinal injection of MCMV showed a dramatic, statistically 
significant increases in mRNA expression of all target transcripts when compared to the media 
treated eyes, the eyes that underwent a simple needle stick into the subretinal space, and the 
unmanipulated eyes. Therefore, the results suggest that the stimulation of these pyroptosis-
associated molecules and associated inflammasomes is substantially enhanced by MCMV, and 
the needle stick itself is not contributing to this expression.   
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Figure 3.16. Pyroptosis-associated mRNA was not stimulated in unmanipulated eyes, or 
eyes not infected with MCMV. 
MAIDS-10 mice were either injected with MCMV or media, poked with a media without 
injection of any fluid (poke), or not manipulated with a needle (unman) . At six dpi, whole eyes 
of each group (n=5) were harvested and assessed for caspase-1 (A), caspase-11 (B), GSDMD 
(D), IL-1beta (B), and IL-18 (E) mRNA. *p<0.05, **p<0.01, and ***p<0.001, MCMV 
compared back to other groups as indicated with brackets.  
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Figure 3.17. Inflammasome mRNA was not stimulated in unmanipulated eyes, or eyes not 
infected with MCMV. 
MAIDS-10 mice were either injected with MCMV or media, poked with a media without 
injection of any fluid (poke), or not manipulated with a needle (unman) . At six dpi, whole eyes 
of each group (n=5) were harvested and assessed for NLRP3 (A), NLRP1b (B), NLRC4 (C), and 
AIM2 (D) mRNA. *p<0.05 and **p<0.01, MCMV compared back to other groups as indicated 
with brackets.  
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4 SP ECIFIC AIM 2 
 
Specific Aim 2: Test the Hypothesis that MCMV Replication directly Stimulates 
Pyroptosis in Infected Cells. 
HCMV and MCMV both undergo a temporal, step-wise viral gene expression and 
replication cascade [12]. The interaction of glycoproteins on the envelope of the virus and host 
receptors, mediates fusion or endocytosis of the virion into the host cell [25]. Viral tegument 
proteins are then released into the cell, and some are believed to be transported to the nucleus of 
the host cell via interactions with the host microtubule machinery. These tegument proteins are 
bound to capsids, and once in the nucleus, viral transcription, genome replication, and 
encapsidation occur [26-28]. The transcription and subsequent translation of viral genes follow a 
specific sequence, starting with IE genes followed by E genes, which results in viral DNA 
synthesis and expression of L genes. This then allows for the assembly of progeny virions, which 
egress from the cell. If pyroptosis directly results from CMV infection of the host cell, then at 
least one of these virologic events may drive the host cell expression of pyroptosis-associated 
mRNA or protein production.  
4.1 Pyroptosis-Associated Expression Kinetics Following MCMV Infection in IC-21 or 
MEF Cells 
Several pyroptosis-associated mRNA transcripts were stimulated in MCMV-
infected IC-21 mouse macrophages. We have previously demonstrated that pyroptosis-
associated mRNA and protein are stimulated in MCMV-infected eyes during the onset and 
progression of MCMV retinitis in mice with retroviral-induced immunosuppression [6]. It is 
unclear, however, if this stimulation of pyroptosis was from direct cellular infection with MCMV 
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within the retina, or if it was induced by a host response following MCMV infection. Following 
acute infection, MCMV will establish latency in monocytes and has repeatedly been shown to 
replicate in macrophages [255, 256]. Therefore, we sought to determine if MCMV infection 
would stimulate the production of pyroptosis-associated mRNA transcripts in IC-21 mouse 
macrophages. Monolayers of IC-21 mouse macrophages were infected with MCMV at a moi of 
3 and allowed to propagate for up to 72 hpi. MCMV infected IC-21 monolayers showed a 
statistically significant upregulation of mRNA transcripts for caspase-1 (Fig 4.1A), GSDMD 
(Fig 4.1B), and IL-1β (Fig 4.1C) at early time-points following infection. Peak expression for 
these transcripts occurred between 2-4 hpi, which correlates to a relatively early time during 
productive MCMV infection following viral attachment, adsorption, and release of tegument 
protein, as well as transcription and translation of MCMV IE gene in macrophages [41]. 
Interestingly, however, IL-18 mRNA production showed no stimulation in MCMV infected cells 
when compared to the media treated cells at 1-4 hpi (Fig. 4.1D).  
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Figure 4.1. MCMV infection stimulated pyroptosis-related mRNA in mouse macrophages. 
IC-21 mouse macrophages infected with MCMV (moi = 3 PFU/cell) or treated with media 
control. At indicated time points, cells were harvested and assessed for caspase-1 mRNA (A), 
GSDMD mRNA (B), IL-1beta mRNA (C) or IL-18 mRNA (D) by real-time RT-PCR assay using 
the comparative 2
-ΔΔCt
 method, with all samples compared back to the media group at the same 
time point. Means ±SD of duplicate experimental repeats are shown. * p<0.05, ** p<0.01, and 
*** p<0.001, compared with respective media controls at the same time points as determined by 
one-way ANOVA 
 
Most pyroptosis-associated mRNA transcripts were stimulated in MCMV-infected 
MEF cells. As it has been shown that MCMV replication kinetics differ between macrophages 
and fibroblasts [257], we sought to determine if the stimulation in pyroptosis-associate mRNA 
transcripts would also differ between these cell lines following MCMV infection. MEF 
monolayers were infected with MCMV, at a moi of 3, and allowed to propagate for up to 3 days. 
Similar to what was seen for IC-21 mouse macrophages, caspase-1 (Fig 4.2A), GSDMD (Fig 
4.2B), and IL-1β (Fig 4.2C), but not IL-18 (Fig 4.2D) mRNA transcripts showed significant 
stimulation in MCMV-infected MEFs. Interestingly, the stimulation seen following MCMV 
infection in MEFs was more robust than that seen during infection of IC-21 mouse macrophages 
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and continued for a longer duration. Stimulation of both caspase-1 and IL-1β mRNA expression 
showed an upregulation starting as early as 30 minutes following MCMV infection and 
continued to be highly stimulated until approximately 6 hpi. GSDMD mRNA upregulation 
begins a little later in MEF cells with peak stimulation occurring between 4-8 hpi. This duration 
of stimulation correlates not only with the viral attachment, adsorption, release of tegument 
protein, and transcription of MCMV IE gene in macrophages [41], but also the transcription of 
MCMV E gene. A biphasic upregulation of caspase-1 started to emerge at 24 hpi which could be 
associated with the transcription and translation of MCMV L gene during productive infection. 
 
Figure 4.2. Infection of MEFs with MCMV stimulated pyroptosis-associated mRNA 
transcripts. 
MEFs were infected with MCMV (moi = 3 PFU/cell) or treated with media control. At indicated 
time points, cells were harvested and assessed for caspase-1 mRNA (A), GSDMD mRNA (B), 
IL-1beta mRNA (C) or IL-18 mRNA (D) by real-time RT-PCR assay using the comparative 2
-
ΔΔCt
 method, with all samples compared back to the media group at the same time point. Means 
±SD of duplicate experimental repeats are shown. * p<0.05, ** p<0.01, and *** p<0.001, 
compared with respective media controls at the same time points as determined by one-way 
ANOVA. 
107 
4.2 Pyroptosis-Associated Expression Following Infection with UV-inactivated MCMV in 
MEF cells 
UV-inactivated MCMV does not significantly stimulate pyroptosis-associated 
mRNA expression in MEF cells. MCMV infection of MEF cells showed the greatest 
upregulation of the pyroptosis-associated mRNA when compared to the stimulation seen within 
infected IC-21 mouse macrophages. To determine if the different stages of MCMV gene 
transcription were responsible for the stimulation of these pyroptosis-related mRNA transcripts, 
or if early virologic events of attachment, adsorption, and release of tegument proteins were 
sufficient for this stimulation, we infected monolayers of MEF cells with MCMV inactivated by 
ultraviolet light (UVi-MCMV). This inactivation leaves glycoproteins and immunologic 
components of MCMV intact although the virus is unable to undergo viral gene expression and 
replication in the infected cell [224]. Contrary to the notable upregulation of caspase-1 (Fig 
4.3A), GSDMD (Fig 4.3B), IL-1β (Fig 4.3C), and IL-18 (Fig 4.3D) mRNA in MEF cells at early 
time points following MCMV infection, UVi-MCMV infected cells did not show any 
upregulation of these mRNA transcripts at any time point.  
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Figure 4.3. UV-inactivation of MCMV abrogated MCMV-related stimulation of pyroptosis 
mRNA transcripts in MEFs. 
MEFs were infected with MCMV (moi = 3 PFU/cell) or treated with either media (control) or 
equal volume of UVi-MCMV. At indicated time points, cells were harvested and assessed for 
caspase-1 mRNA (A), GSDMD mRNA (B), IL-1beta mRNA (C) or IL-18 mRNA (D) by real-
time RT-PCR assay using the comparative 2
-ΔΔCt
 method, with all samples compared back to the 
media group at the same time point. Means ±SD of duplicate experimental repeats are shown. * 
p<0.05, ** p<0.01, and *** p<0.001, compared with respective media controls at the same time 
points as determined by one-way ANOVA. No statistically significant differences were found 
between the media controls and the UV-MCMV groups at any time point. 
 
To determine if expression of pyroptosis-associated proteins are substantially stimulated 
in MEF cells following MCMV infection but not UVi-MCMV infection, immunofluorescence 
(IF) was done on MCMV-infected and UVi-treated monolayers and assessed for expression of 
pyroptosis-associated proteins at 6 and 24 hpi. At 6 hpi, caspase-1 (Fig 4.4A) and GSDMD (Fig 
4.4B) protein of MCMV-infected cells showed a stark level of protein expression not seen in 
media treated cells. Although there was some expression of caspase-1 and GSDMD in UVi-
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MCMV infected cells, this level was nowhere near the level of expression seen in the MCMV 
infected cells. IL-1β protein expression was also substantially greater in MCMV-infected cells 
than seen for media treated cells at 6 hpi (Fig. 4.4C), while no real expression was seen 
following UVi-MCMV infection. Despite the lack of mRNA upregulation seen during MCMV 
infection of MEFs at any time point except 1 hpi, IL-18 protein did show a robust level at 6 hpi 
when compared to the lack of expression seen of IL-18 in the media treated cells (Fig. 4.4D). 
This expression was ablated in MEF cells treated with UVi-MCMV.  
 
Figure 4.4. UV-inactivation of MCMV reduced MCMV-related stimulation of pyroptosis-
related protein in MEFs at 6 hpi. 
MEFs MEFs were infected with MCMV (moi = 3 PFU/cell) or treated with either media 
(control) or equal volume of UVi-MCMV. All 6 hpi all groups were fixed and assessed by 
immunofluorescent staining for caspase-1 (A), GSDMD (B), IL-1beta (C), or IL-18 (D) protein 
(green), counterstained with DAPI (blue). Original magnification, 100x. 
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At 24 hpi, protein expression for caspase-1 (Fig 4.5A), GSDMD (Fig 4.5B), and IL-1β 
(Fig 4.5C), but not IL-18 (Fig 4.5D) of MCMV-infected cells was greater than that seen at 6 hpi, 
which were all still remarkably higher than the protein expression seen in the media treated cells. 
Expression of these proteins were still seen in cells treated with UVi-MCMV when compared to 
the media treated controls, but the level of stimulation appeared substantially less than that seen 
in the respective MCMV-infected cells at 24 hpi.  
 
Figure 4.5. UV-inactivation of MCMV reduced MCMV-related stimulation of pyroptosis-
related protein in MEFs at 24 hpi. 
MEFs MEFs were infected with MCMV (moi = 3 PFU/cell) or treated with either media 
(control) or equal volume of UVi-MCMV. All 24 hpi all groups were fixed and assessed by 
immunofluorescent staining for caspase-1 (A), GSDMD (B), IL-1beta (C), or IL-18 (D) protein 
(green), counterstained with DAPI (blue). Original magnification, 100x. 
 
 
 
 
111 
4.3 Pyroptosis-Associated Expression Kinetics Following HCMV Infection in ARPE-19 
or MRC-5 Cells 
Pyroptosis-associated mRNA transcripts were not stimulated upon HCMV infection 
of ARPE-19 or MRC-5 cells. Following our confirmation that MCMV-infected cells can 
directly stimulate the expression of pyroptosis-related mRNA and/or proteins in an individual 
cell line, it is feasible to suggest that the stimulation of these mRNA transcripts and proteins seen 
during our experimental model of MCMV retinitis could be from the direct stimulation of 
MCMV-infected cells rather than host response to infection. If this is true, then it is likely that 
the same may be true of HCMV infected cells of individuals with AIDS-related HCMV retinitis 
as HCMV has been shown to penetrate all layers of the retina and the contiguous RPE where it 
can actively replicate, as demonstrated by the formation of cytomegalic cells and inclusion 
bodies throughout necrotic retinal tissue [98, 99]. Therefore, to test our hypothesis that HCMV 
infection can directly result in the stimulation of pyroptosis-related mRNA transcripts, we 
infected ARPE-19 cells, a human RPE cell line, with HCMV and measured the production of 
pyroptosis-associated mRNA transcripts. Monolayers of ARPE-19 cells were infected with 
HCMV, at a moi of 3, and allowed to propagate for 3 days. At all measured time points, HCMV 
failed to stimulate mRNA production of caspase-1 (Fig. 4.6A), GSDMD (Fig. 4.6B), IL-1β (Fig. 
4.6C), or IL-18 (Fig. 4.6D) at any time post-infection above that seen for the media treated cells.  
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Figure 4.6. Pyroptosis-associated mRNA transcripts were not stimulated in HCMV-
infected ARPE-19 cells. 
ARPE-19 cells were infected with HCMV (moi = 3 PFU/cell) or treated with media control. At 
indicated time points, cells were harvested and assessed for caspase-1 mRNA (A), GSDMD 
mRNA (B), IL-1beta mRNA (C) or IL-18 mRNA (D) by real-time RT-PCR assay using the 
comparative 2-ΔΔCt method, with all samples compared back to the media group at the same time 
point. Means ±SD of duplicate experimental repeats are shown. * p<0.05, ** p<0.01, and *** 
p<0.001, compared with respective media controls at the same time points as determined by one-
way ANOVA. 
 
Since RPE cells have so many protective functions aimed at protecting the retina to 
maintain the visual cycle, we thought it might be possible that this cell type could be actively 
suppressing this type of programmed cell death or inflammation to avoid provoking an 
inflammatory response directly adjacent to the retina. Therefore, we wanted to see if cell type 
made a difference in HCMV stimulation of inflammation and programmed cell death. Since 
MRC-5 cells are often used to titer HCMV, we knew that HCMV is able to replicate in this cell 
line. Therefore, MRC-5 fibroblasts were also infected with HCMV at a moi of 3, and infection 
was allowed to progress for 3 days. Similar to ARPE-19 cells, no mRNA production of caspase-
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1 (Fig. 4.7A), GSDMD (Fig. 4.7B), IL-1β (Fig. 4.7C), or IL-18 (Fig. 4.7D) was shown, 
suggesting that HCMV infection alone may not be enough to stimulate a pro-inflammatory cell 
death response in these cells. 
 
Figure 4.7. MRC-5 cells infected with HCMV did not show stimulation of pyroptosis-
associated mRNA transcripts. 
MRC-5 cells were infected with HCMV (moi = 3 PFU/cell) or treated with media control. At 
indicated time points, cells were harvested and assessed for caspase-1 mRNA (A), GSDMD 
mRNA (B), IL-1beta mRNA (C) or IL-18 mRNA (D) by real-time RT-PCR assay using the 
comparative 2-ΔΔCt method, with all samples compared back to the media group at the same time 
point. Means ±SD of duplicate experimental repeats are shown. * p<0.05, ** p<0.01, and *** 
p<0.001, compared with respective media controls at the same time points as determined by one-
way ANOVA. 
 
 
 
114 
5  Specific Aim 3 
Specific Aim 3: Test the Hypothesis that Other Immune Response Genes or Pathways are 
Stimulated during the Pathogenesis of MAIDS-related MCMV Retinitis 
In addition to the research obtained through the completion of these two specific aims, 
other experimental endpoints were determined on MAIDS-4 and MAIDS-10 mice to further 
advance our understanding past these well-known pyroptosis-related molecules and associated 
inflammasomes. If pertinent, the findings we determined from these studies could help shape the 
future focus of our investigation on the mechanisms underlying the pathogenesis of MAIDS-
related MCMV retinitis.  
5.1 Expression of IFI204 during MAIDS-related MCMV Retinitis 
Interferon-gamma-inducible protein 16 (IFI16) is a PYD-containing HIN-200 protein that 
is constitutively expressed in lymphoid cells [258] and acts as a nuclear innate DNA sensor that 
results in inflammasome activation. Although we have never studied the involvement of the 
murine homolog of IFI16, IFI204, during MAIDS-related MCMV retinitis, IFI16 has been 
associated with several human herpesvirus infections [259-264], and the knockdown of IFI204 in 
corneal epithelium was shown to lead to susceptibility to HSV-1 infection [265]. Therefore, we 
sought to determine the extent by which IFI204 is stimulated in both MAIDS-4 and MAIDS-10 
mice to determine whether IFI204 may also be contributing to MCMV retinitis. mRNA analysis 
showed that in MAIDS-4 mice (Fig. 5.1A), MCMV-infected eyes saw a slight stimulation of 
IFI204 that was greater at 3 days post-infection and subsequently decreased by day 10 post-
infection when compared to media-injected control eyes. In retinitis susceptible MAIDS-10 mice 
(Fig. 5.1B), IFI204 mRNA expression showed peak expression at 6 days post-infection that was 
statistically significant compared to media-injected eyes and was also similar to the highest fold-
115 
change seen in MAIDS-4 mice. Western blot analysis showed a substantial stimulation of IFI204 
protein in MCMV-infected eyes of MAIDS-4 mice at both 3 and 6 days post-infection, which 
had greatly reduced by 10 days post-infection (Fig. 5.1C). MAIDS-10 mice showed an increase 
in IFI204 protein expression in MCMV-infected eyes when compared to media-injected eyes at 
all time points, and this trend of expression was similar to that seen during MAIDS-4 (Fig. 
5.1D). These results suggest that while IFI204 inflammasomes may be activated in response to 
MCMV infection, it may not be contributing substantially to the pathogenesis of MCMV retinitis 
seen in MAIDS-10 mice, possibly due to the stimulation of other inflammasomes that may 
directly result in the onset of pyroptosis. 
 
Figure 5.1. Intraocular IFI204 mRNA and protein were moderately stimulated in MCMV 
infected eyes of both retinitis susceptible MAIDS-10 mice and retinitis-resistant MAIDS-4 
mice. 
Whole eyes were collected at 3, 6, and 10 days post-infection (dpi) from MCMV infected eyes 
and media control eyes from groups (n=3-5) of MAIDS-4 and MAIDS-10 mice. Homogenized 
eyes were assessed for IFI204 mRNA from the MAIDS-4 mice (A) and the MAIDS-10 mice (B). 
Western blot analysis (C) was performed to assess ocular IFI204 protein expression in MAIDS-4 
mice (C) and MAIDS-10 mice (D) with GAPDH used as a loading control. *p<0.05, MCMV 
groups compared with media control at the same time points. 
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5.2 Role of Autophagy during MAIDS-related MCMV Retinitis 
Unlike pyroptosis and necroptosis, autophagy is a non-inflammatory form of cell death 
that is largely a protective process-induced under stress conditions by which cells engulf 
damaged organelles or large portions of their cytoplasm [234]. Recently, a link between 
autophagy and pyroptosis has emerged in which there is thought to be an interplay between the 
induction of autophagy and the inhibition of pyroptosis. Induction of autophagy in host cells in 
response to infection may be a means of protecting the cells from cell death [266]. Autophagy is 
known to play a protective role in the eye, including regulating the homeostasis of the RPE 
[267]. However, it was recently shown that MCMV might contain a mechanism to inhibit late-
stage autophagy in RPE cells [268]. As evidence for multiple cell death pathways has been 
shown to be stimulated in MAIDS-related MCMV retinitis, it is possible that the induction of 
cell death may be related to inhibition or downregulation of autophagy. To determine the extent 
that autophagy was affected in MCMV-infected eyes during the pathogenesis of MCMV 
retinitis, mRNA analysis for beclin-1 was assessed. Beclin-1 mRNA was not significantly 
stimulated at 3, 6, and 10 days post-infection in MCMV-infected eyes of both retinitis resistant 
MAIDS-4 (Fig. 5.2A) mice and retinitis susceptible MAIDS-10 mice (Fig. 5.2B) when compared 
with uninfected control eyes. Western blot analysis showed that beclin-1 protein was expressed 
at 3, 6, and 10 days post-infection within MCMV-infected eyes of both MAIDS-4 (Fig. 5.2C) 
and MAIDS-10 (Fig. 5.2D) mice, however, the protein expression was substantially more in 
those of MAIDS-4 eyes than MAIDS-10 eyes. To determine the presence of autophagosome 
formation, a known hallmark of autophagy, LC3B-I, and LC3B-II protein expression was 
measured. No significant difference was seen for LCB-I protein expression between infected and 
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uninfected control eyes of both MAIDS-4 and MAIDS-10 mice at days 3, 6, and 10 days post-
infection. However, LC3-I protein expression within MCMV-infected MAIDS-4 eyes was 
substantially increased when compared to LC3B-I protein expression within MCMV-infected 
MAIDS-10 eyes. Whereas LCB-II formation was detected within both MCMV-infected and 
media-injected control eyes at days 3, 6, and 10 post-infection, LCB-II formation was not 
detected within MCMV-infected eyes of MAIDS-10 mice. Taken together, these results suggest 
that autophagy may play a protective role in the eye that is mitigated during the development of 
MCMV retinitis in MAIDS-10 mice. 
 
Figure 5.2. Intraocular beclin-1 mRNA and protein were moderately stimulated in MCMV 
infected eyes of both retinitis susceptible MAIDS-10 mice and retinitis-resistant MAIDS-4 
mice. 
Whole eyes were collected at 3, 6, and 10 days post-infection (dpi) from MCMV infected eyes 
and media control eyes from groups (n=3-5) of MAIDS-4 and MAIDS-10 mice. Homogenized 
eyes were assessed for beclin 1 mRNA from the MAIDS-4 mice (A) and the MAIDS-10 mice 
(B). Western blot analysis (C) was performed to assess ocular beclin 1 and LC3B protein 
expression in MAIDS-4 mice (C) and MAIDS-10 mice (D) with GAPDH used as a loading 
control. *p<0.05, MCMV groups compared with media control at the same time points. 
118 
5.3 Transcriptional Analysis of Immune Response Genes During Pathogenesis of 
MAIDS-related MCMV retinitis 
It is evident through our previous studies that several factors contribute to the 
pathogenesis of MAIDS-related MCMV retinitis. Although extensive, our previous work has 
only scratched the surface of the events employed during this disease progression. Therefore, we 
opted to use an ultrasensitive technology, NanoString, to investigate hundreds of genes that span 
several pathways associated with the immune response, following MCMV infection throughout 
the course of MAIDS development. The goal of this study was to find other potential 
immunological pathways or targets that could be contributing to the retinal destruction seen 
during the pathogenesis of experimental MAIDS-related MCMV retinitis. 
NanoString technology is a unique technique used to analyze the expression of hundreds 
of genes simultaneously and has been extensively used to investigate a variety of diseases [269-
271]. The multiplexed probe library is made with two probes that are specific to each gene of 
interest. One probe is the capture probe that contains approximately 50 base pair sequence 
complementary to a specific target mRNA and is coupled with biotin as an affinity tag. The other 
probe is the reporter probe that contains approximately 50 base pairs complementary to the target 
mRNA and is also coupled to a color-coded tag. This color-coded tag is labeled explicitly with 
specific fluorophores used for detection. The order of the colors on the tag provides a unique 
barcode for each of the genes of interest, which are scanned by the Nanostring nCounter 
system, allowing the system to get a raw count of all the target RNA hybridized to the probes 
[270]. Utilizing this technology, we were able to get an overview of the involvement of more 
than 500 genes during the onset and progression of retinitis in MCMV-infected eyes of MAIDS-
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10 mice and compare that to the expression of the same genes in both MAIDS-4 and healthy 
mice, both resistant to retinitis.  
Hierarchical Clustering Analysis of 561 Immune Response Gene Transcripts Within 
MCMV-Infected Eyes of Healthy Mice, MAIDS-4 Mice, and MAIDS-10 Mice. We have 
previously shown that the upregulation or downregulation of several pathways is involved during 
the pathogenesis of MAIDS-related MCMV retinitis, yet the knowledge we gained in these past 
studies have not been at the depth needed to identify and compare the extraordinary number of 
immune response genes expressed simultaneously within the ocular compartment at critical 
times during the evolution of MAIDS-related MCMV retinitis Initial studies were performed to 
determine the overall upregulation or downregulation of 561 immune defense genes during the 
pathogenesis of MCMV retinitis. This was accomplished using a commercial NanoString 
nCounter Murine Immunology Panel that included 15 additional internal reference and 
housekeeping genes. The left eyes of groups of healthy mice, MAIDS-4 mice, and MAIDS-10 
mice (n = 3 – 5) were inoculated with MCMV; the contralateral right eyes of each animal group 
were mock-infected with maintenance medium only and served as internal controls. At 3, 6, and 
10 days after intraocular inoculation, individual MCMV-infected and mock-infected eyes were 
collected from all animal groups, subjected to total RNA extraction, pooled by groups, and 
subjected to NanoString nCounter analysis.  
Hierarchical clustering analysis showing the upregulation (blue), downregulation 
(yellow), or no change (black) in the expression of each of the 561 immune response gene 
transcripts analyzed for each group of MCMV-infected eyes or mock-infected eyes are shown on 
Fig 5.3. Inspection of data shows that patterns of gene expression differed greatly when 
comparing mock-infected and MCMV-infected eyes at each time point examined. More 
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importantly, the patterns of immune response gene expression were remarkably distinct for each 
animal group, reflecting resistance or the degree of susceptibility to MCMV retinitis 
development. The MCMV-infected eyes of healthy mice without MAIDS that show absolute 
resistance to retinitis development nonetheless exhibited active gene expression (Fig 5.3A). At 
least some of this transcriptional activity might be attributed to an intraocular trauma created in 
response to the needle stick that takes place during mock infection. In comparison, MCMV-
infected eyes of MAIDS-4 mice and MAIDS-10 mice also showed active gene expression but 
with increased upregulation of genes when compared with MCMV-infected eyes of healthy 
mice. Of interest, MCMV-infected eyes of MAIDS-4 mice that fail to develop full-thickness 
retinal necrosis but nonetheless exhibit RPE proliferation showed an unexpected and extensive 
upregulation of a majority of the 561 immune response genes investigated at day 6 after virus 
inoculation (Fig 5.3B) when compared with retinitis-susceptible MCMV-infected eyes of 
MAIDS-10 mice at day 6 after virus inoculation (Fig 5.3C). This outcome was particularly 
surprising because of our previous observation that the MCMV-infected eyes of both animal 
groups harbor high and equivalent amounts of infectious virus. When compared at day 10 when 
full-thickness retinal necrosis develops within the MCMV-infected eyes of MAIDS-10 mice (but 
not within MCMV-infected eyes of MAIDS-4 mice), distinctly different patterns of upregulation 
or downregulation of individual immune response genes were observed.    
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Figure 5.3. Hierarchical clustering analysis of 561 immunology related genes on healthy, 
MAIDS-4, and MAIDS-10 mice. 
MCMV infected eyes and eyes injected with media were collected 3, 6, and 10 dpi from healthy 
(a), MAIDS-4 (b), and MAIDS-10 (c) mice. RNA was extracted from each eye (n= 3-5 
mice/group), and total RNA was pooled for each group. 100ng of RNA from each group was 
loaded onto the NanoString nCounter immunology panel. Hierarchical clustering analysis was 
done using the nSolver software. The columns represent the specified groups, and the lines 
represent each of the 561 genes on the immunology panel. Yellow color indicates low RNA 
expression and blue color indicates high RNA expression. 
 
 
 
 
 
 
122 
Comparison of MCMV-infected eyes of healthy mice, MAIDS-4 mice, and MAIDS-
10 mice for the expression of genes associated with distinct immunologic pathways. We next 
processed the hierarchical clustering analysis of the 561 immune response gene transcripts from 
MCMV-infected eyes of healthy mice, MAIDS-4 mice, and MAIDS-10 mice at all time points 
examined for their involvement in 32 distinct immunologic pathways using the NanoString 
nSolver software. After determining the fold-change upregulation or downregulation for 
differentially expressed immune-response genes of MCMV-infected eyes when compared with 
mock-infected eyes for each animal group, a fold-change of less than two was used to exclude 
that particular gene from further analysis. This approach revealed 17 genes upregulated and 15 
genes downregulated within MCMV-infected eyes of healthy mice, 83 genes upregulated and 4 
genes downregulated within MCMV-infected eyes of MAIDS-4 mice, and 92 genes upregulated 
and 54 genes downregulated within MCMV-infected eyes of MAIDS-10 mice (Fig 5.4). A 
growing increase in immune response gene activity within MCMV-infected eyes during 
increased susceptibility to the development of full-thickness retinal necrosis (when analysis 
proceeded from healthy mice to MAIDS-4 mice to MAIDS-10 mice) was expected as suggested 
by prior heatmap findings.  
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Figure 5.4. Number of upregulated and downregulated genes of MCMV-infected eyes of 
healthy, MAIDS-4, and MAIDS-10 mice. 
Analysis of the differentially expressed genes with a fold-change of higher than two revealed the 
number of genes that were upregulated and downregulated in groups of healthy, MAIDS-4, and 
MAIDS-10 mice. Of the 561 genes on the immunology panel 17 genes were upregulated and 15 
genes downregulated within MCMV-infected eyes of healthy mice, 83 genes were upregulated 
and 4 genes were downregulated within MCMV-infected eyes of MAIDS-4 mice, and 92 genes 
were upregulated and 54 genes were downregulated within MCMV-infected eyes of MAIDS-10 
mice. 
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This trend also continued when the differentially expressed immune response genes 
showing upregulation of activity were organized into NanoString-defined immunologic 
pathways for each animal group with the understanding that each gene could be involved with 
multiple pathways. Categorization into immunologic pathways revealed that five of the 32 
NanoString-defined pathways exhibited relatively substantial stimulation of gene activity within 
MCMV-infected eyes when compared with other pathways of MCMV-infected eyes of healthy 
mice, MAIDS-4 mice, and MAIDS-10 mice during progressive susceptibility to MCMV retinitis. 
Those pathways showing the most robust stimulation gene activity included pathways associated 
with the broad categories of adaptive immunity, innate immunity, host-pathogen interactions, 
cytokine signaling, and lymphocyte activation (Fig. 5.5A-E). More functionally focused 
pathways such as those involved with NF-kB signaling, toll-like receptor signaling, NOD-like 
receptor signaling, chemokine signaling, type 1 interferon signaling, type 2 interferon signaling, 
tumor necrosis factor (TNF) family signaling, MHC class I antigen presentation, and 
phagocytosis and degradation also showed less robust but nonetheless heightened gene activity 
when comparing MCMV-infected eyes of MAIDS-4 and MAIDS-10 mice with MCMV-infected 
eyes of healthy mice (Fig 5.5F-N). Overall, these findings demonstrated that gene activity 
associated with immunologic pathways become progressively and dramatically more active in 
numbers and functions as MCMV-infected eyes become progressively more susceptible to the 
onset and development of full-thickness retinal necrosis as retrovirus-induced 
immunosuppression ensues. Moreover, this progressive gene activity is far more complex than 
originally thought and involved a large number of immune pathways of which several were 
never considered by us to be involved in the evolution of cytomegalovirus retinitis in retrovirus-
immunosuppressed hosts.  
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Figure 5.5. Number of upregulated genes associated with different pathways in MCMV-
infected eyes of healthy, MAIDS-4, and MAIDS-10 mice. 
Analysis of the differentially expressed genes with a fold-change higher than two were classified 
into the different NanoString-defined pathways. The number of upregulated genes associated 
with each pathway was graphed for healthy, MAIDS-4, and MAIDS-10 mice at days 3, 6, and 10 
postinfection. A-E) Represents the pathways that had the most robust stimulation and included 
broad pathways associated with adaptive immunity, innate immunity, host-pathogen interactions, 
cytokine signaling, and lymphocyte activation. F-N) Represents more functionally focused 
pathways including those involved with NF-kB signaling, toll-like receptor signaling, NOD-like 
receptor signaling, chemokine signaling, type 1 interferon signaling, type 2 interferon signaling, 
tumor necrosis factor (TNF) family signaling, MHC class I antigen presentation, and 
phagocytosis and degradation which also showed a substantial numbers of stimulated genes. 
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A comparison of the top 15 differentially expressed immunologic-associated genes 
within MCMV-infected eyes of healthy mice, MAIDS-4 mice, and MAIDS-10 mice. In an 
attempt to provide a more quantitative analysis of differences in the expression activity of the 
561 individual immune response genes analyzed within MCMV-infected eyes of mice showing 
progressive susceptibility to retinitis development, we focused on 15 differentially expressed 
genes showing the greatest upregulation at peak levels of expression at 3, 6, or 10 days after 
intraocular MCMV inoculation and compared them with mock-infected eyes for groups of 
healthy mice, MAIDS-4 mice, and MAIDS-10 mice. Table 5.1, Table 5.2, and Table 5.3 
summarizes our findings for MCMV-infected eyes for each animal group (healthy, MAIDS-4, 
and MAIDS-10, respectively) with respect to individual genes, their known function(s) [226, 
272-313], their overall fold-change at peak expression, and their p values when compared with 
mock-infected eyes. The fold-change for stimulation of the top 15 individual genes within 
MCMV-infected eyes appeared to increase markedly from healthy mice to MAIDS-4 mice and 
MAIDS-10 mice as a reflection of increased susceptibility to the onset and development of 
MCMV retinitis among these animal groups, especially MAIDS-4 animals when compared with 
MAIDS-10 animals. While the average fold increase for peak expression in activity of these 15 
genes was 3.04 for MCMV-infected eyes of healthy mice, the average fold increase for peak 
expression in activity increased to 20.14 and 20.74 for MCMV-infected eyes of MAIDS-4 mice 
and MAIDS-10 mice, respectively, suggesting a far more dynamic intraocular gene transcription 
activity in response to MCMV infection during progressive retrovirus-induced 
immunosuppression than during immunocompetence. It is also noteworthy that a subset of 
individual genes exhibited remarkable transcription activity, such as ccl5, a gene encoding for a 
chemokine associated with inflammation which showed an 83.32-fold increase in activity within 
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MCMV-infected eyes of MAIDS-10 mice susceptible to full-thickness retinal necrosis 
development.  
Table 5.1: Top 15 genes differentially expressed in MCMV-infected eyes of healthy mice. 
 
Table 5.2: Top 15 genes differentially expressed in MCMV-infected eyes of MAIDS-4 mice. 
 
Table 5.3: Top 15 genes differentially expressed in MCMV-infected eyes of MAIDS-10 mice. 
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A detailed comparison of the top 15 immune response genes activated within MCMV-
infected eyes of healthy mice, MAIDS-4 mice, and MAIDS-10 mice also revealed that some 
upregulated gene activities were exclusive to each animal group whereas some upregulated gene 
activities were shared between groups. This is depicted in the Venn diagram shown in Fig 5.6. 
Whereas the top 15 upregulated genes of the eyes of MCMV-infected mice of healthy mice that 
are absolutely resistant to MCMV retinitis development were found to be exclusive to this 
animal group, 4 of the top 15 upregulated genes of the eyes of MCMV-infected mice of MAIDS-
4 and MAIDS-10 groups were shared between these animal groups. This observation, however, 
should not diminish the observation that 11 of the top 15 upregulated genes of the MCMV-
infected eyes of these animal groups were exclusive to MAIDS-4 mice and MAIDS-10 mice, 
animals that exhibit remarkably distinct patterns of MCMV-induced retinal disease.   
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Figure 5.6. Venn diagram comparing the shared expression of the top 15 differentially 
expressed genes between healthy, MAIDS-4, and MAIDS-10 mice. 
The top 15 upregulated genes of MCMV-infected eyes differentially expressed in healthy, 
MAIDS-4, and MAIDS-10 mice were compared between groups to see if any genes were 
amongst that highest stimulated in more than one group of mice. Of the 15 genes with the highest 
RNA fold-changes, only 4 genes are found to be commonly expressed between MAIDS-4 and 
MAIDS-10 mice. 
 
Analysis of 14 additional immune response gene transcripts of MCMV-infected eyes 
of healthy mice, MAIDS-4 mice, and MAIDS-10 mice associated with programmed cell 
death pathways. Use of the commercially available NanoString nCounter Murine Immunology 
Panel provided a wealth of new and at times unexpected knowledge on the upregulation or 
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downregulation of 561 immune response genes during the onset and development of MAIDS-
related MCMV retinitis. Given our present interest in programmed cell death pathways and their 
relative roles in the pathogenesis of MCMV-induced full-thickness retinal necrosis in MAIDS-10 
mice, we created a custom panel consisting of 14 genes. These included 3 genes associated with 
autophagy, 3 genes associated with necroptosis, 2 genes associated with parthanatos, and 6 genes 
associated with pyroptosis and inflammasomes. Importantly, gene transcription analysis using 
this custom gene panel for cell death pathways was performed using the same samples collected 
from MCMV-infected eyes of healthy mice, MAIDS-4 mice, and MAIDS-10 mice that were 
used above to generate data using the commercially available murine immunology gene panel. 
Genes associated with apoptosis were excluded from this custom panel because we have already 
determined previously and with confidence, using mice with MAIDS deficient in key apoptosis-
associated genes, that this programmed cell death pathway contributes only minimally to the 
pathogenesis of MAIDS-related MCMV retinitis.  
A summary of the upregulation or downregulation for each of the 14 immune response 
genes within MCMV-infected eyes of each animal group at 3, 6, and 10 days after intraocular 
MCMV inoculation, their overall positive (upregulated) or negative (downregulated) fold-change 
at peak expression, and their p values when compared with mock-infected eyes is shown in Table 
5.4, Table 5.5, and Table 5.6 for healthy mice, MAIDS-4 mice, and MAIDS-10 mice 
respectively. Due to the relatively small size of 14 genes being analyzed in this experiment, a 
two-fold-change in gene activity was not used to exclude some genes for analysis as was done 
for the 561 immune response genes analyzed above. The MCMV-infected eyes of healthy mice 
absolutely resistant to the development of MCMV retinitis exhibited a pattern of cell death 
pathway-associated gene activity that suggested significant quiescence of activity for each 
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pathway at all days post-infection examined. In fact, downregulation of gene activity was 
consistently observed for all 3 necroptosis genes and all 6 pyroptosis and associated 
inflammasome genes at 3, 6, and 10 days post-infection. Gene activities for autopathy and 
parthanatos were also found to be either downregulated or only minimally upregulated (< 2-fold 
increase) within MCMV-infected eyes of healthy mice at all days post-infection examined. As 
MCMV-infected eyes of animals at different stages of MAIDS development became more 
susceptible to the development of retinal disease, however, genes associated with some but not 
all cell death pathways under investigation became increasingly active. This was apparent within 
the MCMV-infected eyes of MAIDS-4 mice and MAIDS-10 mice for necroptosis and pyroptosis 
and pyroptosis-associated inflammasomes but not for autophagy and parthanatos. 
Table 5.4: RNA expression of MCMV-infected eyes of healthy mice for genes on a custom 
NanoString panel. 
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Table 5.5: RNA expression of MCMV-infected eyes of MAIDS-4 mice for genes on a custom 
NanoString panel. 
 
Table 5.6: RNA expression of MCMV-infected eyes of MAIDS-10 mice for genes on a custom 
NanoString panel. 
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6 DISCUSSION AND CONCLUSION 
6.1 Specific Aim 1: Pyroptosis and Inflammasome Expression during MCMV Infection 
Specific Aim 1: Test the Hypothesis that Pyroptosis and Associated Inflammasomes 
are Stimulated by MCMV during Immunosuppression, Contributing to the Onset and 
Development of MCMV Retinitis 
Our finding that GSDMD was upregulated in MCMV-infected eyes of MAIDS-10 but 
not MAIDS-4 mice provides further evidence of a role for pyroptosis in MAIDS-related MCMV 
retinitis. Therefore, we want to determine the role that pyroptosis-related genes and associated 
inflammasomes have on the development of full-thickness retinal necrosis by inducing MAIDS 
in mice devoid of one of these molecules and determining the affect ocular MCMV infection has 
on retinitis development. Further evidence for the involvement of this pathway in the 
development was assessed by inducing MCMV retinitis in another model of immunosuppression 
and checking for the stimulation of these pyroptosis-related molecules and associated 
inflammasomes.  
6.1.1 GSDMD and Caspase-11 Expression Following MCMV Infection in MAIDS-4 
Mice 
Whereas mRNA levels of caspase-1, IL-1β, and IL-18 were not previously shown to be 
stimulated in the MCMV-infected eyes of MAIDS-4 mice, the mRNA for both GSDMD and 
caspase-11 showed similar levels of stimulation in MCMV-infected eyes of MAIDS-4 mice as in 
MAIDS-10 mice when compared to their relative mock infected control eyes. Despite being 
considered part of the noncanonical pathway, caspase-11 is like caspase-1 in its ability to cleave 
and activate GSDMD. Therefore, it is not surprising that a consistent pattern of GSDMD mRNA 
upregulation throughout the course of viral infection in both MAIDS-4 and MAIDS-10 mice 
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mirrors that seen for caspase-11. While the increase in expression of both caspase-11 and 
GSDMD at MAIDS-4 suggests the activation of the noncanonical pathway of pyroptosis, 
MAIDS-4 mice are resistant to retinitis, and it appears that only with the stimulation of the 
canonical pathway during MAIDS-10 is there resulting retinal damage. This could be attributed 
to caspase-11 being unable to directly cleave IL-1β and IL-18 [267], thereby preventing the 
release of the active forms of these cytokines, which may be the driving force behind retinal 
necrosis. Therefore, the role caspase-11, and its cleavage of GSDMD independent of 
inflammasomes, plays prior to the onset of retinitis remains to be explored.  
6.1.2 The Loss of the Pyroptosis Pathway and MAIDS-related MCMV Retinitis 
Inflammasomes and their downstream effector, pyroptosis, are increasingly becoming a topic 
of interest in ocular disease. Pyroptosis was first described as an alternative cell death pathway 
involving inflammation [143], a feature that distinguishes it entirely from apoptosis (reviewed in 
[314]). For this reason, inflammasome driven pyroptosis [315] and its implication in various 
diseases are of interest. Of note are the recent discoveries centered on the extent to which 
inflammasomes and/or pyroptosis play a role in several ocular disorders. AMD is a sight-
threatening, progressive disorder of the retina that specifically targets and damages the macula, 
the part of the retina responsible for sharp, central vision. Recently, elevated levels of the NLRP3 
inflammasome, IL-1β, and IL-18 expression were found in AMD macular lesions [208]. The 
destructive effects of AMD can also be seen by resultant RPE thinning or depigmentation, which 
can lead to RPE atrophy and death of photoreceptors. The NLRP3 inflammasome was found to 
be upregulated in the RPE during the pathogenesis of advanced AMD following RPE atrophy 
[209]. Inhibition of the NLRP3 inflammasome components prevented RPE degeneration in a 
model of AMD [210], providing evidence for NLRP3 driven pyroptosis in the pathophysiology 
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of AMD. Analysis of photoreceptor cell death in a model of retinal degeneration showed the 
upregulation of NLRP3, caspase-1, IL-1β, and IL-18 in cone photoreceptors but not rod 
photoreceptors [211], suggesting that the overall induction of pyroptosis in the retina may be 
unique to specific cell populations, or influenced by the mechanism leading to cell death. As 
AIDS-related HCMV-retinitis is also associated with retinal destruction and RPE pathology, it is 
not surprising that pyroptosis-related molecules, caspase-1, IL-1β, and IL-18, along with several 
inflammasomes, were previously shown to be stimulated in our mouse model of experimental 
MAIDS-related MCMV retinitis.  
The pyroptosis pathway and several inflammasomes have a profound impact on the 
development of full-thickness retinal necrosis in MCMV-infected eyes of MAIDS mice. 
Herein we provide new information showing that pyroptosis and associated inflammasomes 
indeed play a prominent role in the progression of classic cytomegalovirus retinitis during 
retrovirus-induced immunosuppression. Our findings provide new evidence: (i) whereas a 
deficiency in the canonical pyroptosis pathway during MAIDS does not result in a reduction in 
the amount of infectious virus produced within MCMV-infected eyes when compared with 
MCMV-infected eyes of wildtype MAIDS animals, the frequency of full-thickness retinal 
necrosis is significantly reduced to zero within MCMV-infected eyes of pyroptosis-deficient 
mice with MAIDS when compared with a frequency of 100% within MCMV-infected eyes of 
wildtype MAIDS mice (ii) a deficiency in several inflammasomes result in a significant 
reduction in the amount of infectious MCMV produced in infected eyes when compared to 
wildtype MAIDS mice, but this value is still substantially higher than seen in MCMV-infected 
eyes of healthy mice; and (iii) the retinas of MCMV-infected eyes of pyroptosis-deficient and 
inflammasome-deficient mice with MAIDS consistently exhibit abnormal histopathologic 
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features characterized by RPE proliferation but with relative preservation of the neurosensory 
retina regardless of which pyroptosis-associated gene of the canonical pyroptosis pathway is 
compromised.  
It is important to note that IL-1R1KO micewere used for this study instead of mice deficient 
in IL-1β, as these mice are not commercially available from the vendor used for all previous and 
concurrent studies. IL-1R1 is a cytokine receptor that binds IL-1 which then initiates intracellular 
signal transduction resulting in the activation of inflammatory mediators [316]. Although mice 
lacking the IL-1R1 gene are still capable of producing IL-1β, the receptor is imperative for the 
biological actions of IL-1β do not respond to the IL-1β produced [317]. 
The RPE is the likely the source for the high amounts of infectious virus. Because 
MCMV-infected eyes of all animal groups with MAIDS that were deficient in different genes of 
the pyroptosis pathway or inflammasomes consistently showed prominent RPE proliferation but 
without destruction of the neurosensory retina, we postulate that the source for the high amounts 
of infectious virus production observed within MCMV-infected eyes of KO mice with MAIDS 
was the RPE rather than cells comprising the neurosensory retina. Whereas virus-induced 
nuclear inclusions indicative of productive MCMV replication were observed within the RPE of 
MCMV-infected eyes of KO mice with MAIDS, virus-induced inclusions were not observed 
within the relatively intact neurosensory retinas of these animals. The neurosensory retina was 
also devoid of cytomegalic cells that are often prominent within the full-thickness retinal 
necrosis of MCMV-infected eyes of wildtype MAIDS mice. This support the notion that the RPE 
are initially infected with virus that originates from the blood and supports rounds of virus 
replication subsequent to the infection of cells of the neurosensory retina and ultimate 
development of full-thickness retinal necrosis.  
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The retinal architecture of all KO mice is like that seen in MAIDS-4 mice. Consistent 
with other studies that shows a neuroprotective role [318-320] or ocular preservation [243, 246, 
252] effects when inhibiting inflammasomes during the course of disease, MAIDS mice deficient 
in the NLRP3 and the NLRP1b inflammasomes showed a remarkable reduction in the frequency 
of retinitis, albeit there was still evidence of RPE proliferation and retinal folding. The same 
resulting architecture was consistent with that seen in all other KO mice utilized throughout this 
study. It is interesting to note that that loss of the pyroptosis pathway within the MCMV-infected 
eyes of MAIDS-10 mice converted the pattern of retinal disease to that already observed for 
MCMV-infected eyes of MAIDS-4 mice. This intriguing observation suggests that pyroptosis is 
indeed essential for the development of full-thickness retinal necrosis in mice with MAIDS, and, 
more importantly, suggests that pyroptosis as a key contributor to the pathogenesis of MAIDS-
related MCMV retinitis becomes operative later than four weeks after retrovirus infection during 
the evolution of MAIDS. It is noteworthy that this would be at a time after a shift in cytokine 
production from a Th1 profile to a Th2 profile that has been shown to commence at 3 to 4 weeks 
after retrovirus infection during MAIDS development. An identical Th1/Th2 shift in cytokine 
production has been identified in HIV-infected patients with AIDS. 
6.1.3 Ocular MCMV Infection during Corticosteroid-induced Immunosuppression 
The results of our study show that MCMV infection highly stimulates both mRNA and 
protein expression of pyroptosis-related molecules caspase-1, caspase-11, GSDMD, IL-1β, and 
IL-18, during experimental MCMV retinitis in both retinitis-susceptible MAIDS mice and mice 
with corticosteroid-induced immunosuppression. This stimulation correlates with the expression 
of several inflammasomes, NLRP3, NLRP1b, NLRC4, and AIM2 which is also significantly 
stimulated in both models of immunosuppression. The expression of these proteins in both 
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models of MCMV retinitis further implicates that these proteins are involved in the pathogenesis 
of MCMV retinitis. The stimulation of the pyroptosis pathway and associated inflammasomes 
would invoke large-scale inflammation to the MCMV infection, and this inflammatory response 
could attribute for the full-thickness retinal necrosis seen during MCMV retinitis.  
Although both the retroviral-induced immunosupression and the corticosteroid-induced 
immunosuppression render C57BL/6 mice susceptible to the development of MCMV retinitis, 
there are vast differences in the way the immunosuppression develops between these two 
models. MAIDS have a slow and progressive development, which goes through distinct phases 
of immune cell dysfunction over the course of several weeks. Corticosteroid-induced 
immunosuppression, however, results in a rapid, acute decline in the immune system, which 
develops over the course of several days and shows a difference in immune cell populations, 
particularly macrophages and cytokine response to infection [115, 116]. However, as both 
models of immunosuppression results in the development of MCMV retinitis, it is not surprising 
that the overall stimulation of these inflammatory molecules are similar between corticosteroid-
induced immunosuppression and mice with MAIDS-10. These data provide further evidence that 
pyroptosis-related proteins and associated inflammasomes are involved in the onset and 
development of experimental MCMV retinitis in susceptible, immunologically suppressed mice.  
6.2 Specific Aim 2: Pyroptosis Expression Following MCMV Infection of Cells 
 
Specific Aim 2: Test the Hypothesis That MCMV Replication Directly Stimulates 
Pyroptosis In Infected Cells 
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6.2.1 Pyroptosis-Associated Expression Kinetics Following MCMV infection in IC-21 
or MEF Cells 
Pyroptosis-associated molecules are more highly expressed in MCMV-infected 
MEFs than in MCMV-infected IC-21 mouse macrophages. We characterized the expression 
of pyroptosis-related expression during either MCMV or HCMV infection in cell culture models. 
MCMV infection of IC-21 macrophages and MEF cells resulted in stimulation of several 
pyroptosis-associated mRNA transcripts. However, despite the early stimulation of caspase-1, 
GSDMD, and IL-1β of mRNA transcripts in both IC-21 mouse macrophages and MEFs, the 
level of stimulation was substantially higher in MEFs cell and stayed stimulated for a longer 
duration. Although, IL-18 mRNA in MEFs showed only a slightly significant stimulation of 
mRNA transcripts 1 hpi, protein for IL-18 showed robust expression at 6 hpi and 24 hpi 
suggesting that this pro-inflammatory cytokine is stimulated following MCMV-infection in this 
cell line. On the contrary, IL-18 mRNA expression was not stimulated following MCMV-
infection in IC-21 mouse macrophages and was in fact downregulated at later time-points post-
infection. Since IL-18 plays a role in the induction of inflammatory cytokines, TNF-α, IL-6, IL-
1β, in addition to being a chemoattractant for neutrophils [321] it is possible that this cytokine is 
being suppressed by MCMV as an attempt to control inflammation, or prevent destruction by 
neutrophils. As this downregulation is not seen following ocular MCMV in MAIDS-10 mice 
developing retinitis [6], it is possible this might be a response specific to macrophages as a 
means for MCMV to establish latency in these cell types. Further investigation needs to be done 
to determine which ocular cell types are directly undergoing pyroptosis following MCMV 
infection during the pathogenesis of MAIDS-related MCMV retinitis.  
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6.2.2 Pyroptosis-Associated Expression Following Infection with UV-inactivated 
MCMV in MEF cells 
The stimulation of pyroptosis by MCMV may be dependent on viral replication. The 
substantial reduction of pyroptosis-related mRNA and protein stimulation in MEFs infected with 
UVi-MCMV suggests that attachment, adsorption, and release of tegument proteins are not 
sufficient to stimulate this pathway in MCMV-infected MEFs. Therefore, this proposes that 
MCMV viral gene expression is necessary for triggering the expression of these mRNA 
transcripts and proteins. The temporal kinetics of MCMV viral replication has previously been 
characterized in fibroblasts. It has been determined that MCMV IE gene transcription occurs 
between 1-4 hpi in fibroblasts and is seen as early as 1 hpi in macrophages [32]. E genes for 
MCMV are detected at about 2 hpi and are seen until about 16 hpi in fibroblasts [33], the point in 
which MCMV L gene expression begins and can continue for at least 36 hours [30]. The 
transcription of these L genes encodes for most of the viral tegument and glycoproteins which 
are involved in capsid assembly, virion maturation, and egress from host cell. Any part of this 
stepwise viral gene expression and replication has the potential to invoke a response in the host 
cell that may provoke the induction of pyroptosis. Due to the timing of the mRNA production, it 
appears as though the induction of caspase-1 and IL-1β mRNA transcription is stimulated 
immediately following the start of IE transcription. This may mean that the transcription of 
GSDMD mRNA may result following the transcription of mRNA upstream in the pyroptosis 
pathway, or it may be that GSDMD mRNA production is directly stimulated by the transcription 
of viral E genes. Although no mRNA production of pyroptosis-associated molecules is seen as a 
response to infection with UVi-MCMV, there does appear to be slight expression of these 
proteins, especially at 24 hpi. Although this expression is nowhere near the level seen for 
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MCMV infected cells, it could indicate that the presence of foreign viral proteins responsible for 
either attachment, adsorption, or release from the tegument might stimulate the activation of 
proteins already expressed by the cell. However, without the stimulation of viral gene 
expression, there may not be enough danger signals detected by the cell to induce transcription of 
the mRNA transcripts responsible for carrying out pyroptosis.  
6.2.3 Pyroptosis-Associated Expression Kinetics Following HCMV Infection in 
ARPE-19 or MRC-5 Cells 
The lack of stimulation of pyroptosis in HCMV infected ARPE-19 cells may be 
dependent on the cell type. It was astonishing to observe that HCMV infection of APRE-did 
not result in the stimulation of mRNA transcripts associated with pyroptosis. RPE cells are 
polarized epithelial cells that reside between the retina and choroid and provide several functions 
necessary for the survival of the neurosensory retina. Some of these functions include 
transportating of nutrients to the retina, regulating homeostasis, scavenging free radicals and 
reactive oxygen species, and phagocytosis of the rod outer segments following normal circadian 
shedding [87]. Damage to the RPE could result in the pathogenesis of several retinal diseases, 
and since the viral proliferation of CMV has been found in the RPE layer in CMV retinitis, it is 
possible that damage caused by viral infection could lead to the retinitis developed in this model 
of ocular disease. The use of primary human RPE cultures are often used to study the RPE 
physiology in vitro [322], but this method does not come without limitations. First, primary RPE 
cells cultured from different donors may display genetic variability and physiological differences 
between donors. Additionally, it is possible that these cells may also lose their ability to 
differentiate within a few numbers of passages [323]. Another major disadvantage of primary 
RPE cells is the difficulty in obtaining human donors. For this reason, the use of an immortalized 
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cell line of RPE, ARPE-19 [324], has been widely used to study the physiology and 
characteristics of this tissue. The use of these cells is also not without limitations. A major 
concern is that ARPE-19 cells may not preserve the specialized characteristics and functions as 
those seen in RPE in vivo. Recently, an RNA-Seq analysis demonstrated that the transcriptome 
of ARPE-19 cells, appropriately cultured and with a low-passage number, closely resembles 
those of native human RPE. The study shows that the only differences seen in ARPE cells 
passaged for 4 months was an increase in genes related to RPE functions, such as visual cycle, 
phagocytosis, and pigmentation, while there was a decrease in genes regarding cell cycle and 
proliferation, as well as apoptosis [325]. Since pyroptosis shares a few characteristics with 
apoptosis, it is feasible that these ARPE-19 cells may also be losing gene transcription that 
would engage pyroptosis. However, without transcriptome analysis on signaling specific for 
pyroptosis comparing the cells at different passages, it would be hard to say for sure. Duplication 
of this study in primary RPE cells obtained from a suitable donor may also help determine if the 
results of this experiment are related to culture specifications.  
The lack of stimulation of pyroptosis in HCMV infected MRC-5 cells may be 
dependent on virologic replication. Regardless of the lack of stimulation of pyroptosis in 
ARPE-19 cells, it is rather interesting that infection of MRC-5 cells also did not result in the 
stimulation of pyroptosis-associated proteins. Contrary to these findings, one study did show that 
max expression of caspase-1 and IL-1β in CMV infected fibroblasts did show fold-changes over 
media control cells of 2.4 and 8.9, respectively. However, this study did not specify the kinetics 
of this stimulation, and therefore it cannot be said with certainty that this expression was during 
the time points investigated in this present study. Several studies have focused on HCMV’s 
ability to suppress the induction of cell death pathways as a means to prevent inhibition of their 
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replication. Recently, HCMV was shown to be able to block the induction of necroptosis [326]. 
Although no substantial evidence has demonstrated that HCMV is capable of inhibiting 
pyroptosis, one study did suggest that expression of the HCMV gene UL83 was able to reduce 
the expression of one inflammasome, AIM2, which has been shown to respond to CMV 
infection, and that this reduced expression inhibited the processing of IL-1β in HEK293T cells 
[327]. More work needs to be done to investigate if CMV is, in fact, capable of suppressing 
pyroptosis as a means to promote replication and to determine if this is preventing the 
stimulation of these mRNA transcripts in MRC-5 fibroblasts. 
6.3 Specific Aim 3: Additional Immunological Expression and MCMV Infection 
Specific Aim 3: Test the Hypothesis that Other Immune Response Genes or Pathways 
are Stimulated during the Pathogenesis of MAIDS-related MCMV Retinitis 
6.3.1 Expression of IFI204 during MAIDS-related MCMV Retinitis 
Inflammasomes are multiprotein complexes that are part of innate immunity and regulate 
caspase-dependent inflammation and cell death. Inflammasomes, specifically those belonging to 
the NLR subset, have widely been attributed to ocular diseases [227, 228, 236-238, 328]. The 
inflammasome-associated protein, IFI16, is a dsDNA sensing protein, and it is well known to be 
associated with human herpesviruses, all of which contain a dsDNA genome. HSV-1 has been 
shown to have reduced viral titers in the presence of IFI16 [260]. Additionally, the siRNA 
mediated knockdown of IFI16 has been shown to result in reactivation of EBV as well as the 
enhancement of HCMV replication, while overexpression of IFI16 resulted in decreased viral 
loads for both these herpesviruses [261]. Furthermore, the murine homology, IFI204, has also 
been shown to be associated with murine models of ocular herpes infection [265]. For this 
reason, it is not surprising that IFI204 is upregulated in MCMV-infected eyes of both MAIDS-4 
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and MAIDS-10 mice in response to the dsDNA genome of MCMV. As there appears to be no 
substantial difference between the stimulation and expression of IFI204 between MCMV-
infected eyes of MAIDS-4 mice resistant to retinitis and MAIDS-10 mice susceptible to retinitis, 
likely, IFI204 is merely responding to the MCMV infection and may not be contributing to the 
onset and progression of MAIDS-related MCMV retinitis, as might be the case with other 
previously investigated inflammasomes. 
6.3.2 Role of Autophagy during MAIDS-related MCMV Retinitis 
Autophagy is a well-conserved pathway that, under normal physiological conditions, 
regulates cellular homeostasis by eliminating damaged organelles and proteins. Autophagy can 
also serve adaptive mechanisms during cellular stresses, such as starvation, depletion of growth 
factor [329], and the removal of intracellular pathogens [329, 330]. Autophagy-related proteins 
are strongly expressed in several layers of the retinal— the ganglion cell layer, inner nuclear 
layer, outer nuclear layer—as well as the underlying RPE layer, which depend on autophagy 
mechanisms to maintain the structure and normal physiological function. Autophagy has been 
shown to play a protective role against diseases of the retina and RPE, and dysfunction of 
autophagy has been associated with several ocular disorders such as AMD and a model of 
photoreceptor degeneration in the rd/rd mouse during light-damage [331]. It can also be activated 
to prevent Fas-mediated apoptosis, as seen in the photoreceptors following retina-RPE separation 
[332]. As autophagy plays a role in the ocular clearance of several microorganisms such as T. 
gondii [333], Pseudomonas aeruginosa [334], and HSV-1 [335], we were interested in seeing the 
response of autophagy-related molecules to MCMV ocular infection. Interestingly, there only 
appeared to be stimulation of beclin-1 protein in MCMV-infected eyes of both MAIDS-4 and 
MAIDS-10 mice when compared to the uninfected control eyes. Controversially, beclin-1 
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mRNA, and LC3B protein expression were similar between infected and uninfected eyes of 
MAIDS-4 and MAIDS-10 mice, suggesting that autophagy is not induced upon ocular MCMV 
infection. Surprisingly, the protein levels of beclin-1, LC3B-I, and LC3B-II were all substantially 
higher in MAIDS-4 mice when compared to MAIDS-10 mice, which suggests that retrovirus-
induced immunosuppression impacts the expression of autophagy-associated proteins. This 
stimulation of autophagy markers within MCMV-infected eyes of MAIDS-4 mice resistant to 
retinitis suggests that autophagy may play a protective role that is mitigated during the 
development of MCMV retinitis in MAIDS-10 mice, which as shown, may contribute to the 
destruction seen from inflammation-related programmed cell death pathways, such as apoptosis 
and necroptosis. This is in agreement with other studies that suggest that autophagy protects 
against MCMV retinitis pathogenesis by preventing MCMV infection-induced apoptosis [336], 
as well as a study that shows that decrease autophagy levels were linked to increased RPE cell 
susceptibly to apoptosis in response to stress [267].  
6.3.3  Transcriptional Analysis of Immune Response Genes During during MAIDS-
related MCMV Infection 
Herein we confirmed and extended our understanding of some of the immunologic events 
that take place during the onset and development of cytomegalovirus retinitis in the unique 
setting of retrovirus-induced immunosuppression. Our findings show (i) the pathogenesis of 
retinal disease in MCMV-infected eyes of MAIDS-10 mice susceptible to full-thickness retinal 
necrosis development is associated with the robust upregulation and downregulation of an 
extensive number of immune response genes that operate in several distinct immune response 
pathways; (ii) the temporal development of MCMV retinitis within the eyes of MAIDS-10 mice 
is a dynamic process that involves the upregulation and downregulation of a number of immune 
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response genes at different times after intraocular MCMV infection; and (iii) the pattern of 
immune response gene activation differs remarkably within MCMV-infected eyes of healthy 
mice resistant to retinitis development when compared with MCMV-infected eyes of mice at 
different stages of MAIDS that exhibit a profound difference in their susceptibility to full-
thickness retinitis development. A more focused companion investigation also provided 
compelling evidence for the stimulation of the transcription of multiple genes associated with the 
necroptosis and pyroptosis programmed cell death pathways during the development MAIDS-
related MCMV retinitis. 
For our investigation of immune response gene expression during the pathogenesis of 
MAIDS-related MCMV retinitis, we used the NanoString nCounter assay, a recently developed 
platform capable of making without amplification a direct multiplexed measurement of gene 
expression within the ocular compartment following intraocular MCMV inoculation of mice for 
comparisons during immunocompetence and MAIDS. Although it is a powerful tool that allows 
for the quantification of the expression of hundreds of genes simultaneously and thereby provide 
a snapshot of gene activity at any one-time during disease pathogenesis, we initiated the 
investigation mindful of several limitations using this experimental approach. Firstly, the amount 
of data obtained after the performance of a single experiment is overwhelming and requires 
thoughtful use of statistical analysis to help provide meaningful conclusions. Secondly, 
subsequent performance of quantitative RT-PCR and/or western blot assays is essential to 
confirm the upregulation or downregulation of an individual gene under investigation. Thirdly, 
the data generated is highly descriptive without providing mechanistic insights into the function 
of an individual gene during a pathogenic event. Finally, it has not escaped our attention that the 
NanoString nCounter assay provides only fold-change differences in transcription activity that 
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may or may not be biologically significant during disease pathogenesis. The quantitative fold-
change activity of an individual gene may not be a true reflection of the unique kinetics of that 
particular gene’s mRNA and consequently its functional ability. For example, a two-fold 
increase in transcriptional activity may be biologically significant for one gene, but another gene 
may require a far greater transcriptional increase (and for a greater duration) to be biologically 
significant. 
Despite these limitations, the NanoString nCounter assay has proven to be a useful tool 
to point us quickly in new directions of investigation and thereby expand our knowledge base of 
those immune functions that contribute (or not contribute) to the onset of MCMV-induced retinal 
disease and progression to full-thickness necrosis during MAIDS. More importantly, however, 
use of the NanoString nCounter assay has given us the opportunity to validate previous findings 
by us and others on the role of various immune responses toward the pathogenesis of 
experimental MCMV retinitis during immunosuppression. Most of the findings presented herein 
are in good agreement with findings documented by us in past publications that have focused on 
various immune-mediated pathways and/or individual molecules associated with innate or 
adaptive immunity vis-a-vis the pathogenesis of MAIDS-related MCMV retinitis. These include 
roles for humoral immunity [337], cellular immunity [338, 339] suppressor of cytokine signaling 
(SOCS) pathways [126, 226], TNF-α [103], interferon-γ [103], and a number of proinflammatory 
cytokines associated with innate immunity  [6, 340] as summarized by us in a recent review 
[114]. The findings of the present investigation using a custom panel consisting of genes 
associated with necroptosis and pyroptosis as well as pyroptosis-related inflammasomes also 
confirm our previous reports that these programmed cell death pathways may be involved in the 
progression of MCMV retinitis during MAIDS when we used quantitative RT-PCR assays to 
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show significant intraocular upregulation of many mRNAs involved in the operation of these 
pathways [6].  
In summary, our experience using the NanoString nCounter assay to provide a novel 
transcriptional analysis of the 575 immune response genes within MCMV-infected eyes of mice 
at different stages of MAIDS development compared with MCMV-infected eyes of 
immunologically normal mice has provided new, and at times, unexpected information on the 
pathogenesis of MAIDS-related MCMV retinitis. By extension, our findings may also improve 
our understanding of the pathogenesis AIDS-related HCMV retinitis. While helpful in many 
ways, we have also identified areas of caution when using this powerful research tool. Future use 
of this technology by us will be directed toward the identification of host genes expressed by 
different cell populations of retinal tissues during the onset and progression of MAIDS-related 
MCMV retinitis. Moreover, because host RNA constitutes an overwhelming portion of the total 
RNA recovered from infected tissue samples when compared with pathogen RNA that usually 
comprises a vanishingly small portion of total RNA, this technology will also allow us to 
investigate with greater precision the pattern of mRNA synthesis for individual MCMV genes 
that are expressed within retinal tissues and retina-related cell populations during the course of 
disease development following intraocular MCMV infection of retrovirus-immunosuppressed 
mice. 
6.4 Future Direction  
Clinical inhibition of GSDMD with necrosulfonamide could further signify the 
contribution that the execution of pyroptosis has on the development of experimental 
MAIDS-related MCMV retinitis. Although mice with systemic knockdown of GSDMD have 
recently become available, the demand for these mice are still relatively low, and the duration of 
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time needed to breed and supply these mice can take several months. Additionally, while the use 
of these mice may demonstrate the necessity for the GSDMD for the development of MAIDS-
related MCMV retinitis, it does not directly translate to whether solely ocular inhibition of 
GSDMD, and not systemic treatment, will prevent further retinal damage in AIDS patients 
undergoing treatment for AIDS-related HCMV retinitis. Necrosulfonamide (NSA) has recently 
been identified as a direct chemical inhibitor of GSDMD to inhibit pyroptosis 
pharmacologically. Systemic administration of this drug was shown to be efficacious in a murine 
model of sepsis [341], suggesting the potential use of this drug to treat other inflammatory 
diseases, such as MAIDS-related MCMV retinitis. As many drugs are incapable of crossing the 
blood-retinal-barrier, it is uncertain if systemic administration of NSA will offer ocular 
protection against MCMV. Therefore, it would be necessary to establish the effectiveness of 
systemic or ocular administration of NSA and whether this would need to be given before 
MCMV infection. Determining the effectiveness of inhibiting GSDMD through NSA would help 
determine if this could be a pharmacological treatment for AIDS-related HCMV retinitis. 
6.5 Clinical Significance  
HCMV is an opportunistic infection in individuals with a CD4+ T-cell count below 50 
cells/µL and is, therefore, among the most frequent opportunistic infections in individuals with 
AIDS. AIDS patients are particularly susceptible to sight-threatening retinitis caused by HCMV 
directly infecting the retinal tissues. Factors that contribute to retinal tissue destruction are virus-
induced cytopathology, and inflammation mediated by neutrophils and activated macrophages. 
Before the availability of cART, 46% of patients with AIDS experienced vision loss and 
blindness caused by HCMV retinitis [69-71]. Although treatment with cART has lowered the 
number of new cases of HCMV retinitis, AIDS-related MCMV retinitis remains a significant 
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ophthalmological problem as access to cART is not readily available worldwide and several 
individuals who do have access fail to adhere or respond to treatment [71-73]. Although 
vaccination is one of the more effective methods for controlling problematic infectious diseases, 
attempts at creating an effective vaccine against HCMV have so far been unsuccessful [74, 75]. 
HCMV replication can generally be controlled by lifelong administration of antiviral drugs, such 
as ganciclovir, cidofovir, or foscarnet, yet these drugs may cause harmful side-effects, do not 
eradicate the virus, and merely slows the progression of ocular damage associated with HCMV 
infection [76-78]. Although the clinical features of AIDS-related HCMV retinitis are well 
established, the direct mechanisms by which the HCMV infection of the retina causes the severe 
retinal damage is still unknown. 
To investigate the mechanisms responsible for the onset and progression of the retinal 
damage seen during AIDS-related HCMV retinitis, our lab uses a clinically relevant mouse 
model of MAIDS-related MCMV retinitis. The MAIDS model is a suitable model for this study 
because species-specific retroviruses cause both MAIDS and AIDS, and mice with MAIDS share 
many immunopathologic features with AIDS patients. This includes a characteristic progressive 
development of chronic generalized lymphadenopathy, a polyclonal B-cell activation, and a shift 
in the levels of Th1 and Th2 CD4+ T-cells with an eventual diminishment in CD4+ T-cell and 
CD8+ T-cell counts and functions [112, 119, 121-123]. Retinitis susceptible MAIDS mice will 
then develop retinitis ten days post subretinal MCMV injection, exhibiting histopathological 
features similar to those seen in AIDS-related HCMV retinitis, which include full-thickness 
retinal necrosis, the presence of cytomegalic cells, and transition zones between areas of the 
normal and diseased retina [4, 125]. 
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By using this model, the work contributing to this study also contributed to the 
advancement of ocular research by furthering our fundamental understandings of the 
pathogenesis of AIDS-related HCMV retinitis, as well as the potential contribution to the 
stimulation of pyroptosis-associated proteins may have on the onset of retinal destruction in 
general. If pyroptosis does contribute to the pathogenesis of retinal destruction, prevention of this 
pathway may be a target to help improve the treatment and prevention of further damage to 
affected eyes and/or offer protection to the contralateral eye from undergoing vision loss. As 
several caspases may induce pyroptosis, a pan-caspase-inhibitor, if clinically available, may be 
offered as a locally administered treatment option. As other cell death pathways may be caspase-
dependent, this form of treatment could be a way to mitigate retinal destruction resulting from 
multiple cell death pathways. As the activation of GSDMD is ultimately responsible for the 
formation of pores in the cells and mass release of inflammatory cytokines, inhibition of 
GSDMD by ocular administration of necrosulfonamide, if proven effective, may be another form 
of treatment option to combat the retinal destruction seen with AIDS-related HCMV retinitis.  
6.6 Summary  
Specific Aim 1. The pyroptosis pathway and associated inflammasomes are stimulated 
within the ocular compartment of MCMV-infected eyes of retinitis susceptible MAIDS-10 mice. 
There is a marked reduction in the activity of the pyroptosis pathway and associated 
inflammasomes in MCMV-infected eyes of MAIDS-4 mice resistant to the development of full-
thickness retinal necrosis. The presence of viral inclusion bodies in the RPE but not the 
neurosensory retina of all KO MAIDS mice suggests that the RPE is the source of the high 
amounts of infectious virus in MCMV-infected eyes. The loss of the pyroptosis pathway and 
inflammasomes convert the pattern of retinal disease to that seen for MAIDS-4 mice. This 
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suggests that pyroptosis is essential for the development of full-thickness retinal necrosis in 
MAIDS mice, which becomes operative at least four weeks following retrovirus infection. The 
simulation of pyroptosis associated molecules and associated inflammasomes in MCMV-
infected eyes of mice immune suppressed with corticosteroids suggests that the pyroptosis 
pathway and associated inflammasomes play a role in the development of MCMV retinitis in 
different models of immunosuppressed mice. 
Specific Aim 2. In summary, pyroptosis-associated expression following MCMV 
infection of murine cells lines suggests that pyroptosis-associated molecules are stimulated 
directly by MCMV infection. The failure of UVi-MCMV to stimulate pyroptosis-associated 
molecules to the same extent as seen following MCMV infection suggests that this stimulation is 
largely independent of the attachment, adsorption, or release of viral tegument proteins. CMV 
stimulation of pyroptosis-associated mRNA is both species-specific and cell-type dependent 
Specific Aim 3. All in all, our additional results suggest that other inflammasomes, such 
as IFI204, stimulated following MCMV infection, but may not be directly responsible for the 
development of MCMV retinitis. However, the autophagy form of cell death does not appear to 
be playing a role in the pathogenesis of this disease. Transcriptional analysis revealed that 
MCMV-infected eyes of MAIDS-10 mice susceptible to full-thickness retinal necrosis 
development is associated with a robust upregulation and downregulation of an extensive 
number of immune response genes that operate in several distinct immune response pathways. 
The temporal development of MCMV retinitis within the eyes of MAIDS-10 mice is a dynamic 
process that involves the upregulation and downregulation of a number of immune response 
genes at different times after intraocular MCMV infection. The pattern of immune response gene 
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activation differs remarkably within MCMV-infected eyes of healthy mice resistant to retinitis 
development when compared with MCMV-infected eyes of mice at different stages of MAIDS 
6.7 Conclusions 
The pursuit of these specific aims was to test the central hypothesis that pyroptosis and 
associated inflammasomes contribute to the onset and progression of retinal damage during 
MAIDS-related MCMV retinitis. Several inflammasomes and pyroptosis-associated molecules 
have already been shown to be stimulated during MAIDS-related MCMV retinitis, and the 
stimulation of GSDMD during the pathogenesis of MAIDS-related MCMV retinitis further 
supports the notion that pyroptosis is stimulated during MCMV retinitis in susceptible mice. The 
absence of full-thickness retinal necrosis in mice deficient in pyroptosis-related or 
inflammasomes genes suggest the pyroptosis pathway and associated inflammasomes are 
essential for the onset and progression of MCMV retinitis in susceptible MAIDS-10 mice. The 
simulation of pyroptosis-associated molecules and associated inflammasomes in MCMV-
infected eyes of mice immune suppressed with corticosteroids suggests that the pyroptosis 
pathway and associated inflammasomes play a role in the development of MCMV retinitis in 
different models of immunosuppressed mice. The stimulation of the pyroptosis-associated 
molecules appears to be a direct result of infection by MCMV, and the magnitude of stimulation 
may be specific to the cell type infected. 
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